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ABSTRACT
PEPTIDE AND AMINE ACTIONS ON THE NEUROGENIC LIMULUS HEART: 
BIOCHEMICAL MECHANISMS OF MODULATION
by
James R. Groome 
University of New Hampshire, May, 1988
The biochemical basis underlying the chronotropic and inotropic 
effects of peptides and amines on the neurogenic heart of the horseshoe 
crab. Limulus polvphemus. was investigated. This study focused on the role 
of cyclic nucleotide and phosphatidylinostiol metabolism in specific actions 
of amines and peptides endogenous to the Limulus nervous system. 
Biochemical and electrophysiological analyses of amine and peptide actions 
on specific cellular targets within the neurogenic heart network were 
performed to characterize the intracellular mechanisms responsible for the 
excitatory effects of these neuromodulators.
Octopamine and the catecholamines dopamine, norepinephrine and 
epinephrine utilize the second messenger cyclic AMP at multiple cellular 
sites to increase the rate and strength of heart contractions. These amines 
increase burst rate in the cardiac ganglion by a cAMP-dependent mechanism. 
Amines also increase cardiac muscle contractility and enhance cardiac 
neuromuscular transmission by a cAMP-dependent process. Cyclic GMP does 
not appear to be involved in any of the excitatory actions of amines, 
although it may play a role in cardiac inhibition.
xi
Several proctolin-like and FMRFamide-like peptides are widely 
distributed in the Limulus CNS and may play a role in the regulation of 
cardiac output. The peptide proctolin utilizes the phosphatidylinositol 
second messenger system in its actions on cardiac muscle contractility and 
excitability. Dopamine may also activate this system, as this amine has 
several proctolin-like actions on Limulus cardiac muscle. Finally, the 
FMRFamide-like cardioexcitatory peptide limadrin, like the amines, appears 
to produce excitation of heart rate by increasing levels of cAMP in the 
Limulus cardiac ganglion. These results indicate that peptide and amine 
neuromodulators share several second messenger systems to produce their 
characteristic responses on the Limulus heartbeat.
INTRODUCTION
i. NEUROMODULATION
Animals possess neuronal circuitries which elicit particular 
responses in effector tissues under appropriate conditions. However, a 
nervous system which by necessity employed a separate neural circuit for 
every conceivable event, be it physiological or behavioral, would be 
needlessly complex and thus inefficient. Instead, these organisms produce 
subtle alterations in existing circuitries to cope with a continually 
changing environment and an equally dynamic set of internal physiological 
processes.
Modification of the basic properties of neurons is a process termed 
neuromodulation, and occurs as a consequence of hormonal and synaptic 
input. These neuromodulatory events are as crucial to the expression of 
behavior as is the existing circuitry itself (Kaczmarek and Levitan, 1987).
a. Neurohormonal communication
Neurosecretion of peptide and amine hormones is in many ways 
analagous to synaptic transmission. In both cases, a substance is released 
from a nerve terminal upon depolarization and binds to a specific receptor 
on a target cell membrane in order to elicit a particular response.
However, neurohormones are released not into the synaptic cleft but into 
the circulatory system. In this respect, neurosecretory cells act much like 
endocrine cells. Indeed, the endocrine and nervous systems are closely
related anatomically, functionally and even phylogenetically (reviewed by 
Roith et al., 1982 and Krieger and Liotta, 1979).
Neurohormones may travel long distances in the circulatory system to 
act on specific target tissues, or they may act on local targets not readily 
accessible to the circulation (Branton et al., 1978). Local release and 
action may prevent inadvertent stimulation of inappropriate tissues. 
Neurohormones released near their site of action may also facilitate the 
attainment of appropriate hormonal titer to overcome the effects of 
enzymes which quickly degrade hormones in the general circulation 
(Quistad et al., 1984; Previero et al., 1985).
Neurohormones and neurotransmitters influence ionic conductances in 
cell membranes. Many transmitters open or close ion channels for only the 
short period of receptor binding. Neurohormones, and some 
neurotransmitters, induce long-term conductance alteration by initiating 
intracellular biochemical events (usually enzyme activation and substrate 
phosphorylation) which persist after the termination of receptor-ligand 
interaction (reviewed by Greengard, 1976; Cohen, 1982; Levitan etal., 
1983a). These neuroregulators provide organisms with a means of 
communication appropriate for both short- and long-term events.
b. Neuromodulatory actions of amines and peptides
Amines and peptides have powerful influences on physiological and 
behavioral processes in animals. Investigations into amine and peptide 
actions in both inverterbrate and vertebrate systems have unequivocably 
demonstrated the importance of these compounds in physiological 
regulation (Barchas et al., 1979).
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Many types of physiological and behavioral phenomena are modulated 
by peptide and amine neurohormones and neurotransmitters. Peptides and 
amines may influence an organism's responsiveness to environmental 
stimuli, or modify efferent processes, by specific actions within the 
central nervous system and on peripheral targets. In addition, neuronal 
events crucial in the phenomena of learning and memory are also subject to 
peptidergic and aminergic influences.
Sensory processes in animals may be influenced by release of a 
particular neurohormone or transmitter. For example, photosensitivity of 
the lateral eye in the horseshoe crab, Limulus. is regulated by the activity 
of a circadian clock in the brain which controls efferent optic nerve 
activity (Barlow et al., 1980). Octopamine is present in and released from 
efferent optic nerves (Battelle et al., 1982). These workers have suggested 
that this amine modulates photoreceptor sensitivity, a critical 
physiological process in nocturnal behavior.
In many animals, simple behaviors are controlled by central pattern 
generators (CPG's) whose basic output is independent of sensory 
information. For example, locomotion in several species of lampreys is 
controlled by a CPG (Harris-Warrick and Cohen, 1985). The characteristic 
lamprey swimming program is induced by the classical transmitter 
glutamate. Serotonin, which has no effect on the swim CPG alone, 
modulates several parameters of the glutamate-induced motor program.
Investigations into the cellular basis of neuronal plasticity have 
focused on activity-dependent modulation of synapses. Synaptic efficacy 
in a variety of invertebrate and vertebrate systems may be modulated by 
the amount of stimulation a synapse receives (Bliss and Lomo, 1973;
Weight and Erulkar, 1976; Hawkins et al., 1983; McNaughton, 1983). Thus, a
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given stimulus may produce a strong postsynaptic response after repetitive 
input, even though the same stimulus was ineffective under conditions of 
infrequent input. As detailed in the next section, neurohormones have 
pronounced influences on synaptic efficacy in both vertebrate and 
invertebrate organisms.
Amines
Biogenic amines are widely distributed in the nervous systems of 
both vertebrate (Peroutka et al., 1981; Seeman and Grigoriadis, 1987) and 
invertebrate (Walker and Kerkut, 1978; Laxmyr, 1984; Orchard etal., 1986) 
animals. Amines serve an important role as neuromodulators of neuronal 
and effector tissue properties in these organisms (reviewed by Barchas et 
al., 1979).
Amine enhancement of synaptic efficacy is well documented in 
vertebrates. In sympathetic ganglia of the bullfrog, long term potentiation 
(LTP) of synaptic efficacy may be brought about with increased synaptic 
input (Koyano et al., 1985). However, adrenergic agents also contribute to 
LTP (Kumamoto and Kuba, 1986). Catecholamines appear to play a similar 
role in the mammalian hippocampus (Bliss et al., 1983; Hopkins and 
Johnston, 1984). Release of endogenous amines during repetitive 
stimulation of hippocampal neurons has been postulated as an important 
contributor to the development of LTP. Amine-induced enhancement of 
synaptic responses has been demonstrated for a number of other vertebrate 
neuronal and neuromuscular systems (Ashe and Libet, 1981; Bergman et al., 
1981; llles, 1986).
Amines have potent influences on the cardiovascular system of
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vertebrates. Adrenergic excitation of heart contraction rate and strength 
has been documented in all major vertebrate groups (Benfey, 1980; 
Peyraud-Waitzenegger et al., 1980; Earm et al., 1983; Macey et al., 1984). 
Catecholamines bind with alpha- and beta-adrenergic receptors to produce 
these chronotropic and inotropic actions (Tsien, 1977; Benfey, 1980). 
Activation of amine receptors also regulates contraction and relaxation in 
vertebrate smooth muscle (Jones et al., 1984; Kitazawa et al., 1986).
In invertebrates, amines have been implicated as modulators of well 
characterized, stereotyped behaviors. For example, in the marine mollusc 
Aplvsia. a particular reflex involving the withdrawal of the gill and siphon 
upon touch is modified by simple non-associative learning (Kandel and 
Schwartz, 1982). The synaptic events underlying sensitization, or 
strengthening, of this reflex resemble those observed during LTP in 
vertebrates. In Aplysia. sensitization of gill withdrawal occurs due to 
increased transmitter released from active siphon sensory neurons (these 
cells synapse with gill motor neurons in the abdominal ganglion). 
Modulation of transmitter release is effected by the action of serotonin to 
close K+ channels (and thus broaden presynaptic action potentials) in 
terminals of the sensory neurons (Kandel and Schwartz, 1982; Hochner et 
al., 1986). Habituation, or decrement, of this response is inhibited by 
dopaminergic modulation of gill muscle contractions (Swann et al., 1982; 
Ruben and Lukowiak, 1983). These amines act to enhance the overall 
sensitivity of gill withdrawal by modulatory actions on separate elements 
of the system.
Central pattern generators of behavior in invertebrates appear to 
receive considerable modulatory input from biogenic amines. Amines have 
been shown to have significant effects on neural mechanisms underlying
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such patterned activities as feeding (Wieland and Gelperin, 1983; Trimble 
and Barker, 1984) and flight (Bailey et al., 1983; Sombati and Hoyle, 1984; 
Classen and Kammer, 1986). Serotonin has a profound effect on the pattern 
generating network for locomotion in the leech Hirudo (Willard, 1981). 
Leeches will swim towards a disturbance in the water when hungry; 
serotonin enhances both the sensitivity of movement receptors and the 
probability that the animal will swim (Kristan and Weeks, 1983;
Brodfueher and Friesen, 1984). Serotonin also initiates and organizes 
feeding behavior in the leech (Lent and Dickinson, 1984). Modulation of an 
existing neuronal circuit by this amine produces several coordinated and 
appropriate behaviors for this organism under these conditions.
Peptides
Like the amines, neuropeptides are important regulators of neuronal 
and effector cell properties. Many peptides were first discovered in the 
vertebrate gastrointestinal tract, where they have varied and pronounced 
effects on gut motility and glandular secretion (Brown and Miller, 1982; 
Dockray, 1982; Fox et al., 1983; Bartho' and Holzer,1985). Many of these 
peptides (and others) are also present in the vertebrate nervous system 
(reviewed by Kriegerand Liotta, 1979).
Studies on the neuronal regulation of peptide hormone secretion in 
vertebrates have focused on the hypothalamic-pituitary axis. A variety of 
approaches such as brain-slice electrophysiology and recombinant DNA 
techniques have been employed to investigate the influence of peptide 
release on homeostatic and behavioral regulation (Dudek et al., 1982; Loh et 
al., 1982; Negro-Vilar, 1982; Tuomisto and Mannisto, 1985).
6
Many of the peptides found in the pituitary also function within the 
CNS as neurotransmitters and neurohormones (reviewed by Krieger and 
Liotta, 1979 and Snyder, 1980). Peptides of the vertebrate CNS are 
involved in such diverse processes as cardiovascular control (Cowley et al., 
1983), water balance (Lind and Johnson, 1982; Woods and Johnston, 1983), 
arousal and learning (O'Donohue and Dorsa, 1982), sensory perception 
(Iverson, 1982), hibernation (Muchlinski et al., 1983) and circadian rhythms 
(Albers et al., 1984).
Behavioral regulation may be influenced by opposing effects of 
peptides. For example, cholecystokinin promotes ingestive satiety in 
mammals, while peptides of the opiate family (enkephalins, endorphins and 
dynorphin) are stimulants to feeding behavior (reviewed by Baile et al.,
1986).
Many peptides of the vertebrate gut and CNS are also found in 
invertebrate animals (reviewed by Haynes, 1980 and Greenberg and Price, 
1983). Molluscan and arthropod species have been utilized extensively in 
isolation and physiological characterization of invertebrate neuropeptides. 
Peptides have numerous physiological roles in these animals, including 
modulation of stereotyped behavior patterns.
Several molluscan cardioactive peptides, in addition to their actions 
on the molluscan heart (Greenberg and Price, 1980; Lloyd, 1980; Painter and 
Greenberg, 1982; Boyd et al., 1984), have profound effects on non-cardiac 
muscle and neuronal excitability in a number of molluscs (reviewed by 
Lloyd, 1982 and Greenberg et al., 1983). For example, FMRFamide or related 
peptides act as neurohormones on molluscan smooth muscle (Greenberg and 
Price, 1980) and may act as a transmitter of an identified motor neuron of 
the cerebral ganglion of Helix (Cottrell et al., 1983).
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The molluscan small cardioactive peptides (SCP's) and FMRFamide 
have opposite actions in some systems. In the prosobranch Rapana. SCPB
has a negative chronotropic effect on the heart (Kobayashi and Muneoka, 
1986), while FMRFamide excites heart rate. In Helisoma buccal ganglion 
neurons, FMRFamide inhibits (but SCPB excites) ongoing activity (Coates
and Bulloch, 1985).
The arthropod neuropeptide proctolin was first isolated from the 
cockroach Periplaneta (Brown and Starratt, 1975). Proctolin-like peptides 
have subsequently been found in many species of insects (Brown, 1977; 
Bishop etal., 1981) and crustaceans (Kingan and Titmus, 1983; Schwarz, 
1983). Proctolin has potent cardioexcitatory actions in many arthropod 
species (Miller, 1979; Benson eta l., 1981; Miller and Sullivan, 1981) and 
modulates neuronal and neuromuscular excitability (Schwarz et al, 1980; 
Sullivan and Miller, 1984; Watson and Hoshi, 1985; Marder et al., 1986). 
Proctolin appears to act as a neurotransmitter in some systems (Adams and 
O'Shea, 1983; Witten and O'Shea, 1985; Bishop et al., 1987).
Peptides, like amines, regulate the expression of well-characterized 
behaviors in invertebrate animals. For example, ecdysis in certain species 
of moths is controlled by a CPG (Truman, 1978). The peptide eclosion 
hormone is present in the insect brain (Copenhauer and Truman, 1986) and 
is released prior to ecdysis to initiate the motor program for this behavior.
Obviously, amines and peptides have widespread and similar 
regulatory actions in invertebrate and vertebrate organisms. Not 
suprisingly, a number of investigations have demonstrated the coexistence 
of peptides and amines in certain neurons (reviewed by O'Donohue and 
Dorsa, 1982; Hokfelt et al., 1987). Investigations of dual (peptidergic and 
aminergic) modulation have addressed the question of coexistence in order
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to characterize a particular system (Hoffman et al., 1982; Jacobowitz and 
Olschowka, 1982; Palmer et al., 1983). Multitransmitter neurons may be 
the anatomical basis underlying the interaction of peptides and amines in 
these systems.
Other examples of aminergic and peptidergic modulation of 
physiological events and behavior in invertebrates are discussed in 
Sections iii and iv. The relatively simple nervous systems of these animals 
are amenable to detailed studies of the cellular and biochemical bases for 
peptidergic and aminergic actions. Investigations of fundamental 
regulatory events shared by virtually all animals, such as the biochemical 
events underlying the cellular actions of hormones, have been facilitated by 
the variety of approaches possible with simple systems.
ii. MOLECULAR MECHANISMS
a. Intracellular signalling
Neurohormones or neurotransmitters elicit specific cellular 
responses by various biochemical processes, or mechanisms. Many 
neurotransmitters elicit a brief change in cell membrane potential by 
producing a conformational change in the ion channel upon transmitter - 
receptor interaction. More complex mechanisms, such as the intracellular 
synthesis of second messengers, are required to explain neurohormonal 
actions, and even some actions of transmitters. For example, in vertebrate 
sympathetic ganglia, certain transmitters elicit slow hyperpolarizing or 
depolarizing potentials which may involve the production of cAMP or cGMP 
(Weight et al., 1974; Briggs et al., 1982; Kobayashi, 1982).
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Several basic signalling processes are common to second messenger 
systems. For example, signal transduction, protein kinase activation and 
substrate phosphorylation are phenomena generally associated with the 
actions of peptide and amine neurohormones. These events result in 
particular cellular responses to external stimulation by the "first 
messenger".
Signal transduction
The target site for peptides and amines is generally a cell-surface 
receptor whose configuration dictates selective recognition of a particular 
first messenger. However, multiple receptor types for a given 
neurohormone or neurotransmitter exist, and these receptors activate 
different intracellular processes (for example, dopamine D1 and D2
receptors, reviewed by Seeman and Grigoriadis, 1987). Furthermore, one 
ligand may compete for the binding site of a particular receptor with other 
compounds of similar molecular structure.
In spite of these complexites, it has been possible to determine the 
sequence of events underlying signal transduction of first messenger 
activation of a number of receptors. One particularly well-characterized 
receptor is the beta-adrenergic receptor, which has a high binding affinity 
for catecholamines. Ligand binding is followed by G protein (guanine 
nucleotide-binding protein) activation of the membrane-bound enzyme 
adenylate cyclase (Aurbach,1982; Cerione et al., 1983; Schramm and 
Selinger, 1984). The first messenger signal, in this case, is transduced 
into the second messenger cyclic AMP by the active cyclase moiety.
A number of G protein types have been described, including G„ and G;
b  I
1 0
(stimulatory and inhibitory regulation of adenylate cyclase; reviewed by 
Schramm and Selinger, 1984 and Gilman, 1984), transducin (a G protein 
regulating cGMP phosphodiesterase in the vertebrate eye, Stryer, 1983) and 
GQ (unknown function, Homburger et al., 1987). These proteins consist of
several subunits, which in some cases appear to directly couple receptor 
binding to the conductance state of ion channels without second messenger 
involvement (Codina et al., 1987; Heschler et al., 1987; Logothetis, 1987).
Intracellular actions of second messengers
Increased production of second messenger molecules in response to an 
external first messenger signal acts as a biochemical signal, initiating a 
series of enzyme reactions. In general, second messengers bind to the 
regulatory subunit of a protein kinase, resulting in activation of the 
catalytic subunit of the kinase (reviewed by Levitan et al, 1983a). In a few 
cases, second messengers have been shown to have direct, presumably 
non-kinase mediated effects (reviewed by Huganir, 1987). More typically, 
the activated protein kinase phosphorylates cellular substrates (e. g. the 
sarcoplasmic reticulum, ion channels, other regulatory enzymes, etc.), 
completing the cellular response to external stimulation (Cohen, 1982;
Tada and Katz, 1982; Nestler and Greengard, 1983).
Cellular activities involving second messengers, unlike typical 
synaptic responses of a few milliseconds, are generally longer-lasting 
phenomena. Not only must ligand-receptor interaction be terminated, but 
the intracellular processes described above must be reversed before 
cessation of the cellular response to the original first messenger signal. 
Substrate phosphorylation may be considered as one biochemical basis for
long-term cellular regulation.
b. Categories of second messengers
The diversity of cellular responses to external stimulation is in large 
part a consequence of the variety of second messenger systems activated 
by the interaction of a first messenger with a specific receptor (Fig. 1). In 
other words, two neurohormones may exert completely different effects 
because they act via separate second messengers. Cyclic nucleotides, 
membrane phospholipids, and calcium are three general second messenger 
systems for which the biochemical events following first messenger 
stimulation have been worked out in some detail (Huganir, 1987). Protein 
kinase activation and substrate phosphorylation appear to be the general 
processes by which these second messengers mediate regulation of cellular 
activity.
Cyclic AMP
The first demonstration that cyclic nucleotides are involved in the 
intracellular mechanism underlying hormonal action came from the work 
of Sutherland and his colleagues on epinephrine-induced glycogenolysis in 
rat liver (for review see Robison et al., 1971). These investigators found 
that increased synthesis of cyclic adenosine 3'-5’-monophosphate (cAMP) 
by the membrane-bound enzyme adenylate cyclase was correlated with the 
action of epinephrine in this system. They proposed that the effects of 
epinephrine in rat liver tissue were a result of second messenger (cAMP) 
production. The discovery of a cAMP-dependent protein kinase (Walsh et
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Fig. 1. Cyclic AMP and phosphaditidylinostiol second messenger systems. In both systems, a 
hormone or transmitter binds to a membrane-bound receptor. G proteins translate the external 
signal by activation (or inhibition) of enzymes catalyzing the formation of second messenger 
molecules. These messengers may have effects of their own, but in general they activate protein 
kinases. A series of kinase-promoted phosphorylations culminates in an overt cellular response 
(e. g. the opening or closing of a  particular channel in the cell membrane). Other second 
messenger systems, such as the cGMP and Ca++ / calmodulin systems, also exhibit these basic 
regulatory phenomena (receptor activation, protein kinase activation, phosphorylation, etc.). 
Abbreviations: AC, adenylate cyclase; 5’ AMP, adenosine 5 ’ monophosphate; ATP; adenosine 
triphosphate; cAMP, cyclic 3 ’-5' monophoshate; DAG. diacylglycerol; G; guanine nucleotide 
binding protein; H ,T (hormone, or transmitter); 1C, ion channel; IP3, inositol 1,4,5
triphosphate; IP4, inositol 1,3,4,5 tetrakisphosphate; ORG, intracellular organelle (e. g. the
sarcoplasmic reticulum); PDE, cyclic nucleotide-dependent phosphodiesterase; PIP2.
phosphatidyl inositol 4,5 bisphosphate; PKA, protein kinase A (cAMP-dependent protein kinase); 
PKC, protein kinase C (calcium /  phospholipid-dependent protein kinase); PLC, phospholipase C; 
R, cell-surface receptor.
al., 1968) led to the conclusion that this enzyme (protein kinase A), via its 
phosphorylating actions, was the general effector of cAMP (Kuo and 
Greengard, 1969; Greengard, 1978).
Since the initial discovery of the cAMP mechanism, many studies have 
indicated that cAMP is involved in cellular stimulation. A cAMP-dependent 
mechanism has been demonstrated for many of the actions of amines in the 
vertebrate brain (Williams and Rodnight, 1977; Kebabian and Caine 1979; 
Nestler and Greengard, 1983) and periphery (Cerione et al., 1983; Kranias 
and Solaro, 1983). Many peptides also utilize cAMP as a second messenger 
in central (Etgen and Browning, 1983) and peripheral (Aurbach, 1982) 
actions. Cyclic AMP is involved in neuroregulatory actions of both amines 
and peptides in invertebrate organisms as well. In section iii of this 
introduction, a general review of cyclic nucleotide involvement in 
aminergic and peptidergic actions in invertebrates is presented.
Amines and peptides may activate or inhibit the production of cAMP 
to elicit cellular responses. For example, in many brain regions, dopamine 
increases cAMP by activating D1 receptors (Kelly and Nahorski, 1987;
Seeman and Grigoriadis, 1987). However, dopamine also activates D2
receptors, resulting in adenylate cyclase inhibition (Stoof and Kebabian,
1983; Cooper et al., 1986). Catecholamines act on cardiac and smooth 
muscle beta-adrenergic receptors positively linked to the cyclase enzyme 
(Cerione et al., 1983), but catecholamines can also inhibit cAMP production 
in neurons and other cells by activating certain alpha-adrenergic receptors 
(reviewed by Jakobs et al., 1981). Finally, many of the effects of opioid 
peptides occur as a result of inhibited cAMP synthesis (reviewed by 
O'Donohueand Dorsa, 1982).
This widespread involvement of cAMP in aminergic and peptidergic
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regulation points out the possibility that amine and peptide interactions 
may occur via utilization of a common second messenger system. For 
example, in the rat locus ceruleus, inhibition of adenylate cyclase is 
observed with the activation of either opiate or alpha2-adrenergic
receptors (Andrade and Aghajanian, 1985). The activity of certain 
enzymes, such as tyrosine hydroxylase (critical in the synthesis of 
catecholamines), is regulated in the rat superior cervical ganglion by 
peptide activation of the cAMP system (Ip et al., 1985). Interestingly, the 
activity of tyrosine hydroxylase may also be regulated by activation of the 
cGMP (Roskoski et al., 1987) and phosphatidylinositol (Albert et al., 1984) 
systems.
Cyclic GMP
Cyclic guanosine 3’-5’-monophosphate (cGMP), like cAMP, also acts as 
an intracellular second messenger. Cyclic GMP-dependent protein kinase 
activation and phosphorylation have been demonstrated in nervous and other 
tissues (Kuo and Greengard, 1970; Nairn and Greengard, 1983; Roskoski et 
al., 1987). However, several facts have hindered investigations into the 
messenger role of this molecule. First, cGMP levels within cells are very 
low. The discovery of cGMP and a reliable assay for its detection were 
developed only after cAMP had been established as a second messenger 
(Murad et al., 1979). Second, guanylate cyclase exists in both soluble and 
particulate forms, and assays or pharmacological activation of this enzyme 
have proven substantially more difficult than for adenylate cyclase 
(Garbers and Radany, 1981).
Nevertheless, a number of investigations have indicated that cGMP
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does have a second messenger role in at least some systems. For example, 
there is good evidence indicating that cGMP acts as an intracellular signal 
in visual transduction (Polans et al., 1981; Zimmerman et al., 1985; Cook et 
al., 1987). In the vertebrate retina, cGMP appears to bind directly to rod 
outer segments to close ion channels in response to illumination.
Cyclic GMP may also mediate some actions of neurohormones in 
bidirectional systems. In the vertebrate myocardium, contractility is 
decreased by acetylcholine. This action is correlated with both an increase 
in myocardial cGMP and a decrease in myocardial cAMP (Murad et al., 1979). 
Agonists of beta-adrenergic receptors, on the other hand, promote 
increased contractility, decreased myocardial cGMP and increased 
myocardial cAMP. Similar findings of opposing interactions of cAMP and 
cGMP in bidirectional systems have led to the proposal that these second 
messengers are universal antagonists regulating cellular function 
(Goldberg and Haddox, 1977). However, applicability of this hypothesis to 
other systems remains uncertain, especially with the relative paucity of 
studies which have demonstrated a particular function for cGMP as an 
intracellular signal.
Membrane phospholipids
Many studies have implicated the involvement of membrane 
phospholipids in central and peripheral actions of peptides and amines 
(Berridge and Irvine, 1984; Cotechia et al., 1985; Lynch et al, 1985; Cooper 
et al., 1987). Activation of surface receptors triggers the cleavage of 
phosphatidyl inositol 4,5 bisphosphate (PIP2) by a membrane-bound 
phospholipid diesterase (phospholipase C) into inositol 1,4,5 trisphosphate
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(IP3) and diacylglycerol (DAG), two second messengers of the
phosphatidylinositol (PI) system (Berridge, 1981, Fig. 1).
Diacylglycerol is an endogenous activator of calcium / phospholipid - 
dependent protein kinase (Berridge and Irvine, 1984). This enzyme (also 
termed protein kinase C) apparently is activated in the particulate form 
(Kraft and Anderson, 1983), a process dependent upon the calcium ion (May 
et al., 1985; Wolf et al., 1985). Protein kinase C, like the cyclic 
nucleotide-dependent protein kinases, may modify particular ionic 
conductances in the plasma membrane (reviewed by Kaczmarek, 1986 and 
Huganir, 1987). For example, the modulatory action of epinephrine on the 
voltage-dependent calcium channel in sensory neurons of the dorsal root 
ganglion appears to be a result of protein kinase C activation (Rane and 
Dunlap, 1986). Protein kinase C is also involved in the inhibition of 
calcium and potassium currents in cultured mouse neurons (Grega et al., 
1987; Werz and MacDonald, 1987). Protein kinase C phosphorylates a 
number of substrate proteins and may be involved in neurotransmitter and 
neurohormone release (Haimann et al., 1987; Nichols et al., 1987; Wang and 
Friedman, 1987).
Inositol trisphosphate elicits calcium release from internal stores 
(Streb et al., 1983; Somlyo et al., 1985; Nosek et al., 1986). Additionally,
IP3 may be converted to inositol 1,3,4,5 tetrakisphosphate (IP4), a second
messenger involved in promoting calcium influx (Batty et al., 1985).
Finally, the discovery of cyclic phosphoinositides, which apparently act 
like IP3 to release internal calcium (Wilson et al., 1985; Agranoff, 1986), 
has added even further complexity to our understanding of the PI system.
Both DAG and IP3 appear to be closely linked to calcium mobilization
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within cells. Further studies of neuromodulation in which the PI system 
plays a role are necessary to characterize the general intracellular events 
associated with PI signalling and its relationship to other second 
messenger systems.
Calcium
The calcium ion is an ubiquitous regulator of intracellular activity.
Cells maintain a low concentration of cytosolic calcium (approximately 
10-7 M) so that slight increases in calcium levels may serve as an 
effective intracellular signal (Kretsinger, 1979). Neurotransmitter and 
neurohormone release, ion channel conductance, muscular contraction, 
fertilization, enzyme activities and other cellular processes are regulated 
by the levels of cytosolic calcium (for reviews see Berridge, 1975,
Kretsinger, 1979 and Rasmussen and Barrett, 1984).
Calcium, like other second messengers, effects many of its 
intracellular actions by activation of specific protein kinases. Calcium 
binding proteins such as calmodulin are essential for calcium / kinase 
interaction (Cheung, 1980; Moore and Dedman, 1982). Calcium / calmodulin 
protein kinase is present in nervous tissues (Kennedy and Greengard, 1981; 
Nairn et al., 1985) and has been shown to influence pre- and post-synaptic 
phenomena (Kelley et al., 1984).
Second Messenger Interactions
The biochemical basis of neuromodulation does not consist solely of 
the aforementioned second messenger systems. Consideration must also be
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given to interactions between the various second messenger systems in 
order to understand the intracellular events ultimately responsible for 
cellular responses to external stimulation. The production (or the 
degradation) of one second messenger may rely on the relative 
concentrations of other messengers. Likewise, intracellular events 
responsible for a particular overt cellular response may be shared (or 
opposed) by "separate" second messenger systems.
The calcium ion interacts with both the cyclic nucleotide and PI 
second messenger systems. Calcium and calmodulin regulate adenylate 
cyclase in many systems by stimulating (Amiranoff et al., 1983; Ishikawa 
et al., 1985; Wright et al., 1986) or inhibiting (Brostrom et al., 1978;
Schmidt et al., 1982; Oldham et al., 1984) the activity of this enzyme. 
Calcium also regulates the activity of guanylate cyclase (Berridge, 1975; 
Snider et al., 1984; Ogura et al., 1986). This process also appears to 
involve phosphatidylinositides (Berridge and Irvine, 1984; Snider et al.,
1984). Calcium is also an important regulator of cyclic nucleotide 
phosphodiesterse and protein kinase activity (Wolff and Brostrom, 1974; 
Cheung, 1980; Koletsky et al., 1983).
Like the PI system, cyclic nucleotides may exert their cellular 
responses by eliciting intracellular calcium release or by regulation of 
calcium channels (Entman et a!., 1978; Cachelin et al., 1983; Sawada et al., 
1984; Curtis and Catterall, 1985). Calcium, therefore, may interact with 
cyclic nucleotide or PI metabolism at each point in the biochemical 
signalling process.
Second messenger interactions may also occur if two or more 
separate systems exert a common effect on a particular process, such as 
phosphorylation of specific proteins. Cyclic AMP-dependent protein kinase,
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for example, has been shown to phosphorylate many of the same proteins in 
the nervous system as Ca2+ / calmodulin- or Ca2+ / phospholipid-dependent 
protein kinases (Novak-Hofer and Levitan, 1983; Albert et al., 1984).
Cyclic nucleotides and phosphatidylinositides may co-regulate specific ion 
channels. For example, both cAMP, which activates protein kinase A, and 
phorbol esters, which activate protein kinase C, reduce the identical 
potassium conductance in mouse neurons (Grega et al., 1987). Similarly, 
both cGMP and phorbol esters increase a particular calcium current in Helix 
neurons (Paupardin-Tritsch et al., 1986).
It is also possible for a single second messenger to have multiple 
intracellular effects. Cyclic AMP has recently been shown to regulate the 
conductance state of as many as three separate ion channels in Aplvsia bag 
cells (Strong and Kaczmarek, 1986). In R15 of the Aplvsia abdominal 
ganglion, serotonin may excite or hyperpolarize the cell, since this amine 
may activate specific potassium, calcium and chloride currents by a 
cAMP-dependent mechanism (Lotshaw et al., 1986). Additionally, the bag 
cell peptide ELH also appears to increase calcium and potassium currents in 
this neuron by a cAMP-dependent mechanism (Levitan et al., 1987). 
Thererfore, second messenger interactions which occur during 
neuromodulatory actions of peptides and amines can be quite complex and 
intriguing.
iii. INVERTEBRATE MODEL SYSTEMS
a. Invertebrate nervous systems
Many invertebrate organisms possess nervous systems with numerous
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advantages to neurobiologists interested in studying the mechanisms 
underlying modulation of physiological and behavioral processes. In 
comparison to the vertebrate nervous system, the neural networks of 
invertebrates are simple, consisting of a relatively small number of 
neurons. This simplicity of organization has facilitated the determination 
of the precise neuronal circuitry responsible for the expression of specific 
behaviors. Furthermore, many of the neurons in invertebrates are large and 
identifiable. These properties have permitted the detailed investigation of 
electrophysiological, biochemical and genetic aspects of neural 
organization and neuromodulation.
Model Systems
Investigations into the neuronal basis of behavior in vertebrate 
organisms must contend with a highly complex CNS comprised of a vast 
number of neurons and their projections. Studies of basic neuronal 
mechanisms require simpler neural networks. For example, some 
neurobiologists utilize brain slice preparations or discrete ganglia in order 
to make possible a detailed study of the neuronal circuitry and 
neurochemistry of one particular system (Dudek et al., 1982; Kobayashi, 
1982; Dunwiddie et al, 1983). Other investigators have approached this 
problem by focusing their efforts on the relatively simple nervous systems 
of invertebrates. The study of neuroregulation in invertebrate organisms, 
in addition to its intrinsic value, is often directed towards achieving a 
greater understanding of similar processes in higher organisms 
(Maynard,1972; Kandel, 1976).
Discovery and investigation of the fundamental properties of neural
21
networks using simple invertebrate systems has contributed greatly in the 
advancement of neurobiology. For example, the ionic basis of the action 
potential, one of the most universal properties of excitable cells, was 
discovered by Hodgkin and Huxley (1952) using the squid giant axon. 
Likewise, the synapse in the squid stellate ganglion provided a preparation 
in which pre- and post-synaptic events underlying chemical transmission 
could be determined in great detail (Bullock and Hagiwara, 1957; Tasaki et 
al., 1965). The neurosecretory sinus gland found in crustaceans can be 
considered analagous to the vertebrate neurohypophysis, and therefore has 
been studied extensively as a model system for neurohaemal release 
mechanisms (Cooke, 1985; Newcomb etal., 1985; Stuenkel, 1985; Lemos 
and Nordmann, 1986).
Invertebrates have also served as models for studying the genetic 
mechanisms underlying neuromodulation of behavior. The large, 
identifiable neurons of Aplvsia are, like those of other invertebrates, 
particularly well-suited for DNA hybridization, biochemical, 
electrophysiological and immunohistochemical analyses. These techniques 
are capable of providing needed insight into the cellular and molecular 
events underlying specific behaviors.
One behavior in Aplysia amenable to such detailed analyses is 
egg-laying behavior, a stereotyped sequence of events culminating in egg 
string deposition (Kandel, 1976; Blankenship et al., 1983). This behavior is 
largely controlled by peptidergic bag cells of the abdominal ganglion 
(Pinsker and Dudek, 1977; Cobbs and Pinsker, 1982). Bag cell peptides act 
at central and peripheral sites in Aplysia to coordinate the behavioral and 
physiological repertoire of egg-laying (Stuart and Strumwasser, 1980; 
Rothman et al., 1983a; Ligman and Brownwell, 1985; Rock et al., 1986). The
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demonstration of simultaneous release of several peptides to elicit 
particular and coordinated responses has been explained on the molecular 
level by examining the genetic machinery of this system. The genes 
responsible for peptide synthesis specify large precursors, the fragments 
of which are released together in an all-or-none fashion (McAllister et al., 
1983; Rothman et al., 1983b; Scheller et al., 1983). This genetic scheme is 
quite similar to the pro-opiomelanocorticotropin (POMC) system of 
vertebrates in which multiple peptide release is guaranteed by the genetic 
machinery (Loh et al., 1982; O’Donohue and Dorsa, 1982). The bag cells of 
the Aplysia abdominal ganglion therefore comprise an ideal model system 
in which to study the genetic control of a stereotyped behavior.
Invertebrates have also been utilized as model systems for the 
investigation of cellular processes crucial to learning. A form of 
associative learning is exhibited by the nudibranch Hermissenda: the 
pairing of light with rotation results in a decrement of this animal's 
natural positive phototactic response (Farley and Alkon, 1982). In this 
system, Type B photoreceptors receive excitatory synaptic input from 
statocyst hair cells during light-rotation pairing, eventually resulting in 
inhibition of phototactic motor neurons (Crow and Alkon, 1980; West et al., 
1982). The well-characterized and long lasting changes in behavior induced 
by stimulus pairing in Hermissenda may be correlated with second 
messenger formation and protein phosphorylation (Alkon et al., 1982; Alkon 
et al., 1983; Neary and Alkon, 1983).
Among the best characterized models of non-associative learning are 
the gill withdrawal reflex in Aplvsia (discused in section ii) and the escape 
response of certain arthropods. In the crayfish, escape consists of an 
extremely rapid tail flick, a behavior for which the complete neuronal
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circuitry has been established (Krasne and Wine, 1977). This response, like 
gill withdrawal in Aplvsia. is subject to amine modulation (Glanzman and 
Krasne, 1983), habituation (Wine et al., 1975) and sensitization (Krasne and 
Glanzman, 1986). These examples point out the value of invertebrate 
systems as models, especially since the relatively simple neural circuitry 
of these organisms is amenable to investigations of the biochemical 
mechanisms underlying neuromodulation of a wide variety of regulatory 
events.
b. Amine actions in invertebrates: role of cyclic nucleotides
Amines, as discussed in section i, have powerful influences on 
physiological processes and behavioral expression in invertebrates. Many 
investigations of the biochemical mechanisms underlying amine actions on 
identified neurons or their target tissues in these organisms have expanded 
our general knowledge of the intracellular events associated with 
neuromodulation. The detection of amine-sensitive adenylate cyclases in 
nervous and peripheral tissues from a wide distribution of invertebrate 
groups, especially molluscs (Weiss and Drummond, 1981; Drummond et al., 
1985; Deterre et al., 1986) and arthropods (Atkinson et al., 1977; Harmar 
and Horn, 1977; Morton, 1984; Pratt and Pryor, 1986) is an indication of the 
widespread role of cAMP in these organisms.
Amine Modulation of Ionic Currents
Actions of amines on the conductance state of ion channels in 
invertebrates have been explained on the molecular level by examination of
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the particular second messenger system involved. For example, serotonin, 
via a cAMP-dependent mechanism, decreases a K+conductance in sensory 
neurons of the Aplvsia abdominal ganglion to promote action potential 
spike broadening and enhance transmitter release (Castellucci et al., 1980; 
Kandel and Schwarz, 1982). Serotonin has a similar effect in Helix neurons 
(Deterre et al., 1981). In these neurons, dopamine, acting on separate 
receptors, also increases cAMP to decrease the same K+ conductance 
(Deterre et al., 1982).
Other evidence indicates that cGMP may also be involved in amine 
actions on ion currents. The action of serotonin on certain identified 
neurons in Helix to enhance a calcium current is mimicked by agents which 
increase levels of cGMP within these cells (Paupardin-Tritsch et al., 1986). 
Cyclic AMP agents, such as forskolin, do not mimic the action of serotonin.
Perhaps the best characterized second messenger-mediated process 
is the serotonin-induced hyperpolarization of a large, identifiable neuron,
R15, in the Aplvsia abdominal ganglion. This cell exhibits rhythmic 
bursting activity consisting of alternating periods of repetitive action 
potentials and interburst hyperpolarizations. Serotonin enhances the 
intensity of interburst hyperpolarization, leading to diminution or abolition 
of bursting activity in this neuron. Cyclic AMP mediates the action of 
serotonin to increase a K+ conductance in R15 and hyperpolarize the cell 
(Drummond et al., 1980; Benson and Levitan, 1983). Inhibition of adenylate 
cyclase (Lemos and Levitan, 1984) or protein kinase (Adams and Levitan, 
1982) blocks the serotonin response, indicating that cAMP formation and 
protein phosphorylation are essential steps in this pathway. Injection of 
labeled 32P-ATP into R15 followed by application of serotonin results in an 
alteration in the labelling pattern of several phosphoproteins (Benson et
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al., 1983; Levitan et al., 1983b), one of which might be a regulatory 
component of the target K+ channel.
Amine Effects on Neuromuscular Transmission and Muscle Contractility
Amines modulate the contraction strength of invertebrate muscle 
directly, by affecting excitation-contraction (E-C) coupling, or indirectly, 
by altering the efficacy of neuromuscular transmission. The role of cAMP 
in amine actions on either process has been documented in many species.
The existence of amine-sensitive adenylate cyclases in invertebrate 
muscle is correlated with a messenger role forcAMP in amine actions on 
muscular contractility. In the gill of Aplvsia. dopamine and serotonin 
increase contractilty of gill muscles by their actions on separate receptors 
coupled to adenylate cyclase (Weiss and Drummond, 1981; Weiss et al.,
1985). Enhancement of buccal muscle contractility in Aplvsia by serotonin 
is also cAMP-dependent (Ram et al., 1983; Weiss et al., 1985).
Cyclic AMP is important in amine enhancement of cardiac output in 
invertebrates. For example, increased ventricular cAMP is associated with 
the positive chronotropic and inotropic effects of serotonin on the heart of 
the clam Mercenaria (Higgins, 1974; Paciotti and Higgins, 1985). In 
Aplysia. serotonin-induced enhancement of cardiac muscle contractility is 
also mediated by cAMP (Weiss et al., 1982; Sawada et al., 1984). In this 
system, amine-induced elevation of cAMP is greatest in the valve or 
pacemaker region of the heart, underlining the pronounced increase in heart 
rate in response to serotonin. In the lobster Homarus. octopamine and 
serotonin increase cardiac muscle cAMP (Sullivan and Barker, 1975;
Battelle and Kravitz, 1978), suggesting that the positive inotropic effect
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of these amines on the lobster heartbeat may be a consequence of cAMP 
formation. Thus, amine stimulation of cAMP production in cardiac muscle 
may be a common mechanism to regulate cardiac output in invertebrate 
species.
Several studies have suggested that cAMP may also be a common 
messenger for amine enhancement of neuromuscular transmission. For 
example, application of a putative phosphodiesterase inhibitor, SQ 20,009, 
or a cyclic nucleotide analogue, 8-benzylthio cAMP, to the crayfish dactyl 
opener muscle preparation produces an increase in evoked junction 
potentials, as does serotonin (Enyeart, 1981). In the locust Schistocerca. 
octopamine2 receptor activation of adenylate cyclase appears to underly
the potentiation of neuromuscular transmission in the extensor tibia 
muscle (Evans, 1984 b,c).
Other studies have implicated both cAMP and cGMP in amine actions 
on neuromuscular synapses. In the mollusc Rapana. serotonin enhances 
neuromuscular transmission in the radula retractor muscle while 
depressing transmission in the protractor muscle. Both of these effects 
are mimicked by dibutyryl cAMP, but also (partially) by dibutyryl cGMP 
(Fujiwara and Kobayashi, 1983). Both cAMP and cGMP may also be 
associated with serotonergic modulation of neuromuscular transmission in 
the lobster claw opener muscle (Goy et al., 1984; Beltz and Kravitz, 1986; 
Goy, 1987). In both of these systems, serotonin has multiple actions on 
synaptic events, which may explain the difficulty in ascribing a role to 
cAMP or cGMP for a specific action of this amine. Further work is clearly 
needed to elucidate the precise second messenger systems underlying 
specific amine actions at the neuromuscular junction.
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Amine Effects on Sensory Processes
Several studies on second messenger mechanisms involved in amine 
modulation of sensory input in invertebrates stand out as examples of 
molecular analyses of model systems. These include the serotonin /  cAMP 
modification of sensory neuronal properties in response to tactile 
stimulation (the Aplvsia oill withdraw! reflex, discussed in section i), the 
analagous response of tail sensory neurons of the pleural ganglion in this 
organism (Ocorr et al., 1985; Scholz and Byrne, 1987), and the alteration of 
the circadian rhythm of photosensitivity by various amines in the 
invertebrate eye. The latter phenomenon is extremely intriguing since 
cyclic nucleotides appear to have a role in primary sensory transduction as 
well as in mediation of the effects of circulating neurohormones.
In many animals, circadian rhythmicity of behavior is driven by a 
biological clock in the nervous system. In Aplvsia. neural output from optic 
neurons collectively generate a daily rhythm of activity (Olson and 
Jacklett, 1985). The period of rhythmicity in the Aplysia eye is advanced 
by light pulses (Jacklett, 1974) and by serotonin, a putative entrainment 
neurohormone released by efferent axons of the optic nerve (Nadakavukaren 
et al, 1986). This action of serotonin on the optic rhythm is mediated by 
cAMP (Benson, 1980; Eskin et al., 1982; Eskin and Takahashi, 1983), as is 
the action of this amine to increase photosensitivity (Eskin and Maresh, 
1982). Photic entrainment, on the other hand, may involve a cGMP 
mechanism, since light selectively increases cGMP in the eye and 
light-induced phase shifting can be mimicked by cGMP analogues (Eskin et 
al., 1984). Cyclic GMP involvement in the response to light has also been 
reported for photoreceptors of the horseshoe crab Limulus and the squid
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Loligo (Johnson et al., 1986; Saibil, 1986).
While in Aplvsia the eye itself generates circadian rhythmicity, in 
Limulus the eye is modulated by a biological clock located in the 
protocerebrum (Barlow et al., 1980). Increased photosensitivity of the 
lateral eyes appears to be at least partly a response to octopamine 
released from efferent optic fibers (Battelie et al., 1982). Cyclic AMP is 
increased in the Limulus lateral eye by octopamine, and pharmacological 
elevation of cAMP in the eye results in an OCT-like electroretinograph or 
single photoreceptor response. Thus, in Limulus. Aplysia. and possibly 
other invertebrates as well, cyclic nucleotides play a crucial role in 
sensory transduction and in amine modulation of sensory receptors.
c. Peptide actions in invertebrates: role of cyclic nucleotides
Peptides have long-lasting effects on neuronal and peripheral target 
tissues, as discussed earlier. The involvement of second messengers in 
cellular responses to neuropeptides is suggested by the typically prolonged 
expression of peptide actions. As more invertebrate peptides have been 
isolated and physiologically characterized, evidence has accumulated 
linking cyclic nucleotide metabolism with their various actions.
Peptide Effects on Invertebrate Hearts
Peptides sharing partial sequence homology, the molluscan 
cardioexcitatory peptide (FMRFamide) and small cardioexcitatory peptides 
(SCP's) have, like serotonin, potent effects on the rate and strength of 
heart contractions in molluscs. Also, like serotonin, these peptides exert
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their actions by elevating levels of cardiac muscle cAMP. For example, in 
Aplvsia, SCPB and serotonin both exert positive chronotropic and inotropic
effects and increase myocardial cAMP (Lloyd et al., 1985). Serotonin 
appears to influence heart contractions by its long lasting and pronounced 
effects on cAMP levels and on contractility in the atrio-ventricular valves.
Small cardioactive peptide, on the other hand, elicits cAMP increases and 
contractile effects of shorter duration localized primarily in the ventricle.
These findings indicate separate peptide and amine regulation of the 
Aplvsia heartbeat, via a common second messenger. In the clam 
Mercenaria. it is FMRFamide which, like serotonin, utilizes cAMP as a 
second messenger to promote increased cardiac muscle contractility 
(Higgins eta i., 1978; Greenberg and Price, 1979). Apparently, serotonin, 
SCPB and FMRFamide augment the rate and strength of heart contractions in
these molluscs by stimulating a myocardial adenylate cyclase.
In the freshwater clam Lampsilis. FMRFamide action is inhibitory and 
opposite to that of serotonin, although both agents increase cardiac muscle 
cAMP (Painter, 1982a; Greenberg et al., 1983). The role of cAMP in peptide 
regulation of the molluscan heart, therefore, appears to be more complex 
than the original hypothesis that FMRFamide is a general cardioexcitatory / 
cAMP-stimulating agent (Greenberg and Price, 1979).
Cyclic AMP may also be involved in peptide modulation of the cardiac 
rhythm of neurogenic hearts in arthropods. An unidentified extract, 
presumably a peptide, from crustacean pericardial neurohaemal organs 
appears to increase (as does serotonin) the cAMP content of the cardiac 
ganglion of Homarus (Lemos and Berlind, 1981). Further studies are 
necessary to establish the mechanism(s) of peptidergic cardioregulation in 
arthropod and molluscan species.
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Peptide Effects on Stereotyped Behavior Patterns
Stereotyped, complex behavior patterns in invertebrates may be 
initiated by neuropeptide actions on identified neurons. Egg-laying in 
Aplysia. and ecdysis in the moth Manduca. are two examples of 
characterized behaviors in which cyclic nucleotides play an important role 
in the initiation of a stereotyped action pattern by a peptide.
In Aplvsia. a sequence of events culminating in egg deposition is 
elicited by stimulation of the bag cell neurons of the abdominal ganglion, 
as discussed earlier in this section. These neurons undergo a prolonged 
period of bursting activity when stimulated electrically (Kupferman and 
Kandel, 1970) or by peptides released from the reproductive tract (Nagle, 
et al., 1985; Rock etal., 1986). Bag cell peptides released during bursting 
activity may also contribute to the afterdischarge in the bag cell clusters 
(Heller et al., 1980; Rothman etal., 1983b; Rock eta l., 1986). During 
afterdischarge, action potentials of bursting bag cell neurons are 
progressively broadened, presumably to increase neurosecretory output 
(and thus insure the necessary circulating peptide titer to trigger 
egg-laying). Both peptide-induced afterdischarge and spike broadening 
involve a cAMP-dependent mechanism (Kaczmarek etal., 1980; Kaczmarek 
and Strumwasser, 1981). At least three potassium conductances in the bag 
cells are regulated by cAMP (Kaczmarek and Strumwasser, 1984; Strong and 
Kaczmarek, 1986), and protein phosphorylation occurs during 
afterdischarge (Jennings et al., 1982; Strumwasser et al., 1982).
Recent evidence has indicated that the PI system, in addition to cAMP, 
is involved in the expression of bag cell afterdischarge. Protein kinase C is
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present and active in bag cell neurons (DeRiemer et al., 1985a).
Stimulation of this enzyme by certain phorbol esters (analogues of 
diacylglycerol) or by injection of protein kinase C elicits an increase in the 
height (not the width, as observed after application of cAMP analogues) of 
action potentials, and enhances a calcium current (DeRiemer et al., 1985b). 
Increased action potential height is characteristic of bag cell neurons at 
the onset of afterdischarge, suggesting that protein kinase C activation 
may occur in synergy with protein kinase A (cAMP-dependent) activation in 
the normal expression of this event (Kaczmarek, 1986).
It has also been suggested that calcium / phospholipid metabolism 
may be responsible for termination of bag cell discharge (Kaczmarek and 
Kauer, 1983; Bruehl and Berry, 1985; Berry, 1986). Prolonged activation of 
the PI system may prevent subsequent (and inappropriate) bag cell activity, 
and also inhibits peptide synthesis. Thus, the Aplysia bag cell system is an 
excellent model in which to study the combined intracellular actions of 
several second messenger systems to precisely coordinate a stereotyped 
behavior.
Ecdysis in insects consists of a complex sequence of behavior 
patterns eventually resulting in cuticular shedding. Molting behavior is 
triggered by a peptide, eclosion hormone (EH), released into the general 
circulation by the insect CNS (Truman and Riddiford, 1970; Reynolds and 
Truman, 1980). The pre-eclosion and eclosion behaviors in several species 
of moths, including Manduca and Hvalophora. may be expressed by the 
isolated ventral nerve cord in response to EH (Truman, 1978). The motor 
programs for EH-stimulated behavior occur in association with increases in 
CNS levels of cGMP, but not cAMP (Truman et al., 1979; Truman and Levine, 
1982). Cyclic GMP analogues and phosphodiesterase inhibitors are capable
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of triggering eclosion behavior in intact moths or inducing their underlying 
motor programs in the isolated nerve cord. Cyclic GMP also appears to be 
involved in other effects of EH associated with ecdysis (Truman and Levine, 
1982; Schwartz and Truman, 1984; Morton and Truman, 1985), making this 
an attractive system in which to study cGMP-dependent phenomena. 
Unfortunately, the neurons responsible for the generation of specific 
ecdysis programs remain undetermined. Identification of these neurons is 
necessary to permit a more detailed analysis of specific biochemical 
events which culminate in the expression of this characterized behavior.
iv. THE NEUROGENIC LIMULUS HEART
a. The cardiac rhythm in Limulus
In the horseshoe crab. Limulus polyphemus. the cardiac rhythm is 
generated by the cardiac ganglion, a network of approximately two hundred 
neurons located on the dorsal surface of the heart (Patten and Redenbaugh, 
1899; Bursey and Pax, 1970a). The heartbeat is neurogenic in origin, since 
removal of the cardiac ganglion abolishes heart contractions (Carlson,
1904). The constituents of the neurogenic Limulus heart are understood in 
terms of their relative contributions to the overall activity pattern of the 
heart (reviewed by Watson and Augustine, 1982). This system has proven 
useful as a model system to investigate the action of various peptides and 
amines upon specific cellular elements of a pattern generating network.
Cellular Organization of the Limulus Heart
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The cardiac ganglion in Limulus consists of two types of neurons 
which contribute to ganglionic burst formation: small (20-40 pm) 
pacemaker neurons and larger (60-150 pm) follower, or motor neurons 
(Patten and Redenbaugh, 1899; Lang, 1971a). This functional arrangement 
is similar to that found in the neurogenic crustacean heart (Maynard, 1955; 
Hartline, 1979). The smaller neurons of the Limulus cardiac ganglion 
exhibit slow depolarizing pacemaker potentials leading to overshooting 
action potentials. These appear to drive the burst activity of the motor 
neurons, which consists of a non-overshooting depolarization (cumulative 
synaptic input from several pacemaker neurons) followed by a prolonged 
plateau potential. During this plateau period, the follower neurons spike 
repetitively; this activity presumably constitutes motor output to the 
cardiac muscle fibers. Synchrony of cardiac muscle contractions may be 
due, at least partially, as a result of electrotonic coupling of the cardiac 
ganglion neurons (Lang, 1971a; Watson and Augustine, 1982).
Follower cells send projections out of the side branches of the 
cardiac ganglion and appear to innervate cardiac muscle fibers. The cardiac 
muscle potentials consist of summated or compound excitatory junction 
potentials (Abbott et al., 1969; Parnas et al., 1969); the muscle fibers 
themselves are normally unexcitable.
Under certain conditions degangiionated hearts may exhibit myogenic 
activity. Stretch, low calcium solutions or the neuropeptide proctolin 
elicit action potentials in cardiac muscle fibers and regular contractions in 
the absence of neuronal input from the cardiac ganglion (Lang, 1971b; Rulon 
et al., 1971; Watson and Hoshi, 1985). The electrical properties of Limulus 
cardiac muscle are thus subject to alteration by physical, chemical and 
neuromodulatory influences.
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Cardioregulation by the CNS
In Limulus. the cardiac ganglion itself is innervated by 
cardioregulatory nerves which originate in the CNS (Patten and Redenbaugh, 
1899; Carlson, 1905). These nerves arise from branches of the dorsal 
nerves exiting the brain (segmental cardiac nerves 6-8) and ventral nerve 
cord (segmental cardiac nerves 9-13). Stimulation of these nerves results 
in cardioinhibitory and cardioexcitatory responses (Pax, 1969; Bursey and 
Pax, 1970b; Hoegler, 1980). The variety of time courses for the onset and 
duration of these effects suggests that both synaptic and neurohormonal 
influences may be involved in cardioregulation (Pax and Sanborn, 1967; Pax, 
1969).
Increases in heart rate occur simultaneously with stereotyped 
ventilatory movements of the book gills in Limulus (Watson and Wyse,
1978). These ventilatory behaviors are controlled by motor programs 
residing within the ventral nerve cord (Watson, 1980; Wyse et al., 1980). 
Correlation between these behaviors and alterations of the cardiac rhythm 
raises the possibility that cardioregulatory neurons of the ventral nerve 
cord may be associated with the pattern generating network for respiratory 
behaviors. This system therefore is of considerable interest as a model in 
which to study neuromodulatory mechanisms underlying physiological 
processes crucial to the integration of specific behaviors.
b. Amine modulation of the Limulus heart
The biogenic amines serotonin, octpamine, dopamine, epinephrine and
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norepinephrine have been identified in various regions of the Limulus CNS 
and cardiac ganglion (Welsh and Moorehead, 1960; Edwards et al., 1979; 
O'Connor et al., 1982; Chamberlain et al., 1986). The hypothesis that these 
amines are important in cardioregulation has been supported by analyses of 
amine actions on the cardiac rhythm. Serotonin has been proposed as a 
likely cardioinhibitory substance, since application of this amine to the 
isolated heart preparation resembles stimulation of cardioinhibitory 
nerves (Pax and Sanborn, 1967). Octopamine and the catecholamines, on the 
other hand, all produce cardioexcitation in Limulus (Augustine et al., 1982).
Amine Actions on the Limulus Heart
Serotonin has been shown to inhibit the burst activity of the isolated 
cardiac ganglion, accounting for its negative chronotropic effect (Pax and 
Sanborn, 1967). However, relatively little attention has been directed 
towards determination of the cellular sites of cardioinhibitory amine 
actions on the Limulus heart.
By comparison, the cardioexcitatory actions of octopamine and the 
catecholamines on the Limulus heart network have been analyzed in some 
detail at the cellular level (Fig. 2). All of these amines excite the isolated 
cardiac ganglion. In addition, dopamine and norepinephrine transiently 
inhibit ganglionic output (Augustine et al., 1982). Amines act on both 
pacemaker and follower neurons within the cardiac ganglion to exert their 
actions on burst activity (Augustine and Fetterer, 1985). In Chapter One, 
the intracellular mechanisms underlying amine actions on the Limulus 
cardiac ganglion are examined.








m u sc le
J \A
v f \ T
9  O O
.  — . . ~ v w
9 o b
A M lltS  - Increase In heart rate
A
AMINES -  increase in transmitter 
released anto muscle
AT1INE5 and PROCTOt IN
increase in contractility 
of cardiac muscle fibers
Fig. 2. Peptides and amines have long-lasting excitatory effects on the Limulus heartbeat. 
The pentapeptide proctolin acts directly on cardiac muscle fibers to enhance heart contraction 
amplitude. Several biogenic amines, including dopamine, act on cellular targets within the 
cardiac ganglion (pacemaker and follower neurons) as well as on cardiac muscle fibers to 
produce long-lasting increases in both the rate and strength of heart contractions. Diagram 
modified from Watson and Augustine, 1982.
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contractions in Limulus (Augustine et al., 1982) Dopamine and 
norepinephrine also have transient negative inotropic effects with a time 
course similar to their initial negative effect on heart rate. Cardiac 
muscle fibers, as well as the neuromuscular junction, are targeted by these 
amines as sites of positive inotropic action (Watson and Hoshi, 1981;
Watson et al., 1985). In Chapter Two, the role of second messengers in the 
positive inotropic effects of amines on the Limulus heart is investigated.
c. Peptide modulation of the Limulus heart
Several cardioactive peptides have been identified in the Limulus CNS 
(reviewed by Watson and Augustine, 1982). Limulus chromatophorotropic 
factor (LCF) may be comprised of several peptides to account for its 
cardioexcitatory, cardioinhibitory and chromatophorotropic activities 
(Pezalla et al., 1978; Dores and Herman, 1980; Watson et al.,1981). Several 
FMRFamide-like peptides are present in the Limulus CNS and in the cardiac 
ganglion: at least one of these Limulus peptides appears to have 
cardioexcitatory and cardioinhibitory effects on the isolated Limulus heart 
(Watson et al., 1984; White and Watson, 1984). Finally, a proctolin-like 
peptide with a molecular weight of approximately 600-800 daltons has 
been detected in the Limulus cardiac ganglion (Benson et al., 1981; Watson 
et al., 1983). Like synthetic proctolin, this peptide increases the strength 
of heart contractions with no apparent effect on the neurons of the cardiac 
ganglion (Fig. 2). Proctolin also induces myogenicity in the deganglionated 
Limulus heart (Watson and Hoshi, 1985).
For each of these cardioactive peptides, purification efforts and 
physiological analyses are incomplete. Part Two of this dissertation
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describes further characterization of Limulus neuropeptides. In Chapter 
Three, the distribution and isolation of proctolin-like and FMRFamide-like 
peptides is investigated. In Chapter Four, the role of cyclic nucleotides and 
phosphatidylinositides in the action of these peptides on the Limulus 
cardiac rhythm is examined.
d. Mechanisms of peptide and amine actions in Limulus
As detailed in the previous sections, amines and peptides have 
pronounced effects on the hearts of a variety of vertebrate and 
invertebrate species. Cyclic AMP is an important second messenger in the 
chronotropic and inotropic actions of peptides and amines on the myogenic 
hearts of vertebrates (reviewed by Tsien, 1977) and many invertebrates, 
such as molluscs (reviewed by Greenberg et al., 1983).
Amines and peptides also have powerful chronotropic and inotropic 
effects on the neurogenic hearts of a number of arthropod species (Grega 
and Sherman, 1975; Florey and Rathmayer, 1978; Miller and Sullivan, 1981 
Watson and Augustine, 1982). However, little is known regarding the 
biochemical basis for neuromodulation of the neurogenic heart network in 
any species. In some crabs and lobsters, octopamine appears to increase 
the cAMP content of the cardiac ganglion, as well as in cardiac muscle 
tissue (Sullivan and Barker, 1975; Battelle and Kravitz, 1978). Also, 
serotonin and a putative peptide extract in Homarus pericardial organs may 
increase the cAMP content in the cardiac ganglion of that species (Lemos 
and Berlind, 1981). However, in none of these studies could a positive 
correlation be made between the cellular actions of a particular 
neurohormone and its effect on tissue levels of cAMP. Additionally, the
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role of other second messengers, such as cGMP or phosphatidylinositides, 
has not been examined in any neurogenic heart.
Evidence suggesting second messenger involvement in peptide and amine 
actions on the neurogenic Limulus heart
Aminergic and peptidergic actions upon a number of cellular sites in 
the neurogenic Limulus heart produce characteristic changes in cardiac 
output. The biochemical mechanisms underlying these effects have not 
been determined. Several facts suggest the involvement of second 
messengers, especially cyclic nucleotides, in the expression of 
cardioexcitatory responses to these neurohormones. First, an 
octopamine-sensitive adenylate cyclase has been demonstrated in the 
Limulus CNS (Atkinson et al., 1977). Second, the positive chronotropic 
and/or inotropic effects of amines and peptides have a slow onset, with 
effects peaking 10-20 min after exposure of the isolated heart preparation 
to these compounds (Augustine et al., 1982). Finally, cardioexcitation 
induced by amines and peptides typically persists for long periods of time 
(60 min or more) after removal of the agent from the preparation. The 
actions of peptides and amines in this system, therefore, may be a result of 
their capacity to influence long lasting biochemical events within the 
Limulus heart network.
Amines and peptides exhibit partial similarity in terms of overt 
responses on the cardiac rhythm in Limulus. Therefore, it is of interest to 
determine whether shared, or separate, second messenger systems mediate 
similar actions of these neuromodulators on the Limulus heart.
Specifically, do amines and the Limulus FMRFamide-like peptide limadrin
4 0
both increase heart rate by the same mechanism? Also, do amines and the 
Limulus proctolin-like peptide both increase contraction amplitude via a 
shared mechanism?
Approaching these questions from a combined physiological and 
biochemical perspective is possible using a simple system. The 
constituents of the neurogenic Limulus heart are amenable to specific 
electrophysiological and biochemical analyses. These advantages may 
facilitate the elucidation of the intracellular mechanisms underlying 
excitation of the cardiac rhythm. This study will examine the roles of 
cAMP, cGMP and phosphatidylinositides in specific amine and peptide 




MECHANISM FOR AMINE ACTIONS ON THE 
LIMULUS CARDIAC GANGLION
ABSTRACT
Evidence is presented indicating that biogenic amines produce their 
characteristic excitatory chronotropic effects on the Limulus heartbeat by 
increasing cAMP in the cardiac ganglion. Amines, at 10'5 M, increased 
cardiac ganglion cAMP with a time course similar to that observed for 
amine-induced excitation of the contraction rate of the intact heart or the 
burst rate of the isolated cardiac ganglion. The apparent order of potency, 
at 10'5 M amine, for either rate excitation or cAMP elevation, was 
octopamine > epinephrine ^ dopamine > norepinephrine. Elevation of
cardiac ganglion cAMP by octopamine or dopamine was dose-dependent, 
with a threshold of 10'6 M to 3 x 10'6 M, at 3 min incubation, for either 
amine. The phosphodiesterase inhibitor IBMX potentiated amine-induced 
increases in heart rate and cardiac ganglion cAMP. Cyclic GMP levels in 
the Limulus cardiac ganglion were unaltered in the presence of any of 
these amines, at all doses tested.
The adenylate cyclase activator forskolin, 8-substituted cyclic AMP 
analogues and IBMX had long-lasting positive chronotropic effects on the 
intact Limulus heart. Like the amines, these agents also increased the 
burst rate of the isolated cardiac ganglion.
Follower cell burst parameters (interburst interval, burst duration
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and number of spikes per burst) were decreased by these cyclic nucleotide 
agents in an amine-like fashion. Pharmacologically isolated follower 
neurons were depolarized by octopamine, forskolin and IBMX. These 
agents, as well as dopamine, also caused burst-like potentials in isolated 
follower neurons. The combined results indicate that several excitatory 
effects of these biogenic amines on the Limulus cardiac ganglion are 
mediated by increases in cardiac ganglion cAMP.
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INTRODUCTION
The heartbeat in the horseshoe crab, Limulus oolvphemus. is 
neurogenic in origin (Carlson, 1904). Pacemaker and follower neurons of 
the cardiac ganglion drive rhythmic contractions of the myocardium. The 
cardiac rhythm is modulated by the biogenic amines octopamine (OCT), 
dopamine (DA), epinephrine (EPI) and norepinephrine (NE), which are 
endogenous to the nervous system of the horseshoe crab (O'Connor et al., 
1982). These amines have long-lasting excitatory effects on the rate and 
strength of heart contractions in Limulus (Augustine et al., 1982).
The excitatory chronotropic effects of amines on the Limulus 
heartbeat are a result of actions upon cardiac ganglion neurons (Augustine 
and Fetterer,1985). Amines increase the burst rate in the Limulus cardiac 
ganglion by increasing the rate of firing of pacemaker neurons. Increased 
burst rate in the cardiac ganglion is accompanied by multiple changes in 
follower cell (motor neuron) bursting activity. These include a decrease in 
the duration of individual bursts and a reduction in the number of action 
potentials per burst. Amines also depolarize (OCT, EPI) or hyperpolarize 
(DA, NE) follower neurons isolated pharmacologically from pacemaker 
neuron input. The cellular sites of action of these amines on neurons in 
the Limulus cardiac ganglion have thus been determined, but the 
intracellular events underlying amine modulation in this system have not 
previously been investigated.
Several previous studies have suggested that cyclic nucleotides may 
be involved in the response of neurogenic hearts to amines. In some 
species of crabs and lobsters, octopamine increases tissue levels of cAMP 
in the cardiac ganglion and produces long-lasting excitation of heart rate
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(Sullivan and Barker, 1975; Battelle and Kravitz, 1978). In Limulus. 
amine-induced excitation of heart contraction rate is slow in onset and is 
long-lasting. For example, peak effect is 10-15 min after amine 
application, and rate effects typically last 30-60 min following removal 
of amines from the bath (Augustine et al.,1982). However, there are no 
studies to date which clearly define the role of cAMP in the response of 
neurogenic hearts to amines. In this chapter, physiological and 
biochemical findings are presented which detail the relationship between 





The incubation, extraction and radioimmunoassay (RIA) protocols for 
cAMP and cGMP determination in Limulus cardiac ganglia are described in 
Appendix - General Methodology. The assay for either of these cyclic 
nucleotides is sensitive enough (0.1 pmol) to determine levels of both 
cAMP and cGMP in individual cardiac ganglia.
Recording of heart contractions
Limulus hearts were removed as described in Appendix - General 
Methodology. The isolated hearts were pinned to Sylgard resin in the 
bottom of small (10 ml) plexiglass chambers. The lateral boundary of each 
heart was hooked via thread to a force transducer (Grass FT .03 C; Grass 
Instruments, Co., Quincy, Massachussetts.). Rate and tension 
measurements were recorded on an oscillograph (Grass Model 79 D). 
Preparations were perfused continuously (flow rate 5 ml/min) with 
natural seawater at room temperature. Amine or drug solutions were 
added via the perfusion reservoir.
Extracellular recording
Isolated cardiac ganglia were pinned to the bottom of small (5 ml) 
plexiglass chambers and perfused continuously (5 ml/min) with natural 
seawater at room temperature. The anterior ends of cardiac ganglia were
46
drawn into the tips of suction electrodes. Extracellular potentials were 
filtered and amplified (Grass P-15) and then recorded on both an 
oscillograph and a chart recorder (Brush 220, Gould Inc., Cleveland, Ohio). 
Noise levels were less than 2 pV peak to peak, so individual cardiac 
ganglion bursts were clearly distinct.
Intracellular recording
Follower neurons within isolated Limulus cardiac ganglia were 
impaled with 3 M KCI-filled glass microelectrodes (20-40 MQ). Membrane 
potentials were recorded with a high impedance electrometer (Dagan 
8700, Dagan Corp., Minneapolis, Minnesota or WPI M 701, W-P Instruments, 
New Haven, Conn.). Potentials were displayed on a storage oscilloscope 
(Tektronix 5111, Beaverton, Oregon) and recorded on a chart recorder. 
Apparent input resistances of pharmacologically isolated follower neurons 
were measured by injecting hyperpolarizing and depolarizing current (0.1 
to 0.3 nA internal source).
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RESULTS
Amine effects on the Limulus heart and isolated cardiac ganglion
The biogenic amines OCT, DA, EPI and NE, as previously described 
(Augustine et al, 1982), all increased the contraction rate of the Limulus 
heart. Most of the experiments in this study focused on the action of two 
of these amines, OCT and DA. While DA transiently inhibited the heart, 
both amines produced positive chronotropic responses which were slow in 
onset and were long-lasting (Fig. 1a).
All four amines tested (OCT, DA, EPI and NE, ac 10'5 M) increased the 
burst rate of the isolated cardiac ganglion (Table 1). At this 
concentration, the apparent order of potency was OCT > EPI ~ DA > NE. Like 
their effect on the intact heart, the excitatory effect of either OCT or DA 
on the cardiac ganglion was gradual in onset, as burst rate reached a peak 
increase after 10 min of amine application (Fig. 2). Removal of amine 
from the bath resulted in a slow decline of the burst rate to control values 
over the course of 1-2 hr continuous perfusion. Cardiac ganglion burst 
rate remained elevated if amines were not removed from the recording 
chamber (data not shown).
Amine effects on levels of cyclic nucleotides in the cardiac ganglion
All four amines, at 10‘5 M, increased cAMP in the Limulus cardiac 
ganglion (Table 1). The apparent order of potency for cAMP elevation in 
this tissue was OCT > EPI ~ DA > NE. This result correlated exactly with 





B. CYCLIC NUCLEOTIDE AGENTS
Forskolin |
IBMX
Fig. 1. Amine-induced excitation of the neurogenic Limulus heart (A) is mimicked by 
cAMP-elevating agents (B). Amines and agents were added at the arrow and continually 
perfused. Both dopamine and octopamine, at 10*6 M, produced long-lasting increases in the 
rate and strength of heart contractions. Forskolin (an activator of adenylate cyclase), at 5 x 
10 '6 M, precisely mimicked the excitatory chronotropic and inotropic actions of these 
amines. The phosphodiesterase inhibitor IBMX, at 10'3 M, also produced a long-lasting 
increase in heart rate, but its postive inotropic action was followed by long-lasting inhibition. 




TABLE 1 - Physiological and biochemical effects of amines and 
pharmacological agents on the Limulus cardiac ganglion
AGENT DOSE % CTL RATE pmolcAMP pmol cGMP
CONTROL 100 28.0  ±10.6 (8) 5.8 ± 0 .7  (7)
Amines
OCT 10‘5 M 246.8 ± 1 5 .9  (1 2 )f 117.0 ± 3 0 .6  (8)* 4.1 ± 0 .3  (6)
EPI 10-5 M 225.2 ± 4 8 .3  (17)+ 81.2 ± 1 5 .6  (8)* 7.3 ± 0 .8  (5)
DA 10 '5 M 216.8 ±  14.4 (1 4 )t 61.8 ± 7 .1  (8)* 5.2 ± 0.7 (6)
NE 10-5 M 166.1 ± 7 .2  (20)* 42.6  ± 8 .9  (8) 6.6 ± 0 .8  (5)
Pharmacoloaical aqents
FORSK 5 X 10"6 M 225.0 ± 1 1 .3  (12)+ 65.8 ± 1 1 .9  (8)* 4 .2  ± 0 .6  (6)
IBMX 10'3 M 201.4 ±  10.6 (15)+ 55.3 ± 1 0 .4  (7)* 73.5 ± 1 8 .3  (i
RO-20-
1724 10'3 M 118.0 ± 7 .6  (8) 21.6  ±  7.8 (9)
Table 1. Summary of the effects of various amines and pharmacological agents on burst 
rate in the isolated Limulus cardiac ganglion and on levels of cyclic nucleotides in that 
tissue. The mean (± S. E.) of n experiments is represented for measurements of peak 
physiological effect, and for RIA measurements obtained after exposure of cardiac ganglia to 
these agents for 10 min. Level of significant difference from control was determined by a 
Student's t-test.






















C O N T R O L O C T O P A M IN E
C O N T R O L D O P A M IN E
Fig. 2. Amines produced long-lasting increases in the burst rate of isolated cardiac ganglia. 
Top: OCT (10 ® M) or DA (10‘5 M) were added to isolated ganglia for a period of 10 min 
(solid line) and subsequently removed from the bath (note the gradual reduction in frequency 
towards the control rate). Each point represents the mean increase in rate (± S. E.) recorded 
in 12 to 14 preparations. Bottom: extracellular recordings of cardiac ganglion output prior 
to and during amine application. Calibration: vertical, 50 pV; horizontal 2 sec.
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rate (Fig. 8).
The increase in cardiac ganglion cAMP produced by OCT or DA reached 
a peak with 10 min amine incubation (Fig. 3a). When cardiac ganglia were 
incubated in 10'5 M OCT or DA for 10 min and then transferred to 
amine-free solutions, cAMP levels dropped rapidly (Fig. 4). Within 5 to 10 
min after removal of amine, cardiac ganglion cAMP levels had returned to 
control values. Continued presence of amine in the incubation solution 
resulted in continued elevation of cardiac ganglion cAMP (data not shown). 
None of these amines affected the levels of cGMP in the Limulus cardiac 
ganglion (Table 1, Fig. 3b).
Both OCT and DA increased cardiac ganglion cAMP in a 
dose-dependent manner (Fig. 5a). The threshold dose for either DA or OCT 
for cAMP elevation, at 3 min incubation, was between 10'6 M and 3 x 10'6 
M. At all doses tested (10‘6 M to 5 X 10 5 M), neither OCT or DA 
influenced the levels of cardiac ganglion cGMP (Fig 5b).
Effects of forskolin and IBMX on the Limulus heart and-isolated cardiac 
ganglion
Forskolin, which increases intracellular levels of cAMP by 
stimulating adenylate cyclase (Seaman et al., 1981), and IBMX, which 
elevates cAMP and/or cGMP by inhibiting cyclic nucleotide - dependent 
phosphodiesterases (Chasin and Harris, 1976; Levitan and Norman, 1980), 
elicited amine-like increases in the rate of Limulus heart contractions 
(Fig. 1b). The excitatory effects of both compounds were dose-dependent 
(Fig. 6a), but forskolin was approximately 100 x more potent than IBMX in 
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Fig. 3 Octopamine {10'5 M) and dopamine (10'5 M) increased cAMP, but notcGMP, in 
Limulus cardiac ganglia. A. Amines produced increases in cardiac ganglion cAMP with a time 
course and potency similar to their effect on burst rate. Each point represents the mean 
content of cardiac ganglion cAMP (± S. E.) compared to control levels in 6 to 8 experiments.
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Fig. 4. Onset and washoff kinetics of amine-induced changes in cardiac ganglion cAMP content. 
Cardiac ganglia were immersed in 10'5 M OCT or 10 '5 M DA for 30 sec to 10 min (solid 
line). Ganglia were then processed for determination of cAMP content, or washed in 
amine-free seawater for 5 to 80 min and then processed. Cyclic A M P levels were increased 
by either amine, and dropped back to control values within 10 min after amines were removed 
from the incubation solution. Each point represents the mean content of cardiac ganglion cAMP 






























Fig. 5. Octopamine and dopamine produced dose-dependent increases in cAMP (A), but not 
cGMP (B) in Limulus cardiac ganglia. Each point represents the mean ±  S . E. of 5  
experiments in which individual cardiac ganglia were exposed to a particular dose of amine for 
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Fig. 6. Forskolin and IBMX, which increase cAMP in Limulus cardiac ganglia, also increased 
heart contraction rate. A. Both forskolin and IBMX produced dose-dependent increases in 
heartbeat frequency. Each point represents the mean increase in heart rate (± S. E.) of 10 to 
16 experiments. B. Onset and washoff kinetics of equipotent doses of forskolin (5 x 10‘6 M, 
n*14) and IBMX (10'3 M, n -16). Agents were added to the isolated Limulus heart as 
indicated by the solid line. Both agents, like the amines, produced long-lasting increases in 
heart rate.
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In order to compare the time course of the responses of the Limulus 
heart to these drugs, doses of each compound which produced comparable 
increases in heart rate were applied (5 x 10‘6 M forskolin, 90.8 ± 10.0% 
S.E.M. increase, n=17 and 10'3 M IBMX, 89.3 + 7.5% increase, n=16). The 
effects of either agent, like those of the amines, were slow in onset and 
long-lasting (Fig. 6b). The IBMX-elicited increase in the rate of Limulus 
heart contractions was slightly more rapid in onset, and in decline, than 
the effect of forskolin.
Forskolin (5 x 10'6 M) or IBMX (10*3 M) increased the burst rate in 
isolated Limulus cardiac ganglia (Table 1, Fig. 7). The excitatory effect of 
forskolin or IBMX was similar in time course and magnitude to their 
effects on the contraction rate of the intact Limulus heart.
Forskolin and IBMX both increased cAMP in the Limulus cardiac 
ganglion (Table 1). IBMX-, but not forskolin-induced increases in cardiac 
ganglion cAMP were observed as early as 3 min incubation. At this time 
point, IBMX increased cardiac ganglion cAMP levels to 162.5 ±11.4%  
control (n=6), while forskolin did not increase cAMP levels (84.5 ± 16.7% 
control, n=6). This finding may explain the more rapid onset of the 
positive chronotropic effect of IBMX on the intact heart or isolated cardiac 
ganglion. Forskolin had no effect on levels of cGMP in the cardiac ganglion 
(Table 1). IBMX, on the other hand, produced a dramatic increase in cardiac 
ganglion cGMP content after 3 min (1531.5 ± 313.6 % control) or 10 min 
(1270 ± 328.4 % control) incubation.
The effects of forskolin, IBMX and the amines suggested a correlation 
between the relative magnitude of increased cAMP and of increased burst 
frequency in the cardiac ganglion (Fig. 8). Therefore, the potency and 























Fig. 7. Forskolin (5 x 10*6 M) and IBMX (10"3 M) increased burst frequency in the isolated 
Limulus cardiac ganglion. Drugs were added to the preparation for 10 min, as indicated by the 
solid line (top). The time course and magnitude of the effect of either drug was similar to 
their effect on heart rate. Each point represents the mean increase in cardiac ganglion burst 
rate (± S. E.) in 12 to 16 experiments. Bottom: extracellular recordings of cardiac ganglion 
output before addition of agent to the preparation and during the peak response. Calibration: 
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Fig. 8. Correlation between the extent to which amines (10‘5 M), forskolin (5 x 10-6 M) 
and IBMX (10-3 M) produced increases in the burst rate of the isolated Limulus cardiac 
ganglion and their capacity to increase cardiac ganglion cAMP. For any agent, the y 
co-ordinate represents the mean increase in cAMP (± S. E.). after 10 min incubation in 7 to 
8 experiments. The x co-ordinate represents the mean increase in burst rate after 10 min in 
12 to 20  experiments. Simple regression of these data points indicates a good correlation (R 
*  0.94) between levels of cAMP and burst rate in Limulus cardiar ganglia.
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was consistent with the kinetics of their effect on cardiac ganglion cAMP.
Effects of cyclic nucleotide analogues and phosphodiesterase inhibitors
The cAMP analogue 8-para-chlorophenylthio cAMP (10"3 M) produced 
a 34.0 ± 9.9% increase in the contraction rate of the intact Limulus heart 
in 7 preparations. Dibutyryl cAMP, dibutyryl cGMP and 8-bromo cGMP {each 
at 10 '3 M) had no effect on the cardiac rhythm (n=5).
In contrast to the excitatory chronotropic actions of IBMX, several 
phosphodiesterase inhibitors elicited weak effects when applied to the 
isolated heart preparation. Papaverine (1 O'3 M) elicited a 10.5 ± 4.3% 
increase in heart rate (n=13). RO-20-1724 (10~3 M), in 12 preparations, 
increased contraction rate only slightly (4.9 ± 2.4%). Theophylline (1 O'3 
M) had no effect (n=6). Finally, SQ 20,009 (10'4 M) had no effect on heart 
rate (n=14). At higher doses SQ 20,009 caused the cardiac rhythm to 
become irregular.
Cyclic nucleotide analogues, like forskolin and IBMX, mimicked the 
action of amines on the isolated Limulus cardiac ganglion (Fig. 13). The 
cAMP analogues 8-benzylthio cAMP and 8-parachloro-phenylthio cAMP, at 
10'3 M, produced increases of 49.7 ± 9.7% (n=9) and 33.9 ± 7.7% (n=7), 
respectively, in the burst rate of cardiac ganglia exposed to these agents 
for 30 min. The phosphodiesterase inhibitor RO-20-1724, at 10'3 M, had 
only a mild stimulatory effect on cardiac ganglion burst rate (18.0 ± 8.4% 
increase, n=8). The finding that RO-20-1724 did not increase cardiac 
ganglion cAMP (Table 1) was consistent with its weak effect on cardiac 
ganglion burst rate.
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Potentiation of amine responses bv IBMX
Octopamine, dopamine or IBMX were topically applied to the 
continually perfused Limulus heart preparation at doses that produced only 
slight increases in contraction rate. After the contraction rate returned 
to its original value, the same dose of amine was then added with IBMX 
present. Dopamine produced a 21.4 + 5.7% (n=7) greater increase on heart 
rate when IBMX was present, and octopamine elicited a 13.5 ± 2.7% (n=7) 
greater response with IBMX (Fig. 9a). At this low dose (1 ml, 10'5 M), IBMX 
itself had a minimal effect on heart rate (2.6 + 1.7% increase, n=14).
IBMX also potentiated amine-induced elevation of cAMP. At 10'4 M, 
IBMX had no effect on levels of cardiac ganglion cAMP after 3 min 
incubation. However, when IBMX was combined with a threshold dose 
(10'6 M) of either OCT or DA, significant increases in cAMP were produced 
after 3 min (Fig. 9b). These results suggest that in the cardiac ganglion, 
IBMX suppressed cAMP-dependent phosphodiesterase activity sufficiently 
to permit additional cAMP accumulation with exposure to low doses of 
amine. Therefore, inhibition of phosphodiesterase activity in the Limulus 
cardiac ganglion was associated with potentiation of the physiological and 
biochemical actions of amines.
Suppression of cAMP accumulation bv phentolamine
The alpha-adrenergic receptor antagonist phentolamine (10"4 M) 
inhibited the elevation of cAMP induced by 10"5 M OCT or 10"5 M DA in the 
Limulus cardiac ganglion (Fig. 10). Suppression of amine-induced 






























Fig. 9. Potentiation of physiological and biochemical effects of amines in the Limulus cardiac 
ganglion. A. The phosphodiesterase inhibitor IBMX enhanced the chronotropic effects of 
either OA (1CT6 M in 1 mi) or OCT (3 x 10'7 M in 1 ml). B. In separate experiments, IBMX 
also enhanced the capacity of DA (1 O'6 M) or OCT (10‘6 M) to increase cardiac ganglion 
cAMP. IBMX (1 O'4 M) was added to isolated cardiac ganglia in the presence or absence of 
amine for 3 min after which cardiac ganglion cAMP levels were measured by RIA. In either 
type of experiment, level of significance was determined using a paired Student's t-test 
comparing the effects of a particular amine + IBMX to the sum of the effects of that amine and 
IBMX added individually.























Fig. 10. The alpha-adrenergic antagonist phentolamine blocked amine-induced increases in 
cardiac ganglion cAMP. Cardiac ganglia were treated with 1(T5 M DA or OCT for 3 min in the 
presence or absence of 10*4 M phentolamine and then processed for cAMP content. Numbers 
positioned over the areas representing cAMP accumulation in ganglia exposed to amine + 
phentolamine signify the percent inhibition by phentolamine of the response to a particular 
amine in comparison to control cAMP levels.
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for DA in this tissue. Earlier findings indicated that phentolamine 
effectively blocks amine induced excitation of heart rate in Limulus 
(Augustine et al., 1982). Together, these findings indicate that 
phentolamine blocks the excitatory chronotropic action of amines by 
inhibiting amine-induced synthesis of cAMP in the cardiac ganglion.
Pharmacological agents: effects on follower neuron bursting activity
Forskolin (5x 10"6 M) and IBMX (10"3 M) produced multiple 
amine-like effects on the bursting activity of individual follower neurons 
in the Limulus cardiac ganglion (Figs. 11,12). First, interburst interval 
was decreased by these agents as burst frequency increased. Second, the 
duration of each burst was shortened. Finally, the number of action 
potentials fired per burst decreased as the plateau component of each 
burst was compressed. These changes in burst parameters are quite 
similar to those elicited by amines (Augustine and Fetterer, 1985).
Cyclic nucleotide agents also had amine-like effects on follower 
neuron bursting activity (Fig. 13). Both 8-benzylthio cAMP and 
8-parachloro-phenylthio cAMP, at 10"3 M, produced alterations in follower 
neuron burst characteristics similar to those observed during the 
application of amines, forskolin or IBMX.
Direct effects of forskolin and IBMX on follower neurons
Follower neurons were pharmacologically isolated from pacemaker 
neuron input with the introduction of 30 mM Mn++ to the bath. At this 








Fig. 11. Amines (1 O'5 M), forskolin (5 x 1 c 6 M) and IBMX (1 O'3 M) alter several 
characteristics of follower cell activity in the Limulus cardiac gagnlion. Agents were perfused 
over the ganglion for 10 min and then removed from the bathing solution. Left: intracellualar 
recordings of follower cells 1 min before addition of a particular agent. Right: recordings of 
the same cells during the peak rate response of the cardiac ganglion to a particular amine or 
drug. Follower neuron bursts were more frequent, shorter in duration and contained fewer 






























Fig. 12. Time course of alteration in follower cell characteristics in cardiac ganglia exposed 
to 5 x 10 '6 M forskolin or 10 '3 M IBMX for 10 min. Interburst interval (A), burst plateau 
duration (B) and number of action potentials recorded per burst (C) all declined during 
application of these agents. These effects were long-lasting and only gradually returned 
towards control values as the burst rate in the cardiac ganglion declined. Each point 





Fig. 13. Cyclic nucleotide analogs produced amine-like effects on the Limulus cardiac 
ganglion. At 10*3 M. 8-benzylthio cAMP and 8-parachloro phenylthio cAMP increased 
cardiac ganglion burst rate (top record in each trace). These agents, like the amines, also 
decreased follower neuron interburst interval, burst duration and the number of spikes per 
burst (bottom record in each trace). Calibration: vertical, 50 pV (top); 10 mv (bottom); 
horizontal, 2 sec.
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in the cardiac ganglion. Follower neurons were depolarized by 10-15 mV 
and became quiescent, with the exception of infrequent (< 1 per 10 min) 
and small (1-2 mV) changes in resting potential.
In cobalt-treated cardiac ganglia, DA decreases the apparent input 
resistance of and hyperpolarizes these cells, while OCT depolarizes 
follower neurons without altering apparent input resistance (Augustine 
and Fetterer, 1985). In the present study, similar effects of these amines, 
at 10'5 M, were observed in follower cells of cardiac ganglia treated with 
manganese (Fig. 14). Forskolin, at 5 x 10"6 M, depolarized these cells by 
7.4 ± 0.7 mV (n=8) and IBMX, at 10'3 M, produced a 6.0 ±1.1 mV 
depolarization (n=9) over the course of 15 min drug application. Neither 
forskolin or IBMX altered the apparent input resistance of follower 
neurons.
In these experiments, amines, forskolin and IBMX all increased the 
frequency and magnitude of changes in follower neuron resting potential 
(Fig 14). These changes in resting potential resembled follower neuron 
bursts to some extent, since they consisted of a sharp rise in potential 
followed by a slow depolarizing plateau. Like the depolarizing effect of 
octopamine and the pharmacological agents, this effect persisted well 









Fig. 14. Effects of DA (1 O'5 M), OCT (10'5 M), forskolin (5 x 10*6 M) and IBMX (10‘3 M) on 
follower neurons in Limulus cardiac ganglia pretreated with 30 mM manganese to isolate these 
cells from synaptic input. While DA hyperpolarized follower neurons, OCT. forskolin and IBMX 
all gradually depolarized these cells by several mV. Input resistance was decreased slightly 
during exposure to DA, as evidenced by a lesser response to current injection and a reduction in 
the amplitude of membrane "noise". Other agents did not influence apparent input resistance. All 
these agents elicited burst-like potential changes in follower cells after several minutes. 
Calibration: vertical, 15 mV; horizontal, 1 min.
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DISCUSSION
The findings of this study indicate that the excitatory chronotropic 
actions of OCT, EPI, DA and NE on the neurogenic Limulus heart result from 
amine-induced increases in levels of cAMP in the cardiac ganglion. The 
magnitude of the excitatory effect of these amines on burst frequency in 
the cardiac ganglion was precisely correlated with their relative effects 
on cAMP metabolism within this tissue. Further, pharmacological agents 
which also increased cardiac ganglion cAMP had amine-like effects on 
heart rate and on burst rate in the isolated cardiac ganglion. These agents 
also mimicked several actions of the amines on follower cell activity.
Finally, cGMP was not involved in any actions of the amines. Octopamine
I
and the catecholamines apparently utilize a common second messenger, 
cAMP, to produce their characteristic excitation of heart rate in Limulus.
Amines, especially octopamine, have excitatory chronotropic actions 
on other neurogenic hearts in a variety of crustacean species (Grega and 
Sherman, 1975; Battelle and Kravitz, 1978; Florey and Rathmayer, 1978; 
Miller and Sullivan, 1981). Neurons of the cardiac ganglion are the cellular 
site of chronotropic amine actions on the neurogenic heart of crustaceans
i
(reviewed by Beltz and Kravitz, 1986) and Limulus (Augustine and 
Fetterrer, 1985). Further, OCT has been reported to increase the cAMP 
content of cardiac ganglia in crabs and lobsters (Sullivan and Barker,
1975). However, this is the first study to demonstrate a cAMP-dependent 
mechanism underlying chronotropic amine actions on any neurogenic heart.
Role of cAMP in chronotropic amine actions
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In the Limulus cardiac ganglion, the small (20-40 jim) bipolar or 
multipolar cells control the heartrate (Lang, 1971a). These neurons 
exhibit a slowly decaying pacemaker potential which leads to a single 
overshooting action potential during each heartbeat. The pacemaker 
neurons apparently synapse with larger (60-150 pm) follower neurons and 
initiate the burst activity in these cells.
Octopamine and the catecholamines DA, EPI and NE all increase burst 
frequency in the Limulus cardiac ganglion by increasing the frequency of 
pacemaker neuron action potentials (Augustine and Fetterer, 1985). These 
amines increase the rate of pacemaker potential depolarization between 
action potentials and increase the rate of pacemaker repolarization. A 
consideration of the biochemical and pharmacological data outlined in this 
chapter suggests that the excitatory action of these amines on the Limulus 
cardiac ganglion is probably the result of elevated cAMP in the pacemaker 
neurons. Amines, forskolin and IBMX had identical effects on heart 
contraction rate, ganglionic burst rate or follower cell activity. All of 
these agents increased cardiac ganglion cAMP to a degree matched 
precisely with their capacity to increase burst rate in the isolated cardiac 
ganglion. Potentiation or suppression of chronotropic amine action was 
associated with enhanced or inhibited synthesis, respectively, of cAMP in 
the cardiac ganglion. Therefore, cAMP clearly is the second messenger 
underlying the positive chronotropic actions of amines on the Limulus 
cardiac ganglion, and these actions most likely involve increased cAMP 
synthesis in the pacemaker neurons.
Role of cAMP in amine actions on follower neurons
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Excitation of burst rate in the Limulus cardiac ganglion by amines, or 
by other agents which also increased cAMP, was associated with an 
alteration of activity in the follower, or motor neurons. Cyclic AMP 
appears to be involved in some direct amine actions on follower cells.
Both OCT and EPI gradually depolarize follower neurons without affecting 
membrane conductance (Augustine and Fetterer, 1985). The depolarizing 
action of OCT on pharmacologically isolated follower cells was mimicked 
by adenylate cyclase activation or phosphodiesterase inhibition.
Therefore, OCT and EPI probably depolarize follower neurons by increasing 
cAMP in these cells.
The hyperpolarizing effect of DA and NE on follower neurons, on the 
other hand, involves a rapid conductance increase (Augustine and Fetterer, 
1985). Apparently, neither of these effects of DA and NE involves cyclic 
nucleotides, since they are not mimicked by forskolin or IBMX.
Many of the effects of amines on follower cell activity (decreased 
interburst interval, burst duration, or number of action potentials per 
burst) appear to be an indirect consequence of increased pacemaker firing 
frequency (Augustine and Fetterer, 1985). Local application of DA onto 
pacemaker neurons produces these characteristic follower cell responses, 
suggesting that amine-induced alteration in pacemaker input to these 
cells underlies the observed changes in follower burst activity. Further, it 
is possible to entrain the bursts of isolated cardiac ganglia with rhythmic 
electrical stimuluation and gradually increase burst rate in the absence of 
amines (Watson and Groome, unpublished results). In these experiments, 
artificially increased burst rate resulted in an alteration of follower 
neuron burst activity similar to that elicited by amines or forskolin.
These findings suggest that cAMP may be only indirectly responsible (by
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increasing burst rate) for observed changes in follower neuron burst 
activity during amine application.
Possible involvement of cAMP in pacemaker-follower svnaptic efficacy
The observation that follower cells exposed to 30 mM Mn++ exhibited 
(albeit very infrequently) small changes in resting potential indicates that 
Mn++ was not quite as effective as other cations (e. g. cobalt, Augustine 
and Feterrer, 1985 and personal observations) in blocking 
calcium-dependent synaptic transmission in the Limulus cardiac ganglion. 
Therefore, pacemaker neurons may release transmitter during Mn++ 
blockage which at times is sufficient to elicit partial activity in the 
follower cells.
The results of the experiments performed with Mn++ suggest a 
possible action of amines in this system that has not previously been 
described. Marked increases in the size, duration and frequency of these 
potential changes occurred during exposure to OCT, DA, forskolin and IBMX. 
These potential changes resembled, to some extent, the burst activity in 
follower cells receiving normal pacemaker input. In cobalt-treated 
cardiac ganglia, application of amines does not result in the appearance of 
burst-like potentials (Augustine and Feterrer, 1985 and unpublished 
observations).
The appearance of these burst-like potential changes in Mn++ treated 
follower neurons may be the expression of a cAMP-mediated action of 
amines to enhance synaptic efficacy between pacemaker and follower 
neurons. Amines may increase cAMP in pacemaker neuron terminals, 
leading to an increase in the amount of transmitter released per
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pacemaker action potential (the pacemaker-follower synapse appears to be 
chemical, Augustine and McCulloh, unpublished).
It is possible that these burst-like potential changes represent the 
appearance of slow driver potentials in Limulus cardiac ganglion neurons. 
Calcium-dependent driver potentials have been demonstrated in the 
cardiac ganglion of several crustacean species (Tazaki and Cooke, 1979; 
Berlind, 1982). In lobsters, the small pacemaker neurons exhibit 
oscillating driver potentials while the driver potential of the larger 
motorneurons is triggered by synaptic input from the pacemaker cells 
(Hartline, 1979; Tazaki and Cooke, 1983). Interestingly, driver potentials 
of the pacemaker neurons in the isolated Homarus cardiac ganglion are 
particularly resistant to manganese in the bathing saline (Berlind, 1985).
In Limulus. amines may utilize cAMP to enhance (e. g. via increased 
transmitter released from pacemaker neurons) a driver potential present 
in follower neurons. Possible amine/cAMP influences on driver potentials 
in follower neurons can only be thoroughly investigated, however, if such 
potentials can be demonstrated in these cells.
Enhancement of the plateau component of the follower neuron burst 
may be of considerable importance in coordinating the effects of amines 
on heart contraction rate and strength. Several facts outline the 
relationship between follower cell activity, ganglionic burst rate and 
heart contraction amplitude. First, the follower cell burst is initiated by 
a rapid depolarization consisting of summated EPSP's (Palese et al., 1970; 
Lang, 1971a). Second, burst plateau duration is associated with the 
relative number of action potentials delivered to the cardiac muscle fibers 
per burst (Augustine and Fetterer, 1985; Watson et al., 1985). Finally, 
increases in cardiac ganglion burst rate are associated with decreased
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plateau duration and, presumably, decreased motor output to cardiac 
muscle fibers (Watson et al., 1985; Watson and Groome, unpublished). The 
amines may act, via cAMP, on pacemaker terminals to enhance transmitter 
release, increasing the size of the compound EPSP in follower neurons. 
Enhancement of follower cell depolarization could be important to 
lengthen the plateau portion of the burst. Therefore, the ultimate 
consequence of this possible action of amines might be directed at 
enhancing heart contraction strength, or at least offsetting the negative 
effects of increased rate on heart contraction amplitude.
Amine receptors and adenylate cvclase in the cardiac ganglion
Octopaminergic and catecholaminergic excitation of heart rate or 
burst rate in the isolated Limulus cardiac ganglion is blocked by the 
alpha-adrenergic antagonist phentolamine (Augustine et al., 1982;
Augustine and Fetterer, 1985). These results pointed out the similarity of 
amine action on the Limulus heart to OCT responses in other invertebrate 
preparations (Batta et al., 1979; Orchard, 1982; Classen and Kammer,
1986; Lange and Orchard, 1986; Evans, 1987). Octopamine receptors have 
been extensively characterized in insects (reviewed by Evans, 1980). Of 
these, OCT2 receptors are specifically linked to adenylate cyclase
(Nathanson, 1985; Lange and Orchard, 1986; Pannabecker and Orchard, 
1986). These receptor types have been described in insect nervous tissue 
(Nathanson, 1979; Gole et al., 1983, Morton, 1984), smooth muscle (Lange 
and Orchard, 1986; Orchard and Lange, 1986) and skeletal muscle (Evans, 
1984 b.c; Evans, 1987).
An octopamine-sensitive adenylate cyclase has also been described
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in the Limulus protocerebrum and circumesophageal ganglia (Atkinson et 
al., 1977). The similarity of octopamine actions on adenylate cyclase 
activity in the Limulus brain and cardiac ganglion suggests the presence of 
OCT2 receptors in these tissues. Dopamine inhibits the ability of
octopamine to activate adenylate cyclase in the Limulus brain, even though 
DA does appear to activate this enzyme in the cardiac ganglion.
The pharmacological profile of adenylate cyclase activity in the 
Limulus cardiac ganglion suggests the presence of separate OCT and DA 
receptors positively linked to adenylate cyclase. Phentolamine did inhibit 
the ability of both amines to increase cardiac ganglion cAMP, but its 
effect was markedly greater for OCT-induced than for DA-induced cAMP 
elevation. However, OCT itself was more potent than DA in its action to 
stimulate cAMP production. These data suggest that, in the Limulus 
cardiac ganglion, DA acts on a receptor distinct from the OCT receptor. 
Therefore, in Limulus. as in several other arthropods (cockroach - Harmar 
and Horn, 1977; moth - Bodnaryk, 1979; mosquito - Pratt and Pryor, 1986), 
separate OCT and DA receptors may be linked to a common second 
messenger system.
Cyclic AMP, cyclic GMP and phosphodiesterase activity in the Limulus 
cardiac ganglion
Cyclic GMP does not appear to be involved in excitatory actions of 
amines on the Limulus cardiac ganglion. None of the amines, or forskolin, 
influenced levels of cardiac ganglion cGMP. However, IBMX was extremely 
potent in its capacity to increase cGMP in this tissue. The relative 
increases in cAMP and cGMP in the cardiac ganglion after exposure to 10’3
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M IBMX indicate that while this agent supressed both cAMP- and 
cGMP-dependent phosphodiesterases, its action was greatest on the 
cGMP-dependent phosphodiesterase.
Although IBMX significantly increased cardiac ganglion cGMP, this 
effect was not correlated with an observed physiological response. 
Forskolin, OCT and the catecholamines, on the other hand, increased 
cardiac ganglion cAMP in proportion with their ability to increase burst 
rate, but had no effect on cardiac ganglion cGMP. Therefore, while 
increases in cardiac ganglion cGMP may bear some physiological 
significance, cGMP does not appear to piay a role in chronotropic amine 
modulation.
The kinetics of amine actions on cAMP levels within the Limulus 
cardiac ganglion indicate the presence of a strong cAMP-dependent 
phosphodiesterase. Removal of amine from cardiac ganglion receptors 
resulted in a rapid drop in cardiac ganglion cAMP. Cardiac ganglion burst 
rate declined during the wash period at a slower rate, presumably due to a 
gradual reversal o f cAMP stimulation of protein kinase A activity and of 
protein phosphorylation.
In the intact heart, negative inotropic actions of amines may occur 
during periods of intense chronotropic excitation. The physiological 
significance of strong phosphodiesterase activity in the Limulus cardiac 
ganglion may be tha t possible negative inotropic actions of amines are 
offset by limiting the duration of chronotropic amine actions. Relative 
phosphodiesterase activities in the cardiac ganglion and in cardiac muscle 
may coordinate the biochemical effects of amines in these tissues as one 
means to maximize cardiac output.
7 7
In summary, cyclic AMP is a general effector of amine action in the 
Limulus cardiac ganglion. Octopamine and the catecholamines DA, EPI and 
NE exert their positive chronotropic actions via a cAMP-, but not cGMP- 
dependent mechanism most likely occuring within pacemaker neurons. 
Octopamine, but not DA, utilizes cAMP to depolarize follower cells.
Finally, both OCT and DA may enhance synaptic efficacy within the cardiac 
ganglion. Apparently, amines utilize a common second messenger, cAMP, 




MECHANISM FOR AMINE ACTIONS ON CARDIAC MUSCLE 
CONTRACTILITY AND ON NEUROMUSCULAR TRANSMISSION
IN THE LIMULUS HEART
ABSTRACT
The mechanism by which octopamine, dopamine, norepinephrine and 
epinephrine increase heart contraction strength in Limulus was 
investigated. Amines produced a long-lasting increase in the amplitude of 
spontaneous (neurally evoked) or electrically evoked heart contractions. At 
10'5 M, the apparent order of potency for amine-induced increases in 
evoked contraction amplitude was dopamine ~ octopamine > norepinephrine 
~ epinephrine. Amines also elevated cardiac muscle cAMP (octopamine > 
dopamine ~ norepinephrine ~ epinephrine) in a dose-dependent manner. 
None of the amines influenced levels of cGMP in Limulus cardiac muscle.
Forskolin, an activator of adenylate cyclase, enhanced cardiac muscle 
contractility and increased levels of cAMP, but not cGMP, in cardiac muscle 
tissue. The phosphodiesterase inhibitor IBMX occasionally increased 
cardiac muscle contractility for a short period, but typically had 
long-lasting negative effects on contractility. This agent increased levels 
of both cAMP and cGMP in Limulus cardiac muscle.
Forskolin, and to a lesser extent IBMX, had amine-like effects on 
cardiac neuromuscular transmission. These agents elicited a prolonged 
increase in the size of evoked, unitary excitatory junction potentials
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(EJP's) in cardiac muscle fibers without affecting the apparent input 
resistance of these cells. The results of these studies indicate that cAMP 
acts as a second messenger of excitatory inotropic amine actions on 
multiple cellular targets in the Limulus heart.
8 0
INTRODUCTION
The neurogenic heart of the horseshoe crab, Limulus polvphemus. is 
modulated by a number of biogenic amines endogenous to the CNS and 
cardiac ganglion (Augustine et al., 1982). These amines, which include 
octopamine (OCT), dopamine (DA), norepinephrine (NE) and epinephrine (EPI) 
act on multiple cellular targets within this system to produce increases in 
both the strength and rate of heart contractions (reviewed by Watson and 
Augustine, 1982).
The excitatory inotropic effects of these amines on the Limulus 
heartbeat are the result of enhancement of both cardiac neuromuscular 
transmission and cardiac muscle contractility (Watson and Hoshi, 1981;
Watson et al., 1985). Amines appear to act presynaptically to increase 
individual quanta of transmitter released by follower neurons onto cardiac 
muscle fibers. They also act postsynaptically on the muscle fibers to 
enhance contractility, apparently by altering the process of 
excitation-contraction coupling.
While the cellular sites of inotropic amine actions in this system 
have been determined, the biochemical mechanisms by which aminergic 
modulation of heart contraction amplitude is effected have not been 
investigated previously. In this chapter, the role of cyclic nucleotides in 
amine actions on cardiac neuromuscular transmission and on cardiac 
muscle contractility is examined.
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METHODS
Recordings of cardiac muscle contractions
Recordings from intact Limulus hearts were carried out as described 
in Appendix - General Methodology. To examine the direct effect of amines 
and drugs on cardiac muscle contractility, cardiac muscle rings (1-2 cm) 
were excised from deganglionated hearts. Muscle contractions were evoked 
by electrical stimulation using a modification of the technique employed by 
Watson et al. (1985). A lateral edge of each muscle ring was pinned to the 
bottom of a 20 ml stimulation chamber. A steel pin was inserted through 
the lumen of the ring and attached via a threaded hook to a force transducer 
(Grass FT. 03C). Contractions were evoked by passing current (1-2 volts,
80 msec at 0.1-0.2 Hz) between vertical stainless steel plate electrodes 
located 2 mm to either side of the cardiac muscle ring. Two stimulators 
(Grass Model SD 9) were synchronized (100 msec delay) to send equal and 
opposing current pulses to prevent electrode plate polarization.
Contraction force was recorded with an oscillograph (Grass Model 79D).
The preparation was perfused continuously at 5 ml/min with seawater at 
room temperature. Test solutions were added via the perfusion reservoir.
Neuromuscular transmission
Small sections (2-3 cm) of deganglionated Limulus hearts were 
opened with a mid-ventral incision and pinned, dorsal side up, to the 
bottom of a 5 ml perfusion chamber. Flow rate was adjusted to 
approximately 3 ml/min. The membrane potential of cardiac muscle fibers 
was recorded (Dagan 8700) after impaling the cells with 10-25 MQ glass
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microelectrodes filled with 3 M KCL. Potentials were displayed and 
monitored on an oscilloscope (Tektronix 5111). A  suction electrode was 
used to stimulate residual motor nerves in this region of the preparation, 
thereby eliciting excitatory junction potentials (EJP's) in these muscle 
fibers. Stimulation parameters were adjusted (0.1 -0.4 V, 2-6 msec at 0.5 
pps) to obtain the smallest, or unitary, EJP's. Successive EJP's were 
averaged (30 sweeps) and stored at 5 min intervals using a Nicolet digital 
oscilloscope (Nicolet Biomedical Instr., Madison, Wisconsin). Test 
solutions were added to the preparation via the perfusion reservoir.
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RESULTS
Amine effects on naturally occurinq or evoked heart contractions
As has been reported earlier (Augustine et al., 1982; Watson et al., 
1985), dopamine and octopamine typically produced long-lasting increases 
in contraction amplitude when applied to the intact Limulus heart 
preparation (Fig. 1a, Chapter One). The positive inotropic effect of DA was 
preceded by a transient inhibition of contraction amplitude. Norepinephrine 
and epinephrine also increased heart contraction strength, but to a lesser 
extent.
In order to test the effect of amines on cardiac muscle contractility, 
deganglionated myocardial rings were prepared and contractions were 
evoked by electrical stimulation. All of the amines tested, at 10"5 M, 
produced a gradual increase in the amplitude of evoked heart contractions 
(Table 2, Fig. 1). Both DA and OCT had larger effects than either NE or EPI 
at this dose. The enhancement of evoked heart contraction amplitude by DA 
and OCT was particularly long-lasting (Fig. 2). Contractions typically 
continued to increase in size for at least 15 min after removal of amine 
from the bath and only gradually declined to control height with 1-2 hr 
continuous washing.
Amine effects on levels of cyclic nucleotides in cardiac muscle
Levels of cyclic AMP in Limulus cardiac muscle rings were elevated 
by 10'5 M amine (Table 2, Fig. 3a). Octopamine had a significantly greater 
effect on cardiac muscle cAMP than any of the other amines tested. The 
apparent order of potency, at 10~5 M, was OCT > DA ~ NE ~ EPI. Both DA and
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TABLE 2 - Physiological and biochemical effects of amines and 
pharmacological agents on Limulus cardiac muscle
AGE N I DOSE % CTL AM PL. pmol CAMP pmoLdBME
CONTROL 100 6.1 ± 1 .1  (10) 1.3 ±  0.2 (9)
Amines
OCT 1 0 '5 M 659.6 ±  135.4 (1 4 )f 54.6 ± 9 .6  (8 )f 0 .9  ± 0 .1  (6)
DA 10 '5 M 680.7 ± 1 6 3 .0  (18 ) f 16.4 ± 2 .6  (9)* 0 .8  ± 0 .1  (6)
NE 10 '5 M 227.7 ± 5 3 .7  (1 2 )f 14.9 ± 1.3 (8)* 1.1 ± 0 .2  (6)
EPI 1 0 '5 M 217.6 ± 9 9 .9  (12)* 14.4 ± 0 .5  (8)* 1.1 ± 0 .3  (6)
Pharmacological Agents
FORSK 5 X 10 '6 M 341.1 ±  100.4 (15)* 11.8 ± 0 .8  (8)* 1.6 ±  0.2 (6)
IBMX 10 '3 M 109.1 ± 5 .8 (1 4 )  
65.4 ± 5 .0  (14)*
10.6 ± 0 .5  (7)* 5.1 ± 1 .3  (6)1
SQ 20,009 10 '4 M 191.3 ± 2 4 .7  (6)* 7.4 ± 0 .6  (6)
RO-20-
1724
10‘3 M 135.5 ± 9 .8  (5)* 6.9 ± 0 .1  (6) . . . .
PAPAVERINE 1 0 '3 M 110.8 ± 6 .4  (4) 7.7 ±  1.0 _____
Table 2. Summary of the effects of various amines and agents on evoked contractions of 
deganglionated cardiac muscle and on levels of cyclic nucleotides in that tissue. T h e  mean 
(± S. E.) of n experiments (shown in parentheses) is represented for measurements of 
peak physiological effect, and for RIA measurements after 10 min incubation. Level of 
significant difference from control was determined by a Student’s t-test.
Level of significance: t  (p ^ -02); * (p ^ .05).
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Fig. 1. Amines, at 10'5 M, increased the amplitude of contractions of deganglionated cardiac 
muscle rings stimulated by electrical current pulses. Amines were added at the arrow and 
continually perfused over the preparation. Responses to DA and to O C T were more rapid and 
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Fig. 2. Dopamine (10‘5 M) and octopamine (10'5 M) produced similar long-lasting 
increases in the size of electrically evoked contractions of deganglionated cardiac muscle. 
Amines were added for 10 min, as indicated by the solid line, and contractions continued to 
increase for approximately 20 min after removal of amine from the perfusion solution. Each 











































Fig. 3. A. Both octopamine {10*5 M) and dopamine (10‘5 M) increased cardiac muscle cAMP 
levels with a  time course similar to their effect on evoked contraction amplitude. However, 
the relative magnitude of the cAMP increase for OCT is much greater than that for DA. Each 
point represents the mean content of cardiac muscle cAMP (± S. E.). in 8 to 9 experiments. B. 
Neither OCT or DA, at 10'5 M, increased the cGMP content of Limulus cardiac muscle.
8 8
OCT, at 10"5 M, produced long-lasting increases in cardiac muscle cAMP 
(Fig. 4). Amine-induced increases in cardiac muscle cAMP persisted for at 
least 20 min after removal of amine from the incubation solution. None of 
the amines increased cGMP in Limulus cardiac muscle (Table 2, Fig. 3b).
Amine-induced increases in cardiac muscle cAMP levels were 
dose-dependent (Fig. 5a), with a threshold of approximately 10"6 M at 3 
min incubation for either amine. Octopamine increased levels of cardiac 
muscle cAMP to a larger extent than dopamine at all doses tested (1 O'6 M 
to 5 X 10-5 M). Neither OCT or DA affected cardiac muscle cGMP content at 
any dose tested (Fig 5b).
Effects of forskolin and IBMX on naturally occurinq or evoked heart 
contractions
The adenylate cyclase activator forskolin and the phosphodiesterase 
inhibitor 3-isobutyl 1-methyl xanthine (IBMX) increased the strength of 
contractions when applied to the intact Limulus heart (Fig. 1 b, Chapter 
One). The excitatory inotropic effects of these compounds were 
dose-dependent (Fig. 6a), but forskolin was at least 100 X more potent than 
IBMX in its capacity to increase heart contraction strength.
The time course of the inotropic responses of the Limulus heart to 
forskolin and IBMX were quite different. Forskolin, at 5 x 10~6 M, in most 
preparations, elicited a gradual and prolonged increase in heart contraction 
amplitude (Fig. 1b (Chapter One), Fig. 6b). IBMX (1 O'3 M), on the other hand, 
consistently produced enhancement of heart contractions for only a short 
period of time, followed by a prolonged decrease in contraction amplitude. 
Such a biphasic inotropic response was also occasionally observed upon 
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Fig. 4. Time course of the onset and washoff of amine-induced cAMP increases in Limulus 
cardiac muscle. Octopamine (10'5 M) or dopamine (10'5 M) were added (solid line) to 
cardiac muscle rings for up to 10 min, or for 10 min followed by removal of amine. Each 
point represents the mean content of cardiac muscle cAMP (± S. E.) in 8 to 9 experiments. 




































Fig. 5. Dose-response curve for amine effects on levels of cyclic nucleotides in Limulus 
cardiac muscle. Tests were performed by incubating cardiac muscle rings in various doses of 
OCT or DA for 3 min. A. Octopamine produced greater increases in cardiac muscle cAMP than 
DA at all doses above threshold (10'6 M). B. Neither OCT or DA, at any dose, influenced 
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Fig. 6. Forskolin and IBMX, agents which elevate cAMP levels in Limulus cardiac muscle, 
produced increases in the contraction amplitude of the intact heart. A. Both agents produced 
dose-dependent increases in heart contraction amplitude. Each point represents the mean 
increase ±  S. E. in 10 to 16 experiments. B. Forskolin (5 x 10'® M, n-14) produced a 
long-lasting increase in contraction amplitude. IBMX (10-3 M, n=14) had a short-lived 
positive inotropic effect, followed by long-lasting inhibition of contraction amplitude.
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Forskolin, at 5 X 10"6 M, induced a gradual and long-lasting increase 
in the size of evoked heart contractions (Table 2, Fig. 7). Enhancement of 
contraction amplitude was not blocked by pre-treatment of the preparation 
with 3 X 1CT7 M tetrodotoxin (TTX). Since TTX appears to block residual 
neuronal activity in this preparation (Watson et al., 1985), this result 
suggests a direct effect of forskolin upon cardiac muscle fibers to increase 
contractility.
In contrast to the positive inotropic effect of forskolin, IBMX (10‘3 
M) consistently decreased the amplitude of evoked contractions (Table 2, 
Fig. 7). The effect of IBMX was long-lasting and TTX-resistant. However, 
in 6 of 14 experiments, IBMX elicited a transient increase in contraction 
amplitude prior to the onset of inhibition (not shown).
Effects of forskolin and IBMX on levels of cyclic nucleotides in cardiac
muscle
Forskolin, at 5 x 10'6 M, and IBMX, at 10"3 M, significantly elevated 
cardiac muscle cAMP (Table 2). Levels of cAMP in cardiac muscle were 
increased to 164.1 ± 6.6% control (n=8) after 10 min exposure to forskolin, 
while IBMX increased cardiac muscle cAMP to 172.8 + 8.0% control (n=7) at 
this time point. IBMX, but not forskolin, also increased levels of cardiac 
muscle cGMP (Table 2). The percentage increase in cardiac muscle cGMP 
elicited by IBMX (401.3 ± 102.9% control, n=6) at 10 min was greater than 
the corresponding cAMP increase in this tissue.
A comparison of the physiological and biochemical effects of amines, 
forskolin and IBMX suggested a rather weak correlation between effects on 
levels of cardiac muscle cAMP and enhancement of evoked contractions by 
























Fig. 7. Effect of forskolin (5 x 1CT6 M) and IBMX (10'3 M) on electrically evoked 
contractions in Limulus cardiac muscle rings. A. Records of contractions before and 30 min 
after initial addition of agent to the preparation. Calibration: vertical 1.5 g; horizontal, 1 
min. B. The time course of the effect of forskolin and IBMX (added for 15 min; solid line) on 
evoked contractions was similar to that on the intact heart. Each point represents the mean 
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Fig. 8. Relationship between capacity of amines (10*5 M), forskolin (5 x 10~6 M) and IBMX 
(1 O'3 M) to increase cardiac muscle cAMP and to alter cardiac muscle contractility. For each 
point, the y co-ordinate represents the mean increase in cardiac muscle cAMP ± S. E. in 7 to 9  
experiments ater 10 min incubation. The x co-ordinate represents the mean increase in 
amplitude of evoked heart contractions in 12 to 18 experiments after 10 min exposure to a 
particular agent. Using all data points, a  simple regression indicated a poor correlation 
between the effects of these agents on cardiac muscle cAMP and on contractility (r -  0.60}. 
Using the four data points indicated in black, a  better correlation was observed (r -  0.98).
The agents which do not fit into this line (dopamine and IBMX) may affect other second 
messenger systems in Limulus cardiac muscle (see discussion).
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only OCT, NE, EPI and forskolin were considered. These findings suggest 
that DA and IBMX may influence cardiac muscle contractility in a way 
which is not solely dependent on their capacity to increase cardiac muscle 
cAMP.
Effect of IBMX on DA- and OCT-induced inotropic responses and cAMP 
elevation in cardiac muscle
The phosphodiesterase inhibitor IBMX was ineffective in potentiating 
the effects of threshold doses of either DA or OCT to 1) increase the 
contraction strength of the intact Limulus heart (Fig 9a) or 2) elevate 
levels of cardiac muscle cAMP (Fig. 9b). Pharmacological and biochemical 
tests were performed in the same manner as described in Chapter One.
Suppresion of amine-induced increases in cardiac muscle cAMP by 
phentolamine
The alpha-adrenergic antagonist phentolamine, at 10'4 M, blocked the 
elevation of cAMP in cardiac muscle rings exposed to either 10'5 M DA or 
to 10-5 M OCT for a period of 3 min (Fig. 10). As was observed in tests of 
the cardiac ganglion, phentolamine was more effective in inhibiting the 
effect of OCT on cardiac muscle cAMP levels than it was in suppressing the 
corresponding effect of DA. Phentolamine itself had a negligible effect on 
levels of cAMP in Limulus cardiac muscle.
Neuromuscular transmission
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Fig. 9. The phosphodiesterase inhibitor IBMX did not potentiate amine-induced physiological 
or biochemical actions in Limulus cardiac muscle. A. IBMX, at doses ranging from 10’5 M to 
lO '4 M in 1 ml. had a slight effect on heart contraction amplitude. IBMX did not enhance the 
inotropic action of either DA (10"6 M in 1 ml) or OCT (3 x 10'7 M in 1 ml) on the intact 
Limulus heart. B. IBMX, at 10 '4 M. had no effect on the capacity of DA (10‘6 M) or OCT  























Fig. 10. The alpha-adrenergic antagonist phentolamine blocked amine-induced increases in 
cardiac muscle cAMP. Cardiac muscle rings were treated with 10‘5 M DA or OCT for 3 min in 
the presence or absence of 10-4 M phentolamine. Numbers positioned over the areas 
representing cAMP accumulation in cardiac muscle exposed to amine + phentolamine signify 
the percent inhibition by phentolamine of the response to a particular amine in comparison to 
control cAMP levels.
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by the application of 5 X 10'6 M forskolin or by 10'3 M IBMX (Fig. 11). This 
effect was slow in onset and long-lasting, similar to the reported effect of 
DA on this preparation (Watson et al., 1985). Application of forskolin 
caused a larger and more prolonged increase in EJP size (180.2 ± 5.9% 
control, n=11)than that produced by IBMX (131.2 +7.0%  control, n=14). 
Neither agent altered the apparent input resistance or resting membrane 













Fig. 11. Forskolin and IBMX enhance cardiac neuromuscular transmission. A. Record of 
averaged (30 sweeps) excitatory junction potentials (EJP's) in cardiac muscle fibers before 
and during peak response to 5  x 10'6 M forskolin. Calibration: vertical, 2 mV; horizontal,
80 ms. B. Time course of the increase in EJP size after addition (solid line) of forskolin (5 x 
10*® M) or IBMX (10"3 M). Apparent input resistance was unaltered by either forskolin or 
IBMX, as indicated by no change in the response of cardiac muscle fibers to a hyperpolarizing 
current pulse prior to elicitation of the EJP.
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Amines regulate the strength of heart contractions in Limulus by 
their actions on cellular targets in both the cardiac ganglion and in the 
myocardium. Specifically, cAMP appears to be an important second 
messenger of amine actions on both cardiac muscle contractility and on 
neuromuscular transmission. While cAMP may be the sole second 
messenger underlying the actions of OCT, NE and EPI to enhance cardiac 
muscle contractility, DA appears to use some other mechanism, in addition 
to cAMP, to elicit a similar effect.
The importance of cAMP as a second messenger in the positive 
inotropic actions of amines has been documented for a wide variety of 
vertebrate species (Reuter, 1974; Tsien, 1977; Benfey, 1980; Kranias and 
Solaro, 1982; Earm et al., 1983; Macey et al., 1984). Similarly, a 
cAMP-dependent mechanism appears to underly the excitatory actions of 
amines on the myogenic hearts of a number of molluscan species (Higgins, 
1974; Weiss etal., 1982; Sawada etal., 1984; Paciotti and Higgins, 1985).
In contrast to these studies correlating cAMP with inotropic amine 
modulation of myogenic hearts, very little is known of the intracellular 
mechanisms by which amines enhance contraction strength in arthropod 
neurogenic hearts. Octopamine has been shown to increase the cAMP 
content and contraction strength of the lobster heart (Battelle and Kravitz, 
1978). However, in that study, physiological and biochemical tests were 
performed on the intact neurogenic heart, so the site of inotropic OCT 
action was not determined. Further, that study did not examine the role of 
cAMP in amine actions on cardiac neuromuscular transmission. The results 
from the present study of the Limulus heart represent the first 
demonstration of a cAMP-dependent mechanism underlying specific and
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localized actions of amines to enhance the contraction strength of a 
neurogenic heart.
Role of cAMP in amine actions on cardiac muscle contractility
Octopamine, NE, EPI and forskolin all increased the amplitude of 
electrically evoked contractions of Limulus cardiac muscle with a potency 
and time course consistent with their relative capacity to increase cardiac 
muscle cAMP. Since these effects are not affected by TTX, it appears that 
amines influence the process of excitation-contraction coupling in the 
Limulus heart by increasing cardiac muscle cAMP. Amines, most notably 
5-HT, also utilize cAMP to enhance E-C coupling in the hearts of Aplvsia 
(Sawada et al., 1984; Drummond et al., 1985) and Mercenaria (Higgins, 
1974, Paciotti and Higgins, 1985). Cyclic AMP has been implicated in a 
variety of direct actions of amines on other invertebrate muscles as well 
(Weiss etal., 1979; Ram eta l., 1983; Evans, 1984 b,c; Weiss et al, 1985; 
Gies, 1986). These and similar studies in vertebrates (reviewed by Cerione 
et al., 1983) suggest a general messenger role for cAMP in amine 
modulation of muscle contractility.
The subcellular sites of cAMP action in the Limulus heart are 
presently unknown. In the vertebrate heart, cAMP-dependent 
phosphorylation is important in regulating a number of processes 
influencing the strength of heart contractions (reviewed by Tsien, 1977; 
Katz, 1979; Winegrad et al., 1983). A likely site of action for cAMP in 
inotropic modulation in the Limulus heart is promotion of internal calcium 
release (e. g. phosphorylation of sarcoplasmic reticulum proteins, reviewed 
by Tada and Katz, 1982 and Kranias and Solaro, 1983). In invertebrates, 
cyclic AMP-induced release of internal calcium has been proposed as the
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means by which serotonin increases cardiac muscle contractility in Aplvsia 
(Sawada et al., 1984).
Dopamine effects on contractility and cardiac muscle cAMP
Dopamine, like the other amines tested, significantly increased cAMP 
in cardiac muscle with a time course similar to its effect on cardiac 
muscle contractility. However, the magnitude of the DA-induced cAMP 
increase, relative to its inotropic effect, was much less than that produced 
by OCT, NE or EPI. While DA appears to utilize cAMP to enhance cardiac 
muscle contractility, this amine probably employs some other system, in 
addition to cAMP, to produce its positive inotropic effect.
The peptide proctolin, like the amines, enhances cardiac muscle 
contractility (Benson et al., 1981; Watson et al, 1983). Dopamine has been 
shown to have a proctolin-like action on deganglionated Limulus heart 
muscle during glutamate-induced contractions (Watson et al., 1985). These 
authors speculated that dopamine and proctolin may act via similar 
mechanisms to produce their similar inotropic effects. In Chapter Four, the 
biochemical mechanisms underlying the similarity of dopamine and 
proctolin actions on Limulus cardiac muscle are investigated.
Role of cAMP in amine actions on neuromuscular transmission
Amines enhance cardiac neuromuscular transmission, and this effect 
contributes to overall inotropic modulation of the Limulus heart (Watson 
and Hoshi, 1981; Watson et al, 1985). The finding that, like the amines, 
forskolin and IBMX increased the size of EJP's in Limulus cardiac muscle 
fibers supports the hypothesis that amines utilize a cAMP-dependent
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mechanism in their excitatory action at the cardiac neuromuscular 
junction.
Increases in EJP size brought about by amines, forskolin or IBMX may 
be a result of cAMP elevation in follower cell terminals. Presynaptic 
cAMP-dependent protein kinase activity appears to be associated with the 
phosphorylation state of synaptic vesicles (Ueda and Greengard, 1977; 
Browning et al., 1987) and voltage-sensitive calcium channels (Curtis and 
Catterall, 1985; Armstrong and Eckert, 1987) in the vertebrate brain.
Cyclic AMP-dependent protein kinase has also been shown to be present and 
active in arthropod synaptosomes (Kelly, 1983; Haro et al., 1987). These 
findings suggest that cAMP may play an important role in the regulation of 
synaptic (e. g. neuromuscular) efficacy via modulation of transmitter 
release.
Other work indicates that Ca++ /  calmodulin protein kinase (Kelly,
1983; Llinas etal., 1985; Robinson et al., 1987) and calcium / phospholipid 
protein kinase (Yandrasitz et al., 1986; Nichols et al., 1987; Haimann et al., 
1987; Ozawa et al., 1987) also are important in the regulation of 
transmitter release. These systems may act independently or in concert 
with cAMP to modulate synaptic efficacy.
In Limulus. octopamine, the catecholamines and forskolin all produce 
a similar excitatory effect on evoked transmitter release at the 
neuromuscular junction. While cAMP appears to be important in this 
process, the contribution of other second messenger systems for the action 
of particular amines remains unknown. For example, dopamine may have a 
biochemical effect at the neuromuscular junction similar to its action in 
cardiac muscle, where the activity of multiple second messenger systems 
appear to be involved.
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Cyclic AMP and cyclic GMP as opposing regulators of heart contraction 
strength
Cyclic AMP appears to play a major role in the excitatory pre- and 
post synaptic inotropic effects of amines on the Limulus heart. Cyclic GMP 
is not involved in excitatory amine actions in this system. It is possible, 
however, that cGMP opposes the excitatory influences of cAMP on heart 
contraction strength.
The phosphodiesterase inhbitor IBMX increased levels of both cAMP 
and cGMP in the Limulus cardiac ganglion (Table 1, Chapter One). Increased 
cGMP in the cardiac ganglion might explain the relatively weak effect of 
IBMX on evoked EJP's. While forskolin (5 x 10'6 M) and IBMX (10‘3 M) 
increased cAMP to a similar extent in the cardiac ganglion, forskolin 
produced much greater and longer-lasting increases in EJP size than did 
IBMX. The magnitude of the effect of IBMX on evoked EJP's could possibly 
have been partially masked by concomitant increases of both cAMP and 
cGMP in follower neuron terminals. In the Mytilus anterior byssus 
retractor muscle, IBMX and 8-bromo cGMP relax muscle tension, apparently 
via actions in presynaptic terminals (Matsuura, 1984). However, cAMP has 
also been proposed as the messenger for relaxation in this system (Painter, 
1982b; Castellani and Cohen, 1987). Similarly, both cAMP and cGMP 
analogues mimic the inhibitory action of serotonin on neuromuscular 
transmission in the radula protractor muscle of Rapana (Fujiwara and 
Kobayashi, 1983). The nature of neuromuscular inhibition in these systems, 
and in Limulus. clearly requires a further investigation of the relative 
roles of cAMP and cGMP as possible intracellular messengers.
It is possible that the biphasic inotropic response of the Limulus 
heart to IBMX is a consequence of the biochemical effect of IBMX on both
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cAMP and cGMP content in cardiac muscle. IBMX clearly inhibited cardiac 
muscle contractility, even though it did increase cardiac muscle cAMP.
IBMX was capable of enhancing the strength of naturally occuring or evoked 
contractions, but only transiently. The negative inotropic effects of this 
compound may be a result of increased cGMP in Limulus cardiac muscle. In 
the locust Schistocerca. millimolar concentrations of IBMX increase levels 
of both cAMP and cGMP in the extensor tibiae muscle (Evans, 1984a). 
Increased muscle cGMP may oppose the stimulatory effects of cAMP on the 
myogenic rhythm in this preparation. In vertebrates, cGMP mediates 
contractile inhibition in vascular muscle in opposition to cAMP (Winquist 
et al., 1984; Macleod etal., 1987).
The discovery that cAMP and cGMP have opposing actions in many 
bidirectional systems has led to the hypothesis that these messengers are 
universal antagonists of intracellular regulation (Goldberg and Haddox,
1977). The results of the present study suggest that while this 
relationship may be applicable in the Limulus heart, further work is clearly 
necessary to clarify the role of cGMP in this system.
Contraction amplitude, heart rate and IBMX
A negative inotropic effect is sometimes observed during bath 
application of amines to the isolated, intact Limulus heart (Watson et al.,
1985). However, this effect appears to be a consequence of increased heart 
rate, and not a direct, negative effect of amines on cardiac muscle 
contractility. Further support for this hypothesis is suggested by a 
comparison of the effects of forskolin or IBMX on neuraly evoked (rate 
effects influence heart contraction amplitude) versus evoked heart 
contractions (rate effects eliminated). Forskolin elicited a much greater
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effect on contraction size when applied to electrically stimulated cardiac 
muscle in comparison to its effect on the intact heart. Additionally, IBMX 
decreased the size of evoked heart contractions to a lesser extent than it 
did the size of spontaneous contractions. Therefore, amines, forskolin and 
IBMX are all capable of reducing heart contraction amplitude due to 
excessive rate increases. However, IBMX also has a direct inhibitory action 
on cardiac muscle fibers, and this action may involve a cGMP-dependent 
mechanism.
Amine receptors and adenylate cvclase
A number of amine receptors may be present in Limulus cardiac 
muscle. The effects of phentolamine on OCT- and DA-induced elevation of 
cAMP in cardiac muscle suggest that separate OCT and DA receptors may be 
coupled to adenylate cyclase in this tissue. Multiple amine-sensitive 
adenylate cyclases have been described in Aplysia cardiac muscle (Kebabian 
et al., 1979; Drummond et al., 1985). In this system, 5-HT is approximately 
10 x more potent than DA in its ability to increase cardiac muscle cAMP, 
but the two amines are virtually equipotent with regard to inotropic 
actions on the Aplysia heart (Wernham and Lukowiak, 1983; Drummond et 
al., 1985). A similar discrepancy exists between OCT and DA in Limulus 
cardiac muscle; the relative magnitude of amine effects on adenylate 
cyclase activity and on inotropy are dissimilar. These findings suggest 
that in the myogenic Aplvsia heart, and in the neurogenic Limulus heart, DA 




Several facts indicate that the cAMP-dependent phosphodiesterase in 
cardiac muscle exhibits weak enzymatic activity in comparison to the 
phosphodiesterase present in the cardiac ganglion. First, cyclic AMP 
produced in cardiac muscle transiently exposed to amine was only slowly 
degraded to the inactive 5-AMP metabolite. Second, IBMX was ineffective 
in potentiating subthreshold doses of DA or OCT on heart contraction 
amplitude or cardiac muscle cAMP. Finally, various phosphodiesterase 
inhibitors had little or no effect on cardiac muscle cAMP.
The relative activities of cardiac ganglion and cardiac muscle cAMP 
phosphodiesterases may be important in the fine tuning of simultaneous 
modulation of heart contraction rate and strength by amines. As discussed 
in Chapter One, rate increases by amine-stimulated cAMP production in the 
cardiac ganglion may be limited by a highly active cAMP-dependent 
phosphodiesterase. Likewise, cAMP elevation (and contractility increases) 
may be maximized in Limulus cardiac muscle by a weak cAMP-dependent 
phosphodiesterase. A balance between the excitatory effects of amines on 
cellular targets in this system might be achieved by the relative activities 
of cardiac ganglion and cardiac muscle phosphodiesterases.
In summary, cAMP is an important second messenger of excitatory 
inotropic amine actions on the neurogenic Limulus heart. Amines utilize a 
cAMP-dependent mechanism to enhance cardiac neuromuscular 
transmission. Additionally, amines increase cardiac muscle contractility 
by increasing levels of cardiac muscle cAMP. Cyclic GMP may have a 
cAMP-opposing, inhibitory action on cardiac muscle contractility. These 
findings, taken together with the results presented in Chapter One, indicate 
that amine modulation of the Limulus heartbeat is effected, in general, by
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simulataneous increases in cAMP at specific cellular targets in the cardiac 
ganglion and in cardiac muscle.
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CHAPTER THREE
DISTRIBUTION AND PURIFICATION OF PROCTOLIN-LIKE AND
FMRFAMI DE-LIKE PEPTIDES IN THE LIMULUS NERVOUS SYSTEM
ABSTRACT
The distribution of proctolin-like and FMRFamide-like peptides in 
Limulus was determined by radioimunoassay. Immunoreactive (iR-) 
proctolin was found in greatest concentrations in the cardiac ganglion 
(185.8 ±  24.8 pg / mg). The brain (97.7 + 9.7 pg / mg), ventral nerve cord 
(74.1 ± 4.5 pg / mg) and cardioregulatory nerves (53.8 ± 7.5 pg / mg) also 
contained substantial amounts of iR-proctolin. Peripherally, high levels of 
iR-proctolin were detected in the Limulus hindgut (69.5 ± 11.3 pg / mg).
Proctolin-like peptides were isolated from acetic acid extracts of 
Limulus brain, cardiac ganglion, ventral nerve cord and hindgut. Two 
factors exhibiting proctolin-like immunoreactivity and bioactivity were 
separated by gel filtration. One of these factors (proctolin-like peak one, 
PP1) co-eluted with synthetic proctolin on Sephadex G-15. The PP1 factor 
also co-eluted with synthetic proctolin on ion exchange and reverse phase 
high pressure liquid chromatography (HPLC) columns. The other 
proctolin-like factor (proctolin-like peak two, PP2) eluted late on 
Sephadex G-15, but co-eluted with synthetic proctolin and with PP1 on 
HPLC. Both factors had proctolin-like actions on cockroach hindgut, 
Limulus hindgut and on the Limulus heart.
FMRFamide-like peptides were also found to be widely distributed in
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Limulus. The ventral nerve cord (12.6 ± 3.3 pg / mg) and brain (11.9 ± 1.7 pg 
/ mg) contained the highest quantities of iR-FMRFamide. Immunoreactive 
FMRFamide was also detected in the branchial nerves (11.2 ±  2.6 pg / mg) 
and in the cardiac ganglion (4.6 ± 2.4 pg / mg).
Limulus brain, cardiac ganglion and ventral nerve cord extracts were 
used to purify FMRFamide-like peptides. A high molecular weight factor 
(FMRFamide-like peak one, F1) was detected on Sephadex G-15. This factor 
did not co-elute with synthetic (clam) FMRFamide on this column, but did 
co-elute with FMRFamide using ion exchange chromatography. The F1 peak 
was separated into two iR-FMRFamide peaks by HPLC. One of these factors 
co-eluted with clam FMRFamide and the other factor co-eluted with the 
Helix FMRFamide-like peptide pQDPFLRFamide. These findings describe the 
presence and partial purification of several proctolin-like and 
FMRFamide-like peptides in Limulus.
111
INTRODUCTION
Several cardioexcitatory peptides are present in the Limulus nervous 
system. These include a proctolin-like peptide or peptides and several 
FMRFamide-like peptides (Watson et al., 1983; Watson et al., 1984).
Proctolin or proctolin-like peptides are present in many arthropods, 
including insects (Brown, 1977; Bishop et al.,1981; Kingan and Titmus,
1983), crustaceans (Sullivan, 1979; Marder etal., 1986; Siwicki and 
Bishop, 1986) and arachnids (Groome et al., in preparation). FMRFamide and 
FMRFamide-like peptides have primarily been described in molluscan 
species (reviewed by Price et al., 1987). However, other members of the 
FMRFamide-like family of peptides are present in coelenterates 
(Grimmelikhuijzen and Spencer, 1984), flatworms (Jennings et al., 1987), 
annelids (Kuhlman etal., 1985), insects (Boer eta l., 1980; White etal.,
1986) and crustaceans (Callaway et al., 1987; Marder et al., 1987).
A proctolin-like peptide has been identified in the cardiac ganglion of 
Limulus (Benson et al., 1981; Watson et al., 1983). This peptide is similar 
to synthetic proctolin in terms of apparent molecular weight and 
susceptibility to enzymatic degradation. Both synthetic proctolin and the 
Limulus cardiac ganglion proctolin-like peptide have positive inotropic 
effects on the Limulus heart. However, purification and physiological 
characterization of this peptide or other proctolin-like peptides in Limulus 
is incomplete at present.
Several FMRFamide-like peptides have also been partially purified 
from various regions of the Limulus nervous system (Watson et al., 1984).
One of these has tentatively been named limadrin (Limulus adrenalin) 
because of its pronounced positive chronotropic effect on the isolated
1 1 2
Limulus heart (White and Watson, 1984). Limadrin appears to be a 
relatively high molecular weight peptide which elicits prolonged 
contracture of the FMRFamide-sensitive radula protractor muscle of the 
left-handed whelk, Busvcon contrarium. Isolation and purification of this 
cardioexcitatory peptide, and other FMRFamide-like peptides in Limulus. is 
necessary in order to understand their physiological actions.
The actions of limadrin and proctolin on the neurooenic Limulus heart 
are quite distinct. The positive chronotropic action of limadrin is similar 
to that produced by biogenic amines, while the positive inotropic action of 
proctolin resembles the effect of amines to enhance cardiac muscle 
contractility. Purification of cardioexcitatory peptides in Limulus will 
facilitate investigation of the comparative cellular and molecular actions 




These procedures are detailed in Appendix - General Methodology. 
Peptide distribution measurements were obtained from acetic acid 
extracts of Limulus tissues using radioimmunoassay (RIA).
Four chromatographic procedures were used to purify peptides from 
extracts of Limulus tissues. Proctolin-like and FMRFamde-like fractions 
from each chromatographic purification step were detected using 
coincidental RIA and bioassay. Peptide levels were calculated by linear 
regression of the standard curve and expressed as immunoreactive (iR-) or 
bioactive pg peptide per milligram of original wet tissue weight.
1. Gel filtration chromatography
Samples were reconstituted in 2 ml column buffer (0.1 N acetic acid 
with .01% thiodiglycol) and applied to a 65 x 1.6 cm Sephadex G-15-120 
molecular sieve column. Fractionation was accomplished at a flow rate of 
0.25 ml/min and 3 ml fractions were collected (Buchler LC-100; Buchler 
Instr., Fort Lee, New Jersey). Fractions were assayed for optical density at 
280 nm, dried by vacuum centrifugation and stored at -20 °C until RIA and 
bioassay. The column was calibrated with the following compounds (the 
molecular weight and assay for these is in parentheses): blue dextran (void 
volume, visible band), vitamin B12 (1355, visible), proctolin (648,




Sep-Pak C18 cartridges (Waters Associates, Milford, Massachusetts)
were rinsed with 5 ml 95% ethanol, followed by 10 ml of distilled water. 
Samples were reconstituted in 5 ml distilled water and loaded into the 
cartridges. Elution was carried out with successive 5 ml rinses of 0%, 10% 
and 80% acetonitrile containing 0.1% trifluoroacetic acid (TFA). 
Immunoreactive peptides were concentrated in the 80% elution. All 
samples were dried and stored at -20 °C.
3. Ion Exchange chromatography
Pooled proctolin-like or FMRFamide-like activities from Sephadex 
G-15 (brain extracts only) were reconstituted in 2 ml 50 mM ammonium 
acetate buffer (pH 6.0) and applied to a 10 x 1 cm CM Sephadex C-25-120 
ion exchange column. The material was eluted with a rinse series of 20 ml 
each of the following: 50 mM ammonium acetate (pH 6.0), 50 mM ammonium 
acetate (pH 8.0) and 500 mM ammonium acetate (pH 8.0). Flow rate was set 
at 0.35 ml/min and 3.3 ml fractions were collected (LKB 2212 Helirac,
Bromma, Sweden). Samples were assayed for both O.D.280 (Beckman DB-GT
spectrophotometer) and osmolarity (Wescor 5100 C vapor pressure 
osmometer), dried, and stored at -20 °C until assayed for peptide content.
4. High pressure liquid chromatography (HPLC)
Samples and standards were reconstituted in 140 jiL 0.1% TFA (Buffer
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A). Buffer B consisted of 90% acetonitrile in 0.1% TFA. Samples and 
standards were then injected onto a 5 jam reverse phase C18 HPLC column
(RP-18 Spheri-5, Brownlee Labs, Santa Clara, California). Flow rate was 
set at 1 ml/min at 1300-1400 psi and 1-2 ml fractions were collected 
(LKB 2212 Helirac). Isocratic and linear acetonitrile gradients were 
established by mixing Buffer A and Buffer B (Perkin Elmer Series 410 BIO 
LC pump and controller). All fractions were measured for absorbance (204 
-285 nm; LKB 2140 Rapid Spectral Detector), assayed by RIA, and the active 
fractions pooled and dried for further HPLC purification if necessary. The 
column was rinsed for 30 min with 100% acetonitrile and 30 min with 
Buffer A before injection of the next sample.
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RESULTS
Distribution of iR-proctolin in Limulus
Immunoreactive proctolin was detected in all regions of the Limulus 
nervous system, and peripherally in the hindgut (Table 3). The distribution 
of iR-proctolin using RIA corresponded to immunohistochemical 
observations (Watson and Detschaschell, personal communication; Wyse, 
personal communication).
The cardiac ganglion contained the greatest amount (185.8 ± 24.8 pg) 
of iR-proctolin per mg tissue. This finding is in agreement with earlier 
results using bioassay to detect cockroach hindgut-stimulating factors in 
the Limulus nervous system (Watson et al., 1983).
In the Limulus brain (prosomal CNS), iR-proctolin was distributed 
equally between the protocerebrum (103.2 + 4.4 pg / mg) and the 
circumesophageal ganglia (91.7 ± 9.4 pg / mg). The first abdominal 
ganglion (127.0 ± 35.7 pg /mg) contained more iR-proctolin than the 
remaining ganglia of the ventral nerve cord, while the second ganglion (44.8 
± 6.7 ± pg / mg) contained the least amount. Segmental cardiac nerves 9 
and 10, which originate from the first and second ganglia of the ventral 
nerve cord, respectively, showed a similar but less dramatic distribution 
of iR-proctolin (SCN 9, 63.1 ± 12.3 pg / mg, n=8; SCN 10, 47.1 ± 7.8 pg I  mg, 
n=11).
The Limulus hindgut contained high levels of iR-proctolin (69.5 ± 11.3 
pg /  mg), distributed equally in the four regions tested. In contrast, the 
foregut and esophapgus contained almost no iR-proctolin.
The gill nerves (the proximal portions of the medial, external and
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TABLE 3 - Distribution of immunoreactive proctolin in Limuius
Tissue do Droctolin /  mo ng proctolin / tissue In)
Cardiac Ganglion 185.8 ±24.8 3.3 ± 0.4 (15)
Cardiac Muscle 3.1 ±0.9 6.9 ±  2.0 (7)
Prosomal CNS 97.7 ± 9.7 30.1 ±1 .2 (15)
a. Protocerebrum 103.2 ±4.4 10.3 ±0.4
b. C. E. Ganglia 91.7 ±9.4 19.7 ±2.0
Ventral Nerve Cord 74.1 ±4.5 12.0 ±0.8 (15)
a. Abd. Ganglion 1 127.0 ±35.7 4.4 ±1 .2
b. Abd. Ganglion 2 44.8 ± 6.7 1.6 ±0 .2
c. Abd. Ganglion 3 60.8 ± 17.8 1.8 ± 0 .5
d. Abd. Ganglia 4,5 63.6 ± 13.4 4.2 ±  0.9
Cardiac Nerves 9,10 53.8 ± 7.5 0.2 ± 0.03 (9)
Optic Nerve 10.0 ±3.0 0.7 ± 0.2 (8)
Lateral Eye 2.2 ± 0.6 0.7 ±0.1 (8)
Leg Nerve 12.1 ±2.6 2.2 ± 0 .5 (10)
Leg Muscle 4.4 ± 0.6 0.8 ±0.1 (13)
Gill Nerve 27.4 ± 2.5 0.8 ±0.1 (12)
Gill Muscle 7.3 ± 1.2 0.5 ±0.1 (10)
Esophagus 4.9 ±1.0 2.7 ±  0.5 (13)
Foregut 4.3 ± 0.7 26.1 ±4 .3 (15)
Hindaut 69.5 ± 11.3 272.3 ± 44.3 (17)
a. Region 1 59.2 ± 10.2 68.1 ±9 .8
b. Region 2 71.9 ± 10.6 72.3 ±10.1
c. Region 3 78.6 ± 14.7 56.6 ± 12.3
d. Region 4 67.1 ±8.6 75.3 ± 9.2
Ostial Tissue 7.7 ±3.1 0.7 ±0.1 (10)
a. Region 1 8.0 ±3.1 0.3 ± 0 .2
b. Region 2 8.2 ±2.6 0.3 ±0.1
c. Region 3 6.6 ±3.7 0.2 ±0.1
Hepatopancreas 1.7 ±0.8 (11)
Blood 2.0 ± 0.3 x 10'10 M -------- (35)
Table 3. RIA for proctolin content of Limulus tissues. Levels of proctolin are expressed in 
terms of pg / mg tissue weight ± S. E. and ng / region ± S. E. For certain tissues (e. g. ventral 
nerve cord), the sum of several ganglia or tissue regions is also calculated.
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internal branchial nerves) contained a relatively high concentration (27.4 ± 
2.5 pg / mg) of iR-proctolin. In contrast, the optic nerves and leg nerves 
had lower levels of iR-proctolin. Several tissues (lateral eye, tibia flexor 
muscle of the second or third walking leg, cardiac muscle and gill muscle 
48 of the second or third gill appendage) contained less iR-proctolin than 
the nerves associated with these tissues. Ostial connective tissues were 
assayed (7.7 ± 3.1 pg / mg) in a preliminary investigation of putative 
pericardial organs in Limulus. Finally, blood levels of iR-proctolin were 
detectable (2 x 10"10 M) in cardiac puncture samples.
Purification of proctolin-like peptides from Limulus tissues
Several Limulus tissues (brain, cardiac ganglion, ventral nerve cord 
and hindgut) were used to isolate and purify proctolin-like peptides.
Extracts of these tissues were subjected to several chromatographic steps 
and purified using reverse phase HPLC.
Molecular weight separation (Sephadex G-15) of TCA extracts of 
these tissues yielded several peaks of proctolin-like activity as 
determined by the cockroach hindgut bioassay and by RIA (Figs. 1,2). In 
general, four peaks of bioactivity were observed in each tissue. Two of 
these peaks, Peak B (PP1, proctolin-like peak one) and Peak C (PP2, 
proctolin-like peak two) were also detected by RIA. The two bioactive 
peaks which did not display immunoreactivity were not considered further 
in the purification sequence. Synthetic proctolin co-eluted with PP1, while 
PP2 eluted further on this column. Activities from PP1 and from PP2 were 
pooled separately and prepared for ion exchange or HPLC chromatgraphy by 
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Fig. 1. Sephadex G-15 gel filtration profiie of proctolin-like activity in Limulus brain 
extracts. A. Four peaks of cockroach hindgut-stimulating activity are observed. Two of these. 
Peak B (PP1) and Peak C (PP2), also are detected by the proctolin radioimmunoassay (B). 
Elution position of standards are indicated by arrows in the top graph. Peak B (PP1) 
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Fig. 2. Sephadex G-15 gel filtration profile of proctolin-like activity in extracts of Limulus ventral nerve cord, 
cardiac ganglion and hindgut. Like the Limulus brain, these tissues contain two peaks (PP1, PP2) of coincidental 
bioactivity and immunoreactivity.
elution.
In a separate Sephadex G-15 run of 20 Limulus brains, active 
fractions from either PP1 or PP2 were pooled and passed through Sep-Pak 
cartridges. The two peaks were dried, reconstituted in 2 ml seawater, 
adjusted to pH 7.6 with .05 M NaOH and applied directly to an intact Limulus 
heart in a 5 ml recording chamber. The effect of either extract was similar 
to that of synthetic proctolin (Fig. 3). Heart contraction amplitude was 
increased by PP1 (80.0%) and by PP2 (63.7%). Rate increases produced by 
PP1 (16.7%) and PP2 (23.8%) were less pronounced.
Proctolin-like peak one was of considerable interest at this time 
since it appeared to resemble the proctolin originally isolated from the 
cockroach Periplaneta (Brown and Starrat, 1975). Most of the material 
collected for further analysis was restricted to PP1 using Limulus brain 
extracts.
Ion exchange chromatography fLimulus brain PP1) yielded one peak of 
activity as revealed by either bioassay or RIA (Fig. 4). This material eluted 
with an increase in osmolarity in the ammonium acetate buffer.
Measurements of O.D.280 of these fractions revealed an absorbance peak in
the first four fractions, indicating that the pH 6, 50 mM ammonium acetate 
stage separated contaminating material from the proctolin-like activity 
which eluted later.
Limulus brain PP1 was run on three separate gradients on reverse 
phase HPLC. At each step, active fractions were detected by RIA and 
pooled. The final HPLC protocol consisted of a 10 min isocratic step (18.0% 
acetonitrile in 0.1% TFA) followed by a 50 min linear gradient to 31.5% 
acetonitrile. Proctolin-like peak one co-eluted with synthetic proctolin on 
this and the other gradients employed. Synthetic proctolin eluted at 10.2
1 2 2
PROCT
Fig. 3. Partially purified Limulus proctolin-like peptides excite the neurogenic Limulus 
heart. Proctolin-like activities (PP1 and PP2) from Sephadex columns were concentrated 
and passed through Sep-Pak C 1B cartridges to eliminate hydrophilic contaminants. Synthetic
proctolin (30 ng), PP1 (20 brain equiv.) or PP2 (20 brain equiv.) was reconstituted in 2 
ml seawater, adjusted to pH 7.5 and added directly to the continually perfused intact heart 
preparation as indicated by the arrow. Proctolin, PP1 and PP2 all caused a long-lasting 
increase in the amplitude of heart contractions. Effects on heart rate were lesser in magnitude 
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Fig. 4. Ion exchange chromatography of Limulus brain extract PP1. This peak was pooled and 
passed through Sep-Pak C 10 cartidges. The 80% acetonitrile elution was dried, reconstituted
in 50 mM, pH 6.0 ammonium acetate buffer and applied to a 10 x 1 cm CM Sephadex column. 
Bioactive (A) and immunoreactive (B) proctolin-like activity was concentrated in two 
fractions with the onset of increased buffer osmolarity. Inset (A): response of the cockroach 
hindgut to a  3 brain equiv. aliquot of fraction 14.
124
>
min (fraction 11) and iR-proctolin in PP1 was detected in fractions 10-12 
(Fig. 5a). Cockroach hindgut-stimulating activity was observed in fractions 
containing iR-proctolin (not shown).
The PP1 factor from the ventral nerve cord, cardiac ganglion and 
hindgut had similar a elution pattern to synthetic proctolin or Limulus 
brain PP1 run on this gradient (Figs. 5b, 6 a,c). Differences in elution times 
between iR-proctolin in these extracts and synthetic proctolin were 
generally 1 min or less.
The cardiac ganglion and hindgut extracts already processed through 
G-15 provided an excellent source of material to compare and purify PP1 
and PP2 by HPLC. Interestingly, both proctolin-like factors from Limulus 
cardiac ganglia and hindgut extracts co-eluted with synthetic proctolin on 
HPLC (Fig. 6). Also, cockroach hindgut-stimulating activity was noted for 
cardiac ganglion PP1 and PP2 after HPLC in the same proportion as that 
observed for these factors after molecular weight separation (Fig. 7a).
These data indicate that some portion of the proctolin-like factor in PP1 is 
structurally very similar to the factor in PP2.
Aliquots of hindgut PP1 and PP2 purified by HPLC were applied to the 
Limulus hindgut (Fig 7b). Like the effect of synthetic proctolin, both PP1 
and PP2 produced rhythmic contractions imposed upon a sustained 
contracture of the hindgut. Purified PP1 from the ventral nerve cord also 
produced a proctolin-like response on the Limulus gut (Fig. 7c).
Distribution of iR-FMRFamide in Limulus
Immunoreactive FMRFamide was detected in all regions of the Limulus 
nervous system (Table 4). Levels of iR-FMRFamide were highest in the
125
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Fig. 5. HPLC profiles of PP1 from Limulus brain (A) or ventral nerve cord (B) extracts. 
Samples were reconstituted in 20% buffer B (90% acetonitrile containing 0.1% TFA), 
injected onto a reverse phase HPLC column and run through the gradient shown by the solid 
line. For either extract, proctolin-like immunoreactivity eluted within 1 min of the elution 
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Fig. 6. HPLC profiles of UmiilUS cardiac ganglion and hindgut PP1 (A,C) and PP2 (B.D). Samples were run 
through Sephadex G-15 columns and Sep-Pak C18 cartridges to concentrate proctolin-like activities. The HPLC






Fig. 7. HPLC purified Limulus PP1 and PP2 elicited proctolin-like responses on the hindgut of Periolaneta and 
Limulus. A. Synthetic proctolin {5.1 ng in 1 ml), cardiac ganglion PP1 (4.3 ng iR-proctolin in 1 ml) and PP2 
(5.6 ng iR-proctolin in 1 ml) all produced similar responses on the cockroach hindgut. B. Synthetic proctolin 
(10.0 ng in 2 ml), hindgut PP1 (4.1 ng in 2 ml) and PP2 (15.2 ng in 2 ml) produced contracture and 
contractions when applied to the Limulus hindgut. C. An aliquot of iR-proctolin from an extract of ventral nerve 
cord PP1 (1.2 ng in 2 ml) produced a similar response to that produced by synthetic proctolin (5.1 ng in 2 ml) in 
a more sensitive Limulus hindgut prepartation. Calibration: vertical, 250 mg (A), 400 mg (B,C); horizontal, 2
TABLE 4 - Distribution of immunoreactive FMRFamide in Limulus
Iissue do FMRFamide /  mo do  FMRFamide /  tissue 10)
Cardiac Ganglion 4.6 ± 2.4 81.0 ±42.2 (11)
Cardiac Muscle 0.5 ± 0.2 817.5 ±327.0 (13)
Prosomal CNS 11.9 ± 1.7 3650.7 ± 262.4 (18)
a. Protocerebrum 12.6± 1.8 1263.2 ± 180.5
b. C. E. Ganglia 11.1 ±1.6 2387.5 ± 344.2
Ventral Nerve Cord 12.6 ±3.3 2097.1 ±113.8 (14)
a. Abd. Ganglion 1 13.1 ±4.9 453.3 ± 169.5
b. Abd. Ganglion 2 9.8 ± 2.3 341.0 ±80.0
c, Abd. Ganglion 3 16.2 ±2.0 466.6 ± 57.6
d. Abd. Ganglia 4,5 11.3 ±2.0 836.2 ± 148.0
Cardiac Nerves 9,10 4.0 ± 0.9 17.9 ±4.0 (9)
Optic Nerve 2.9 ± 0.6 207.7 ± 43.0 (8)
Lateral Eye 1.8 ±0.6 136.4 ±45.5 (11)
Leg Nerve 1.0 ±0.2 177.9 ± 35.6 (8)
Leg Muscle 0.3 ±0.1 51.5 ±17.2 (10)
Gill Nerve 11.2 ±2.6 331.5 ± 77.0 (11)
Gill Muscle 0.4 ± 0.1 27.6 ± 6.9 (11)
Esophagus 0.3 ±0.1 240.0 ± 78.5 (7)
Foregut 0.2 ± 0.1 987.7 ± 456.3 (8)
Hindgut 0.8 ± 0.2 2328.3 ± 582.0 (9)
a. Region 1 1.4 ±0.4 930.2 ± 248.5
b. Region 2 1.0 ±0.3 614.2 ± 164.2
c. Region 3 0.5 ± 0.2 482.4 ± 158.6
d. Region 4 0.2 ±0.1 301.5 ± 134.5
Ostial Tissue 1.6 ±0.3 (9)
a. Region 1 1.8 ±0.3 68.9 ±11.5
b. Region 2 1.9 ±0.6 64.0 ± 19.3
c. Region 3 0.7 ± 0.2 23.9 ± 6.2
Hepatopancreas 0.1 ±0.02 -------- (8)
Blood 1.6±0.5x  10'10 M (40)
Table 4. RIA for FMRFamide in Limulus tissues. Levels of FMRFamide are expressed in terms of 
pg /  mg tissue weight ± S. E. and pg / region ± S. E. For certain tissues (e. g. prosomal CNS), the 
sum of several ganglia or tissue regions is also calculated.
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ventral nerve cord (12.6 ± 3.3 pg / mg) and brain (11.9 ± 1.7 pg / mg). The 
cardiac ganglion contained lesser concentrations of iR-FMRFamide (4.6 ±
2.4 pg /  mg). These findings are consistent with earlier RIA results 
(Watson et al., 1984), although tissue levels of iR-FMRFamide reported here 
are approximately twice those reported in the earlier study. The Limulus 
brain, ventral nerve cord and cardiac ganglion all stain positively for 
FMRFamide using immunohistochemistry (Watson et al, 1984).
The protocerebrum (12.6 ± 1.8 pg / mg) and circumesophageal ganglia 
(11.1 ± 1.6 pg I mg) contained essentially equal concentrations of 
iR-FMRFamide. Likewise, in the ventral nerve cord, all ganglia tested had 
comparable levels of iR-FMRFamide. There may be a slight difference 
between iR-FMRFamide levels of the first (13.1 ± 4.9 pg / mg) and the 
second abdominal ganglion (9.8 ± 2.3 pg / mg). This trend was reflected in 
levels of iR-FMRFamide detected in segmental cardiac nerves 9 (5.0 ± 2.5 
pg /  mg, n=5) and 10 (2.7 ± 1.4 pg /  mg, n=4). These nerves originate 
separately from the dorsal nerves of the first two abdominal ganglia.
Other tissues in Limulus contained considerably lesser levels of 
iR-FMRFamide, with the notable exception of the branchial gill nerves (11.2 
± 2.6 pg / mg). No region of the digestive tract contained a high 
concentration of iR-FMRFamide. However, iR-FMRFamide in the hindgut may 
be regionally distributed, as levels in the anterior sections of the hindgut 
(1.4 ±  0.4 pg / mg in region 1) were much greater than those observed in 
posterior hindgut sections (0.2 ±0.1 pg / mg in region 4). Ostial tissue 
contained low levels of iR-FMRFamide (1.6 ± 0.3 pg / mg). I m mu noreactive 
FMRFamide was detected in Limulus blood at a concentration of 1.6 ± 0.5 x 
10‘ 10 M.
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Purification of FMRFamide-like peptides from the Limulus nervous system
Several nervous tissues (brain, ventral nerve cord and cardiac 
ganglion) were used to purify Limulus FMRFamide-like peptides. Acetic 
acid and TCA extracts were prepared as described in Appendix - General 
Methodology for application to Sephadex G-15 molecular weight columns.
For each of these tissues, Sephadex G-15 filtration revealed three 
areas of FMRFamide-like activity (Figs. 8,9). Two of these peaks, Peak A 
(FMRFamide-like peak one, F1) and Peak C (FMRFamide-like peak two, F2), 
exhibited coincident immunoreactivity and bioactivity. The F2 region 
appeared to be comprised of two overlapping areas of activity: peak 
bioactivity consistently eluted slightly earlier than the main peak of 
immunoreactivity.
Several pieces of evidence indicated that Peak B was acetylcholine 
(Ach) rather than a Limulus FMRFamide-like peptide. First, this factor was 
not immunoreactive. Second, Ach is present in the Limulus nervous system 
(Sukumar et al., 1983). Third, Ach causes a FMRFamide-like contracture of 
the Busycon RPM at 10'7 M (Nagle and Greenberg, 1982). Fourth, bioactive 
aliquots from Peak B, like Ach, eluted from the 0% and 10% acetonitrile 
washes when loaded onto Sep-Pak cartridges (synthetic FMRFamide and F1 
elute with the 80% wash). Finally, Peak B contained a substance which 
produced an Ach-like increase in the frequency of contractions of the 
isolated Lumbricus gizzard (Fig. 10), a preparation in which Ach is a 
putative transmitter (Wu, 1939). For these reasons, Peak B was not 
considered further in purification efforts.
The FMRFamide-like activity of F1 was of the most interest due to 
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Fig. 0. Sephadex G-15 gel filtration profile of FMRFamide-like activity in Limulus brain 
extracts. Three peaks of activity were observed. Peak A (F1) and Peak C (F2) exhibited 
coincidental bioactivity (A) and immunoreactivity (B), while Peak B my be an Ach-like 
factor. Elution positions of standards are indicated by the arrows: note that synthetic 
FMRFamide did not co-elute with any of the brain FMRFamide-like peaks on this column.
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Fig. 9. Sephadex G-15 gel filtration profiles of FMRFamide-like activity in Limulus cardiac ganglion and ventral 




Fig. 10. Response of the isolated Lumbricus gizzard to synthetic Ach (10‘5 M) and to fraction 
20 (10 brain equiv.) from Peak B, Sephadex G-15. Both Ach and fraction 20 produced an 
increase in the size and frequency of contractions of the gizzard. This finding, and the fact that 
Ach is active on the Busvcon RPM, suggests that the effect of this Peak B fraction on the RPM 
is due to the presence of Ach rather than to a FMRFamide-like peptide. Calibration: vertical, 
0.5 g, horizontal, 2 min.
factor eluting near the void volume on Sephadex G-25 columns which 
produced a FMRFamide-like contracture of the Busvcon radula protractor 
muscle (White and Watson, 1984). The F1 peak fractions were pooled for 
further purification, loaded onto Sep-Pak cartridges and eluted with 80% 
acetonitrile after removing hydrophilic compounds with successive 0% and 
10% wahses.
The latter peak(s) of FMRFamide-like activity (F2) also overlapped 
with PP2 (proctolin-like activity), and most of the material eluting in this 
area was used in the purification of PP2. A limited amount of F2 (from 
hindgut extracts also run through Sephadex G-15) was available for further 
analysis. Immunoreactive material was eluted with the 80% acetonitrile 
wash from Sep-Pak cartridges, dried and stored at -20 °C until injected 
onto the HPLC column.
Ion exchange chromatography was performed on F1 activity in the 
Limulus brain. The major peak of FMRFamide-like bioactivity in the brain 
extract eluted with the pH 8, 500 mM ammonium acetate buffer (Fig. 11a). 
This peak was also immunoreactive, and co-eluted with synthetic 
FMRFamide (Fig. 11b). A small amount of bioactivity was also observed in 
fraction 2 before the increase in buffer osmolarity. This fraction was 
within the peak in optical density (280 nm) and was not immunoreactive.
The coincidental bioactive and immunoreactive fractions (13,14) were 
pooled for HPLC.
FMRFamide-like activity from Limulus brain, cardiac ganglion, 
abdominal ganglion or hindgut extracts subjected to Sephadex, Sep-Pak and 
ion exchange (brain only) chromatography were then purified by 2 to 3 
passes through a reverse phase HPLC column. The majority of these 
experiments focused on F1. For each tissue examined, two peaks of
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Fig. 11. Ion exchange chromatography of Limulus brain extract F1. This peak was 
concentrated, passed through a Sep-Pak C 18 cartridge and eluted with 80% acetonitrile. This
material was reconstituted in the 50 mM, pH 6.0 ammonium acetate buffer and applied to a 10 
x 1 cm CM Sepahdex column. Bioactivity (A) was noted early (fraction 2) and with an 
increase in buffer osmolarity (fractions 13 and 14). The latter fractions were also 
immunoreactive (B). Inset: responses of the Busycon RPM to fractions 2 and 14.
136
iR-FMRFamide were detected by HPLC when F1 was put through a sequence 
of 10 min isocratic 18.0% acetonitrile, followed by a linear gradient to 
29.7% acetonitrile in 50 min. The two peaks were run again on a similar 
HPLC gradient (to 31.5% acetonitrile this time) for comparison with known 
peptides (Fig. 12). The first HPLC peak of iR-FMRFamide from brain and 
cardiac ganglion F1 had a similar elution time to clam FMRFamide, while 
the first HPLC peak of iR-FMRFamide from abdominal ganglion F1 eluted 
approximately 3 min earlier. This peak had eluted earlier than clam 
FMRFamide by approximately 3 min in the first HPLC run as well. For each 
of these tissues, the second HPLC peak of iR-FMRFamide from F1 eluted 
very closely with the Helix FMRFamide-like peptide pQDPFLRFamide.
Hindgut F1 and F2 from Sephadex G-15 were also run on this HPLC 
gradient to compare the elution times of these compounds. The first run 
indicated that F2, as well as F1, contained two FMRFamide-like compounds 
(data not shown). At this stage of the purification process, the material 
was not purified sufficiently to compare elution times between the two 
peaks of F2 and known FMRFamide-like peptides. A second passage of the 
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Fig. 12. HPLC profiles of Limulus brain (A), cardiac ganglion (B) and ventral nerve cord (C) F1. Samples were 
reconstituted in 20% buffer B (90% acetonitrile containing 0.1% TFA) and run on the gradient shown (solid 
line). Two peaks of iR-FMRFamide were observed for each F1 extract and their elution times are compared to 









Proctolin-like and FMRFamide-like peptides are widely distributed in 
the Limulus CNS and may act as neurotransmitters, or be released into the 
hemolymph (or locally) as neurohormones to modulate peripheral function. 
These peptides, especially iR-proctolin, are also found in the cardiac 
ganglion and in selected peripheral nerves or tissues. The distribution of 
proctolin-like and FMRFamide-like peptides in Limulus agrees with other 
work using immunohistochemical techniques to localize these peptides in 
Limulus (Watson etal., 1984; Watson and Detschaschell, personal 
communication; Wyse, personal communication). These studies and the 
present work support physiological studies on the actions of peptides in 
Limulus and lay the groundwork for further investigations of peptide 
actions on the heart and other systems in this animal.
Distribution of proctolin-like peptides in Limulus
The Limulus cardiac ganglion contained the highest concentrations of 
iR- and bioactive proctolin of any tissue examined. The high levels of 
iR-proctolin in this tissue, in cardioregulatory nerves and in the CNS is 
supportive of the proposed role for this peptide as a regulator of cardiac 
output (for review see Watson and Augustine, 1982).
Synthetic proctolin and a proctolin-like cardiac ganglion peptide have 
a pronounced positive inotropic effect on the Limulus heart (Watson et al., 
1983). In Limulus. proctolin acts directly on cardiac muscle fibers and not 
on either the neuromuscular junction or on the cardiac ganglion itself. 
However, in the lobster Homarus. proctolin excites cardiac ganglion
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neurons to produce increases in heart rate while having little or no effect 
on cardiac muscle (Sullivan and Miller, 1984). Limulus and Homarus also 
differ in their respective levels of cardiac ganglion iR-proctolin. While the 
Limulus cardiac ganglion contains 10.0 pmol iR-proctolin /  mg protein, the 
Homarus cardiac ganglion contains almost no iR-proctolin (0.4 pmol / mg 
protein, Schwarz, 1983).
The difference in cardiac ganglion proctolin levels in these two 
species might be paralleled by different release sites for this peptide. The 
lobster cardiac ganglion may be acted upon by proctolin released into the 
hemolymph from the pericardial organs (Berlind and Cooke, 1970; Sullivan, 
1979). In Limulus. proctolin may be released from some other site, such as 
the follower (motor) neurons of the cardiac ganglion, in order to produce 
its inotropic actions on cardiac muscle. In the crayfish Procambarws. 
proctolin acts as a co-transmitter in abdominal postural motoneurons of 
the ventral nerve cord (Bisphop et al., 1987). Similarly, in the cockroach 
Periplaneta. proctolin is released as a co-transmitter from motoneurons 
onto skeletal muscle (O'Shea and Bishop, 1982; Adams and O’Shea, 1983). 
Immunohistochemical observations in Limulus have shown that iR-proctolin 
is present within the cardiac ganglion as well as in branches leading into 
the myocardium (Wyse, personal communication). The proctolin detected by 
RIA in Limulus cardiac muscle might possibly be attributed to motor roots 
of the cardiac ganglion within this tissue.
Alternatively, proctolin may be released into the bloodstream by 
cardioregulatory neurons of the Limulus brain or ventral nerve cord in order 
to reach the heart or other tissues. Levels of iR-proctolin in the 
bloodstream (2 x 1 0 10 M) were quite close to the threshold concentration 
(3 x 10-10 M) for the inotropic effect of this peptide on the Limulus heart
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(Watson et al., 1983). Proctolin also acts to augment evoked contractions 
of skeletal muscle in the Limulus leg at a threshold dose of 3 x 10'9 M 
(Rane et al., 1984). These findings suggest that proctolin might be released 
hormonally to reach cardiac or skeletal muscle fibers. Further studies are 
clearly neccessary in order to determine the site(s) of release of proctolin 
in Limulus.
The existence of a pericardial organ system for release of peptides, 
like that described in crustaceans (reviewed by Cooke and Sullivan, 1982) 
may exist in Limulus. and peptidergic terminals of pericardial organs may 
be located in connective tissue located over the ostia of the heart.
Evidence in favor of this hypothesis comes from the observation that 
cardioregulatory nerves send branches into ostial tissue (unpublished 
observations), and that ostial tissue does contain iR-proctolin. Ostial 
connective tissue in Limulus contained approximately 20-30 pmol 
iR-proctolin / mg protein. It should be noted that it is not known to what 
extent ostial tissue in Limulus is comprised of cardioregulatory nerves, 
connective tissue, or nerve terminals. Further studies on the anatomy and 
function of the cardioregulatory nerves and putative pericardial organs in 
Limulus are needed in order to answer this question.
The abdominal ganglia of the Limulus CNS are involved in a variety of 
physiological processes such as cardioregulation and respiration (Fourtner 
et al., 1971; Watson and Wyse, 1978; Wyse et al., 1980). Immunoreactive 
proctolin was detected in the ventral nerve cord and in cardioregulatory 
nerves 9 and 10 of the first two abdominal ganglia, suggesting that part of 
the cardioregulatory function of the abdominal ganglia may involve the 
release of this peptide. Immunohistochemical observations (Watson and 
Detschaschell, personal communication; Wyse, personal communication)
141
have indicated the presence of proctolin-positive somata and fibers in the 
ventral nerve cord and immunoreactive fibers in the cardioregulatory 
nerves to support this hypothesis.
Stereotyped patterns of ventilation and cleaning of the book gills in 
Limulus are controlled by central pattern generators within the ventral 
nerve cord (Wyse et al., 1980). These programs consist of coordinated, 
rhythmic outputs in recordings from the medial, external and internal 
branches of the ventral nerves. The finding that the ventral nerve cord and 
gill nerves contained high levels of iR-proctolin suggests that abdominal 
ganglion motorneurons may utilize proctolin to initiate or augment 
particular gill movements in the normal expression of these behaviors. 
Proctolin is located in lobster ventilatory motor neurons (Siwiki and 
Bishop, 1986), increases ventilatory output in the crab Carcinus (Mercier 
and Wilkens, 1985) and modulates the swimmeret program of the crayfish 
(Mulloney et al., 1987). In Limulus. proctolin may act centrally or 
peripherally to modify specific respiratory movements of the gill 
appendages. This peptide might also be important in the maintenance of 
cardiac output during coordinated heart and respiratory activity (Watson 
and Wyse, 1978).
Immunoreactive proctolin was highly concentrated in the Limulus 
hindgut, while other portions of the digestive tract contained little or no 
iR-proctolin. Proctolin-like peptides have been detected in the hindgut and 
other visceral muscles of a number of arthropod species (Holman and Cook, 
1985; Eckert et al., 1981; Lange et al., 1986). Proctolin has several actions 
on the Limulus hindaut (Fig. 7 b,c and unpublished results) which are 
similar to the action of this peptide on the hindgut and visceral muscles of 
other arthropods (Brown, 1975; Holman and Cook, 1985). In contrast, the
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Limulus foregut is responsive only to high concentrations of proctolin 
(10'6 M or greater, unpublished results), a finding in agreement with 
studies in Leucophaea (Cook and Holman, 1978) in which the effect of 
proctolin is 1000 x greater on hindgut muscles than on foregut muscles.
Proctolin-like immunoreactivity has been observed in nerve fibers of 
the Limulus out (Watson and Detschaschell, personal communicaton; Wyse, 
personal communication). A proctolin-like peptide is present in hindgut 
motorneurons in the lobster (Siwicki and Bishop, 1986) and has been shown 
to be released by high potassium from visceral muscle innervated by 
proctolinergic motorneurons of the terminal abdominal ganglion in the 
cockroach Periplaneta (Lange et al., 1986; Orchard and Lange, 1987).
Proctolin might reach the Limulus hindgut from neurons in the 
abdominal ganglia which send projections to the gut via the intestinal 
nerve (Patten and Redenbaugh, 1899), or via the bloodstream. Interestingly, 
the isolated Limulus hindgut shows a considerable amount of spontaneous 
activity for many hours, which at times resembles the response to 
application of synthetic proctolin (unpublished observations).
Multiple proctolin-like peptides in Limulus
There are at least two proctolin-like peptides (PP1 and PP2) in the 
Limulus CNS, cardiac ganglion and hindgut. The presence of two separate 
iR-proctolin peptides has not previously been described in other arthropods.
Sep-Pak C18 and HPLC purification of PP1 and PP2 did not alter their
activity on any of the preparations used in this study. Additionally, these 
peptides co-eluted with synthetic proctolin on reverse phase HPLC, 
suggesting that both compounds are similar in structure and hydrophobicity
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to each other and to cockroach proctolin. Several possibilities exist to 
explain the presence of two proctolin-like peptides in Limulus.
Proctolin-like peak one (PP1) may be identical to or a close analog of 
synthetic proctolin (H-Arg-Tyr-Leu-Pro-Thr-OH). The second 
proctolin-like peptide (PP2), which is of an apparent lower molecular 
weight, could be a metabolic breakdown product. In the cockroach 
Periplaneta. proctolin degradation in the hemolymph, nervous and gut 
tissues can procede in two directions (Quistad etal., 1984). The primary 
degradation pathway involves cleavage of the Tyr-Leu bond to yield Arg-Tyr 
and Leu-Pro-Thr, but some of the proctolin is cleaved at the Arg-Tyr bond 
to yield Arg and Tyr-Leu-Pro-Thr. A structure-function analysis of 
proctolin fragments and analogues has been performed for the cockroach 
hindgut receptor (Sullivan and Newcomb, 1982). None of the proctolin 
breakdown products proposed by Quistad et al. (1984) are active on this 
preparation. However, as mentioned earlier, both PP1 and PP2 cardiac 
ganglion extracts purified by HPLC were equally active on the cockroach 
hindgut. These findings suggest that PP2 is an independent proctolin-like 
peptide in Limulus. rather than a metabolite.
Both of these peptides are active on the Limulus heart and hindgut, 
suggesting that one or both of these compounds are active in vivo. 
Interestingly, several if not all of the leukokinins (octapeptides isolated 
from head extracts of Leucophaeal also are active on both the heart and gut 
in that species of cockroach (Holman et al., 1986). The presence of 
multiple peptides with apparently similar actions in Limulus and other 
arthropods presents an interesting challenge in understanding peptidergic 
regulation of particular physiological events in vivo.
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Distribution of iR-FMRFamide in Limulus
The brain and ventral nerve cord of the Limulus CNS contained the 
highest quantities o f iR-FMRFamide. The cardiac ganglion and 
cardioregulatory nerves contained 2-3 x less iR-FMRFamide per mg tissue 
than the CNS. The relative distribution of iR-FMRFamide in the CNS and 
cardiac ganglion reported here is in agreement with an earlier study 
(Watson et al., 1984). One exception is the distribution of iR-FMRFamide 
within the brain (prosomal CNS). Earlier results suggested a 3-fold greater 
concentration of iR-FMRFamide in the protocerebrum than in the 
circumesophageal ganglia, while in the present study essentially equivalent 
concentrations were detected.
FMRFamide may function as a transmitter or neurohormone in the 
regulation of cardiac function in Limulus. Immuncytochemical observations 
have indicated the presence of iR-FMRFamide in somata of the Limulus 
brain and ventral nerve cord, nerve fibers in the cardiac ganglion and 
cardiac muscle, and in the arterial sheath surrounding the CNS (Watson et 
al., 1984). Release of Limulus FMRFamide-like peptides into the 
hemolymph could occur within the CNS arterial sheath, or from putative 
pericardial organs within the ostial connective tissues of the heart.
Release of FMRFamide from neuroheamal organs has been demonstrated in 
molluscs (Voight et al., 1983) and in arthropods (Walther and Schiebe,
1987).
It is possible that other FMRFamide-like peptides play a role as a 
neurohormone or neurotransmitter in the regulation of the heart in Limulus. 
While synthetic FMRFamide has weak effects on the Limulus heart (Watson 
et al., 1984), a high molecular weight FMRFamide-like factor present in the
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Limulus brain (termed limadrin, or Limulus adrenalin) has potent 
cardioexcitatory actions (White and Watson, 1984). The endogenous 
FMRFamide-like peptide or peptides which exert these actions in Limulus 
may differ considerably in structure (and thus action) from clam 
FMRFamide. In molluscs, for example, an entire family of 
FMRFamide-related peptides sharing partial sequence homology has been 
described (reviewed by Price et al., 1987). Further, many of these 
FMRFamide-like peptides have pronounced chronotropic and inotropic 
actions on the myogenic hearts of a number of molluscan species 
(Greenberg and Price, 1980; Painter and Greenberg, 1982; Boyd et al., 1984; 
Kobayashi and Muneoka, 1986; Smith, 1987). Therefore, purification, 
sequence analysis and pharmacological characterization of FMRFamide-like 
peptides in Limulus is neccessary in order to clarify the role of these 
peptides in the regulation of cardiac output.
FMRFamide-like peptides in the Limulus CNS may have central 
actions, but little is known regarding central neural circuits in the 
horseshoe crab. However, the motor output of the ventral nerves of the 
abdominal ganglia have been characterized in some detail (Watson, 1980; 
Wyse et al., 1980). Synthetic FMRFamide has no effect on the motor 
programs exhibited by the isolated ventral nerve cord at concentrations up 
to 10'5 M (Watson etal., 1984). However, the FMRFamide-like limadrin 
peptide present in the Limulus brain initiates patterned ventilatory output 
in the isolated ventral nerve cord (Watson, personal communication). 
FMRFamide and related peptides have been shown to have central actions on 
the crustacean stomatogastric ganglion (Hooper and Marder, 1984) and on 
certain identified neurons in molluscs (Murphy et al., 1985; Ruben et al,
1986; Boyd and Walker, 1987).
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The branchial gill nerves contained a substantial concentration of 
FMRFamide-like material. The iR-FMRFamide somata of the Limulus 
abdominal ganglia (Watson et al., 1984) may be the origin of iR-FMRFamide 
in the gill nerves. These cells might release FMRFamide-like peptides onto 
gill muscles to modulate contractions during specific respiratory 
behaviors. However, peripheral regulation of the book gills in Limulus has 
not yet been investigated.
Levels of iR-FMRFamide in the hindgut were extremely low, especially 
in comparison to the high concentration of iR-proctolin located there. 
However, FMRFamide immunoreactive fibers are present in the Limulus gut 
(Watson, personal communication). Synthetic FMRFamide relaxes the 
Limulus gut (unpublished results), but only at high concentrations. In 
Mercenaria. FMRFamide has a contractile effect on hindgut muscles (Doble 
and Greenberg, 1982), while in Aplysia FMRFamide has inhibitory actions on 
contractions of the stomach and gizzard (Austin et al., 1983). 
FMRFamide-like peptides may act on some portion of the Limulus digestive 
system, but at present the significance of iR-FMRFamide in the Limulus 
digestive tract and of its apparent regional distribution in the hindgut is 
uncertain.
FMRFamide-like peptides in Limulus
Immunoreactive FMRFamide in Limulus appears to consist of several 
FMRFamide-like peptides. In crustaceans, the FMRFamide-like peptides 
present in the stomatogastric nervous system are more hydrophobic than 
clam FMRFamide (Marder et al., 1986). HPLC analysis in the present study 
indicates that one of the FMRFamide-like peptides in Limulus nervous
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tissues is also more hydrophobic than clam FMRFamide, but that the other 
FMRFamide-like peptide may be identical to or very similar to clam 
FMRFamide. However, while comparison of elution times of Limulus 
FMRFamide-like peptides to known peptides is a useful tool in their 
purification and characterization, amino acid analysis of the two 
FMRFamide-like peptides in the Limulus brain purified by HPLC is necessary 
to reveal whether or not these peptides are novel or identical to previously 
described FMRFamide-like species.
In summary, proctolin-like and FMRFamide-like peptides are widely 
distributed in the Limulus nervous system. The presence of proctolin-like 
peptides in specific nervous and peripheral tissues support previous 
reports of the inotropic action of synthetic proctolin and a Limulus 
proctolin-like peptide on the neurogenic Limulus heart, and the present 
finding that synthetic proctolin and Limulus proctolin-like peptides have 
pronounced effects on hindgut motility. The presence of iR-FMRFamide in 
the Limulus CNS and cardiac ganglion suggest a role for Limulus 
FMRFamide-like peptides in cardioregulation and possibly for modulation of 
respiratory movements of the book gills.
Limulus may contain authentic proctolin and FMRFamide in addition to 
other proctolin-like and FMRFamide-like peptides. The precise regulatory 
roles played by these peptides in Limulus will be greatly facilitated by 
determination of their amino acid structure and sequence.
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CHAPTER FOUR
MECHANISMS UNDERLYING ACTIONS OF PROCTOLIN-LIKE AND 
FMRFAMIDE-LIKE PEPTIDES ON THE LIMULUS HEART
ABSTRACT
The involvement of cyclic nucleotides and protein kinase C in peptide 
actions on the Limulus heart was investigated. Partially purified 
limadrin, a Limulus FMRFamide-like peptide, had a long-lasting positive 
chronotropic effect and biphasic inotropic actions on the isolated heart. 
These actions were mimicked by the phosphodiesterase inhibitor IBMX. 
Both limadrin and IBMX increased levels of cAMP and cGMP in the cardiac 
ganglion and in cardiac muscle. The positive chronotropic effect of 
limadrin, like that of the amines, appears to involve a cAMP-dependent 
mechanism. The biphasic inotropic action of this compound may involve 
opposing actions of cAMP and cGMP in Limulus cardiac muscle.
Synthetic FMRFamide (10'5 M) or the Helix FMRFamide-like peptide 
pQDPFLRFamide (10'5 M) had only slight effects on the Limulus heart and 
did not increase cAMP levels in the cardiac ganglion or in cardiac muscle. 
Experiments using different extraction procedures revealed that 
cardioexcitation associated with particular fractions from Sephadex G-15 
containing partially purified limadrin was not directly proportional to the 
level of immunoreactive FMRFamide in those fractions.
Proctolin, at 10'6 M, had no effect on cyclic nucleotide levels in 
Limulus cardiac muscle. However, the protein kinase C activator phorbol
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12,13 dibutyrate (3 x 10'7 M) mimicked the positive inotropic action of 
10-7 M proctolin on the intact heart or electrically stimulated 
myocardium. This agent, like proctolin, also elicited contracture and 
rhythmic contractions of deganglionated Limulus cardiac muscle rings. 
Protein kinase C activation, therefore, may be an essential process in the 
modulatory actions of proctolin in this system.
The contractile and myogenic actions of proctolin or phorbol 12,13 
dibutyrate on deganglionated Limulus cardiac muscle were also mimicked 
by 10-5 M dopamine. Octopamine (10'5 M) and forskolin (10'5 M) had only 
slight effects on this preparation. These results suggest that dopamine 
activates protein kinase C, in addition to protein kinase A, to enhance 
cardiac muscle contractility. Apparently, peptides and amines share 
several second messenger systems to produce similar chronotropic and 
inotropic effects on the Limulus heart.
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INTRODUCTION
The neurogenic heart of the horseshoe crab, Limulus polvphemus. is 
modulated by a number of amines and peptides present in the nervous 
system of this animal (for review see Watson and Augustine, 1982).
Amines have long-lasting positive chronotropic and inotropic actions on 
the Limulus heartbeat. These effects of amines involve activation of cAMP 
metabolism in this system (Groome and Watson, 1983; Groome and Watson, 
1987).
Several cardioactive peptides found in the Limulus nervous system 
have amine-like actions on the Limulus heartbeat. Synthetic proctolin, and 
a cardiac ganglion proctolin-like peptide, have been shown to have direct 
actions on cardiac muscle fibers to enhance heart contraction strength 
(Benson et al., 1981; Watson et al., 1983). Synthetic proctolin also 
induces rhythmic contractions in the deganglionated Limulus heart 
(Watson and Hoshi, 1985).
A FMRFamide-like cardioexcitatory compound (limadrin) present in 
the Limulus brain, on the other hand, appears to act on the Limulus cardiac 
ganglion to increase heart rate (White and Watson, 1984). In addition to 
its positive chronotropic action, limadrin has a biphasic effect on heart 
contraction amplitude resulting in prolonged inhibition. These effects are 
shared only partially by synthetic FMRFamide (Watson et al., 1984).
The positive inotropic action of proctolin, and the positive 
chronotropic action of limadrin are overtly similar to the excitatory 
actions of amines on the Limulus heartbeat. Additionally, the prolonged 
time course of peptide actions on the Limulus heart suggests that second 
messengers may be involved. This system, therefore, presents the
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opportunity to study the biochemical basis for similar actions of amines 





Tissue incubations and cyclic nucleotide assays were performed as 
described in Appendix - General Methodology. Synthetic proctolin, 
FMRFamide (clam FMRFamide) or pQPDFLRFamide fHelix FMRFamide-like 
peptide) were used in experiments on peptide effects on cyclic nucleotide 
levels in particular tissues.
The effects of partially purified limadrin from the Limulus brain on 
cardiac ganglion or cardiac muscle biochemistry were examined in three 
separate experiments. In general, Limulus brains were extracted as 
described in Appendix - General Methodology. However, in the first set of 
experiments TCA was not employed in the procedure, and extracts were 
applied directly (e. g. without employing Sep-Pak purification) to a 
Sephadex G-25 column. In the second experiment, both TCA and Sep-Pak 
were used prior to molecular weight separation of the brain extract. In 
the third experiment, TCA was used for one half of the extract only.
Aliquots of 3-10 brain equivalents from the first peak of FMRFamide-like 
(Busycon RPM and RIA) activity were utilized in tests of Limulus heart 
cardioexcitation and for effects on tissue levels of cyclic nucleotides.
Pharmacology
Limulus hearts or cardiac muscle rings were prepared as described in 
Appendix - General Methodology. Recordings were accomplished as 
described in Chapters One and Two. The intact Limulus heart and
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deganglionated myocardium provided two preparations in which to 
investigate the excitatory actions of proctolin, amines and various 
pharmacological agents. Cardiac muscle rings were prepared for 
electrical stimulation as described, or pinned out in 5 ml perfusion 
chambers for tension recordings in the absence of neuronal or electrical 
stimulation.
The intact Limulus heart was employed to compare the chronotropic 
and inotropic actions of limadrin, amines and pharmacological agents.
This preparation was also used to compare several modifications in the 
basic extraction procedure for limadrin. All experiments were carried out 
at room temperature. Natural seawater was used in most experiments. In 
other experiments, artificial Limulus saline was employed. Normal saline 
was of the following composition: 445 mM NaCI, 12 mM KCI, 10 mM CaCI2,
46 mM MgCI2, with 10 mM Hepes buffer at pH 7.5. Zero calcium saline was




Effects of proctolin on cyclic nucleotide levels in cardiac muscle
Proctolin, at concentrations up to 10"5 M, had no effect on the levels 
of either cAMP or cGMP in Limulus cardiac muscle. A 10 min incubation of 
cardiac muscle rings in 1CT7 M, 10‘6 M or 10'5 M proctolin did not 
significantly alter levels of either cyclic nucleotide from control values 
(n=6). When cardiac muscle rings were incubated in 10~6 M proctolin 
solutions for periods of time ranging from 30 sec to 10 min, no transient 
increase in levels of cAMP orcGMP was observed (Fig. 1).
Proctolin and phorbol ester actions on neurallv and electrically evoked 
heart contractions
The protein kinase C activator phorbol 12,13 dibutyrate (Ph dB), at 3 
x 10-7 M, mimicked the positive inotropic action of 10'7 M proctolin on 
the isolated Limulus heart (Fig. 2). Both Ph dB and proctolin produced a 
comparable increase in contraction amplitude, but the effect of the 
phorbol ester was much slower in onset and in decay. In most experiments 
the effects of proctolin and Ph dB were exclusively inotropic, although in a 
few experiments these agents did produce slight increases in the 
contraction rate of the intact heart.
The inotropic effect of proctolin and Ph dB was the result of an 
alteration in the properties of cardiac muscle fibers, since these agents 
also increased the amplitude of electrically evoked contractions of 






























Fig. 1. Proctolin, at 10‘6 M, has no effect on levels of cAMP or cGMP in Limulus cardiac 
muscle. Cardiac muscle rings were incubated in 10'6 M proctolin for 30 sec to 10 min and 
processed for cAMP and cGMP content. Each point represents the mean cyclic nucleotide 






















Fig. 2. Proctolin and the protein kinase C activator phorbol 12, 13 dibutyrate elicit positive 
inotropic, but not chronotropic, responses when applied to the intact Limulus heart. A. 
Record of heart contractions before and during peak response to 10‘7 M proctolin or 3 x 10'7 
M phorbol ester. Calibration: vertical, 1.5 g; horizontal. 1 min. B. Time course of the 



























Fig. 3. The positive inotropic effect of proctolin and phorbol ester was the result of their 
direct actions on cardiac muscle fibers. Cardiac muscle rings were induced to contract by 
applying pulses of electrical current. A. Record of evoked contractions before and during peak 
response to 10 ‘7 M proctolin or 3 x 10'7 M phorbol 12,13 dibutyrate. Calibration: 
vertical. 2 g: horizontal, 1 min. B. Time course of the increase in evoked contraction 
amplitude in response to proctolin or phorbol ester (solid line indicates application).
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not altered by pretreatment of the preparation with 3 x 10 '7 M TTX (not 
shown). The phorbol ester produced an increase in contraction amplitude 
which declined only after two or more hours of perfusion with 
phorbol-free seawater. The positive inotropic response to proctolin was 
also long-lasting, but to a much lesser extent than observed with 
phorbol-treated preparations.
Like proctolin, Ph dB (3 x 10‘7 M) had no effect on levels of cAMP in 
cardiac muscle rings incubated in this drug for 10 min (90.2 ± 6.6% 
control, n=5) or 20 min (86.9 ± 3.4% control, n=5). Phorbol 12-myristate 
13-acetate and 1-oleyl 2-acetyl sn-glycerol, at 10"6 M, had negligible 
effects on the intact heart or electrically stimulated myocardium. At 
higher concentrations, these agents occasionally produced positive 
inotropic effects as well.
Comparison of the effects of proctolin. amines and pharmacological agents 
on Limulus cardiac muscle
Contractures of cardiac muscle rings were consistently observed 
during proctolin (10‘6 M) application to preparations stimuluated by 
electrical current pulses. In several experiments dopamine (10'5 M) 
produced a similar effect (Fig. 4). In several preparations, proctolin and 
dopamine caused the gradual appearance of smaller contractions occuring 
between electrical stimuluations.
Proctolin, at a concentration of 10'6 M, has been shown to produce 
both a contracture and rhythmic contractions when applied to 
deganglionated Limulus hearts (Watson and Hoshi, 1985). In this study, 





Fig. 4. Proctolin (10'7 M) or dopamine (10'5 M) occasionally caused contracture when applied (continuously at 
arrow) to cardiac muscle rings stimulated to contract by regular current pulses. The contractile effect of 
proctolin was observed more often and was more pronounced than that of dopamine. Both agents occasionally 
produced contractions following evoked contractions (bottom arrow points to small after-contraction observed 
during dopamine application). Calibration: vertical, 2 g, horizontal, 1 min.
^
deganglionated 2 cm cardiac muscle rings (Table 5, Fig. 5).
Dopamine (10"5 M), like proctolin, consistently elicited contractures 
and rhythmic contractions in deganglionated cardiac muscle rings (Table 5, 
Fig. 5). In contrast, OCT (1 0 5 M) produced a modest contracture in only 
one of 15 preparations. Octopamine elicited rhythmic contractions in a 
few experiments, but these contractions were of much lesser amplitude 
and frequency than dopamine-elicited contractions.
The phorbol ester Ph dB, at 3 x 10"7 M, also produced a proctolin-like 
effect in this preparation (Table 5, Fig. 5). While the degree of 
contracture produced by this agent was less than that elicited by either 
proctolin or DA, Ph dB more consistently produced rhythmic contractions 
than any agent tested. Forskolin (10-5 M), on the other hand, was much 
less potent in either of these effects. Forskolin-induced contracture was 
observed in only one instance, and the effects of this agent on rhythmicity 
were infrequent and slight.
Rhythmic contractions produced by these agents persisted for 1-2 hr 
after their removal from the bath medium. However, contractions were 
abolished with the introduction of the calcium channel blocker Mn++ (20 
mM) to the bath (not shown). Five to ten minutes after removal of Mn++, 
rhythmic contractions were again apparent. A similar dependency on 
external calcium has been demonstrated for the action of proctolin on the 
deganglionated Limulus heart (Watson and Hoshi, 1985). When cardiac 
muscle rings were perfused with saline containing 0 Ca++ /  2mM EGTA, 
application of proctolin, phorbol ester or DA was without effect (not 
shown). Subsequent washing of the preparation with normal saline 
resulted in contracture and long-lasting rhythmic contractions.
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TABLE 5 - Effects of proctolin, amines and pharmacological agents on
deganglionated cardiac muscle
AGENT DOSE M  Contracture Rhythmic contractions
te n s ion (g l  (% Of preparations tested)
PROCT
2COioY- 12 0.92 ± 0 .2 6 83.3
DA 10‘5 M 30 0.34 ± 0 .1 0 63.3
PHORBOL 
12,13 dB 3 x 10 '7 M 22 0.13 ± 0 .0 4 95.2
FORSK 10 '5 M 15 0.02 ±  0.02 23.3
OCT It ) ’5  M 15 0.01 ±  0.01 23.3
Table 5 . Summary of the effects of various agents to promote contracture of, or initiate 
rhythmic contractions in, deganglionated cardiac muscle rings. Agents were applied to the 
preparation for 10 min and then removed from the perfusion solution. Contracture 
tension was measured as the difference from resting tension and is expressed as the mean 
tension ±  S. E. Appearance or absence of rhythmic contractions in response to a given 
agent was noted and the overall percentage of preparations which responded positively is 
represented. The frequency and magnitude of contractions in response to particular agents 





Fig. 5. Effect of various agents on deganglionated Limulus cardiac muscle. Agents were applied to the preparation 
at the arrow and washed off after 10 min exposure. Proctolin (1 O'6 M), dopamine (10‘5 M) and phorbol 12,13 
dibutyrate (3 x 10 7 M) all produced rhythmic contractions of cardiac muscle. These agents often produced 
contracture of the myocardium prior to the initiation of contractions. Octopamine (1 O'5 M) and forskolin (10‘5 
M) occasionally produced small contractions. Interruptions in the lower 3 traces are equal to a 10 min time 
period. Calibration: vertical, 2 g; horizontal, 1 min.
Limadrin
Partially purified limadrin from experiment one produced several 
effects when applied to the Limulus heart preparation (Table 6, Fig. 6). A 
single dose of limadrin (3 brain equiv. of fraction 23, Sephadex G-25) 
applied directly to the Limulus heart by pipette caused a 90.0% increase in 
heart rate. The positive chronotropic effect was long-lasting, even though 
the limadrin sample was washed off the preparation within a few minutes 
after introduction into the bath. The initial increase in contraction 
amplitude (+25.0%) was followed by long-lasting inhibition of contraction 
amplitude (-68.5%, at 10 min after initial exposure to limadrin).
All of the effects of limadrin on the intact Limulus heart were 
mimicked by 10'3 M IBMX (Fig.1 (Chapter One), Fig. 6 (Chapter Two), Fig. 6). 
Additionally, the magnitude of the positive inotropic and chronotropic 
effects, as well as that of the long-lasting negative inotropic effect, were 
comparable for limadrin and IBMX. The similarity of these effects 
suggested that cyclic nucleotides might be involved in some of the actions 
of limadrin on the Limulus heartbeat.
Limadrin (5 brain equiv., fraction 23 from Sephadex G-25, experiment 
one) and IBMX (10'3 M) significantly increased cardiac ganglion cAMP and 
cGMP levels (Table 6, Fig. 7). These effects were apparent within 3-10 min 
of incubation. Limadrin and IBMX also elicited substantial increases in 
levels of cardiac muscle cAMP and cGMP (Fig. 8). These findings suggest 
that their similar physiological effects may be explained by similar 
biochemical actions.
In experiment two, the physiological and biochemical actions of 
partially purified limadrin from Sephadex G-15 were examined in tests in
164
TABLE 6 - Effects of FMRFamide-like peptides on cAMP levels and 
physiology in Limulus cardiac ganglia and cardiac muscle
Cardiac Ganglion 
Agent Dose pmol cAMP (n) Percent change in 
Heart Rate (n)
OONTROL 28.0 ± 1 0 .6  (8)
FMRFamide 10 '5 M 27.6 ± 4 .5  (8) -0.3 ±  0.7 (8)
pQPDFLRFamide 10'® M 28.1 ± 6 .2 (5 ) +13.2 ± 5 .3  (8)
LIMADRIN., 5, 3 b. e. 79.0  ± 2 4 .9  (5)* +90.0 (1)
l im a d r in 2 10, 8 b. e. 49 .8  ±10.0 (6)* + 2 5 .6 (1 )
Cardiac Muscle
Agent Dose pmol cAMP (n) Percent change in
Contraction Ampl. i
CONTROL 6.1 ± 1 .1  (10)
FMRFamide 1 0 '5 M 6.4 ±  0.4 (8) -2.3 ±  3.3 (8)
pQPDFLRFamide 10'® M 5.4  ±  0.5 (6) -0.3 ±  3 .7  (8)
LIM ADRIN , 5, 3 b. e. 31 .6  ± 2 .6  (6 ) t + 25.0 (1)
-68.5 (1)
l im a d r in 2 1 0 ,8  b. e. 8 .6  ± 1 .2  (6) -3.3 (1)
Table 6. Chronotropic and inotropic effects of FMRFamide-like peptides on the isolated 
Limulus heart and effects on levels of cardiac ganglion or cardiac muscle cAMP. Doses of 
limadrin are expressed as brain equivalents (b. e.) from a Sephadex fraction. 
Measurements were taken after 10 min exposure to a particualr agent and are expressed 
as the mean ±  S. E. Level of significant difference from control values was determined by 
a Student's t-test.




Fig. 6. Similar inotropic and chronotropic actions of limadrin (top) and the phosphodiesterase inhibitor IBMX 
(bottom) on the intact Limulus heart. An extract of limarin (5 brain equiv.) was reconstituted in 2 ml seawater, 
adjusted to ph 7.6 and added to the preparation at the arrow. Limadrin caused a long-lasting increase in heart rate 
and a biphasic alteration of heart contraction amplitude. All of these effects were mimicked by perfusion (at 


















100  - i  
60 
60












Fig. 7. Limadrin (5 brain equiv.) and IBMX (1 O'3 M) increased levels of cAMP (A) and cGMP 
(B) in the Limulus cardiac ganglion. Each area represents the mean content in cyclic 
nucleotide ±  S. E. in 5 to 8 experiments. Level of significance was determined using an 
unpaired Student's t-test.







O  3 min 






B. Cyclic GM P
6
□  3 min








Fig. 8. Limadrin (5 brain equiv.) and IBMX (10'3 M) increased levels of cAMP (A) and cGMP 
(B) in Limulus cardiac muscle rings. Each area represents the mean content in cyclic 
nucleotide ± S. E. in 6 to 8 experiments. Level of significance was determined using an 
unpaired Student’s t-test.
Level of significance: “  (p < .03); * {p < .05).
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which TCA and Sep-Pak C10 cartidges were employed in the extraction
protocol. Under these conditions, limadrin had only modest effects on the 
intact Limulus heart (Table 6). Limadrin (3 brain equiv.) produced only a 
20.0% increase in heart rate, and 8 brain equivalents caused only a 25.6% 
increase. Heart contraction amplitude was not affected at either dose.
The lesser chronotropic or inotropic effects of limadrin in experiment 
two was associated with the finding that 10 brain equivalents of this 
factor had a smaller effect on levels of cAMP in cardiac ganglia or cardiac 
muscle than was elicited by 5 brain equivalents in experiment one (Table 
6). Therefore, the reduction in the cardioexcitatory effect for this factor, 
using a different extraction protocol, was paralleled by a drop in its 
capacity to increase cAMP in the cardiac ganglion or muscle.
In experiment three, the relationship between levels of iR-FMRFamide 
and cardioexcitation of Sephadex fractions was investigated. First, an 
extract of 15 brains were passed throuh Sephadex G-25 without employing 
TCA. Fraction 23 was the peak of cardioexcitation and FMRFamide activity, 
and contained 1.7 pmol iR-FMRFamide / brain equiv. Ten brain equivalents 
in 1 ml were applied to the intact heart preparation, and this dose caused a 
55.2% increase in heart rate. Next, the other 15 brains from the original 30 
brain extract was subjected to TCA extraction prior to gel filtration.
Fraction 23 was again the peak of cardioexcitation and FMRFamide-like 
immunoreactivity, and this fraction contained 0.9 pmol iR-FMRFamide/ 
brain equiv. Ten brain equivalents elicited a 68.4% increase in heart rate.
In either experiment, rate excitation was quite long-lasting, as heart rate 
was elevated above control for 1 hr or more.
These results indicate that FMRFamide levels in Sephadex fractions 
may have been decreased by employing TCA, but there was not a
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corresponding drop in cardioexcitation. Additionally, recovery of 
iR-FMRFamide from Sep-Pak was tested. Virtually 100% of the original 
FMRFamide loaded onto the Sep-Pak cartridge was recovered in the 80% 
acetonitrile wash.
Effect of synthetic FMRFamide-like peptides on the Limulus heartbeat and 
on cAMP levels
Synthetic FMRFamide (10'5 M) or pQDPFLRFamide (10'5 M) had much 
lesser effects on heart contraction rate or strength than the limadrin 
extract tested in experiment one (Table 6). At this dose, pQPDFLRFamide 
had slightly greater effects than FMRFamide on the intact Limulus heart 
(Table 6). Occasionally, these peptides produced transient increases in 
heart rate of 40-50%. However, neither peptide elicited a prolonged 
chronotropic or inotropic response like that elicited by limadrin.
These results were consistent with the finding that neither of these 
peptides (10'5 M) significantly increased cAMP in the cardiac ganglion or in 
cardiac muscle when these tissues were incubated in peptide solution for 
10 min (Table 6).
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DISCUSSION
Several second messenger systems may be involved in the expression 
of peptide and amine actions on the neurogenic Limulus heart. Proctolin, 
which has no effect on cyclic nucleotide metabolism, appears to produce 
its positive inotropic (and myogenic) actions on Limulus cardiac muscle by 
a process involving the activation of protein kinase C. Limadrin, on the 
other hand, may elicit its varied actions by activation of both the cAMP and 
cGMP second messenger systems. Finally, dopamine may activate both 
cAMP and phosphatidylinositol (PI) metabolism in Limulus cardiac muscle. 
These findings suggest that the biochemical basis for peptide and amine 
modulation of the neurogenic Limulus heart consists of multiple second 
messenger systems acting either in concert, or in opposition, to produce 
characteristic cellular responses.
Proctolin and cyclic nucleotides
Proctolin failed to stimulate cAMP or cGMP synthesis in Limulus 
cardiac muscle at doses which have profound effects on cardiac muscle 
contractility. For example, at a concentration of 10'6 M, proctolin had no 
effect on cyclic nucleotide levels in Limulus cardiac muscle. At 10'5 M,
OCT has pronounced effects on cardiac muscle cAMP. However, the 
positive inotropic effect of 10"6 M proctolin is significantly greater than 
that of 10-5 M octopamine (unpublished results).
The lack of increased cAMP or cGMP levels in Limulus cardiac muscle 
in response to proctolin was not an artifact of dose range or of time of 
incubation. Proctolin failed to influence cyclic nucleotide metabolism at
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doses from 10'7 M to 10*5 M. Additionally, proctolin did not elicit a 
transient increase in either cAMP or cGMP, as has been described in other 
peptidergic systems (e. g. the action of SCPB in the Aplvsia ventricle; Lloyd
et al., 1985). These findings clearly demonstrate that proctolin does not 
increase cardiac muscle contractility via a cAMP-dependent mechanism.
Several previous studies have investigated the relationship between 
the actions of proctolin (or a proctolin-like peptide) on arthropod smooth, 
skeletal or cardiac muscle and the effects of this peptide on cyclic 
nucleotide metabolism. Proctolin was shown by S. -Rosza and Miller (1980) 
to have a mild stimulatory effect on adenylate cyclase activity in locust 
heart muscle. However, while the physiological effects of proctolin in this 
system were significantly greater than either DA or OCT, its effect on 
cyclase activity was markedly lower than these or other amines. The 
action of proctolin, to accelerate the myogenic rhythm in locust extensor 
tibia muscle, is mimicked by both forskolin and IBMX (Evans, 1984a). 
However, cyclic nucleotide analogues have the opposite (OCT-like) effect. 
Other studies indicated thatcAMP mediates the inhibitory effect of 
octopamine, and not the excitatory effect of proctolin (Evans 1984 b,c). 
Cyclic AMP has also been proposed as a possible messenger in 
proctolinergic actions on the cockroach hindgut. While cAMP was shown to 
have proctolin-like excitatory effects on the Lecophaea hindgut in one 
study (Cook et al., 1975), another study indicated that other cAMP agents 
produced inhibition of hindgut motility in the same species (Jennings et al., 
1983). Therefore, in these and the present studies, a cAMP-dependent 
mechanism does not appear to be involved in the actions of proctolin on 
invertebrate muscle.
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Proctolinergic activation of protein kinase C in Limulus cardiac muscle
The mechanism by which proctolin increases contractility in Limulus 
cardiac muscle appears to involve activation of protein kinase C and not of 
protein kinase A. The effects of phorbol 12,13 dibutyrate (which activates 
protein kinase C) and proctolin on Limulus cardiac muscle contractility 
were similar in two separate preparations (intact heart and electrically 
stimulated myocardium). First, both Ph dB and proctolin increased the 
amplitude of contractions in these preparations. Second, these effects 
were long-lasting. Finally, neither of these compounds significantly 
altered heart rate, as do the amines.
Stimulation of the phosphatidylinositol system involves the 
production of inositol trisphosphate (IP3) and diacyclglycerol as second
messengers (Berridge, 1987). Phorbol esters mimic the C-kinase 
stimulating action of diacylglycerol in many cells (Kishimoto et al., 1980; 
Castagna et al., 1982). However, another class of C-kinase activators such 
as arachidonic acid have been proposed as second messengers of an 
alternative pathway resulting in the activation of this enzyme (McPhail et 
al., 1985; Snider et al., 1984). Therefore, while proctolin most likely 
activates protein kinase C in Limulus cardiac muscle, any one of several 
second messengers could conceivably be utilized in the inotropic action of 
proctolin.
Proctolin appears to exert its actions in at least one other system by 
stimulation of phosphatidylinositol metabolism. In locust skeletal muscle, 
proctolin increases levels of inositol trisphoshate and enhances 
glutamte-induced contractions (Worden and O'Shea, 1986). Inositol 
trisphosphate causes the release of internal calcium from the sarcoplasmic
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reticulum in invertebrate (Rojas et al., 1987; Tublitz and Trombley, 1987) 
and vertebrate (Streb et al., 1983; Somlyo et al., 1985; Vergara et al.,
1985; Nosek et al., 1986) muscle. Phorbol esters also increase muscle 
contractility in some systems (Sybertz, 1986; Dale and Obianime, 1987; 
Itoh and Lederis, 1987), presumably as a result of activation of protein 
kinase C. While proctolin does appear to utilize the PI system in its 
inotropic actions in the Limulus heart, further studies are needed to 
determine the relationship between stimulation of the PI system by 
proctolin, protein kinase C activation and inotropic modulation.
Activation of protein kinase C in many systems is closely tied to 
calcium movements within the cell or across the cell membrane (for 
review see Berridge and Irvine, 1984). In the present study, experiments 
with proctolin and Ph dB on deganglionated heart muscle indicate that 
C-kinase is important in several actions of proctolin which are dependent 
on calcium. First, proctolin and the phorbol ester elicited prolonged, 
calcium-dependent contractures in Limulus cardiac muscle. A similar 
dependence on calcium has been noted for the postsynaptic action of 
proctolin in skeletal muscle of Limulus (Rane e t al., 1984) and Homarus 
(Schwarz et al., 1980). In contrast, the contractile effect of this peptide 
on smooth muscle in insects is not dependent on external calcium (Holman 
and Cook, 1985). Similarly, contractures of the Limulus hindgut induced by 
proctolin or phorbol esters are independent of external calcium (Groome, in 
preparation). These findings suggest that smooth and striated muscle 
forms o f C-kinase are activated by proctolin in Limulus. and perhaps in 
other arthropods as well, by regulatory mechanisms with distinct 
dependencies for external calcium.
A  second calcium-dependent effect of proctolin or Ph dB on L im u lu s
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cardiac muscle was the production of rhythmic contractions in the absence 
of neuronal input. Contractions produced by proctolin are associated with 
10-20 mV spikes (Watson and Hoshi, 1985). The pharmacological profile of 
this effect of proctolin-induced contractions (sensitivity to Ca++ channel 
blockers but not to TTX) suggested to these authors that proctolin might 
elicit its myogenic action by unmasking voltage-sensitive calcium channels 
in normally unexcitable cardiac muscle fibers.
A proctolin-like effect upon cardiac muscle excitability can be 
elicited following the application of phorbol ester to deganglionated 
preparations. Intracellular recordings from phorbol-treated cardiac muscle 
indicate that contractions of heart musculature are, like those produced by 
proctolin, associated with small (10-15 mV) spike-like potentials in 
cardiac muscle fibers (unpublished results). In Aplvsia. protein kinase C 
activation by phorbol esters results in the enhancement of a 
voltage-sensitive calcium current in the bag cell neurons at the onset of 
afterdischarge (DeRiemer et al., 1985b; Kaczmarek, 1986). Protein kinase 
C activation by proctolin or phorbol ester in Limulus cardiac muscle may 
result in a similar effect on a voltage-sensitive calcium current which is 
not expressed under normal conditions.
Protein kinases involved in the actions of dopamine
Protein kinase C activation may be an important process in the 
expression of both peptide and amine actions on the Limulus heart.
Increased cardiac muscle contractility in response to proctolin appears to 
involve activation of the PI system, while cyclic nucleotides are not 
involved. On the other hand, it seems probable that increased muscle
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contractility in response to DA involves activation of cardiac muscle DA 
receptors linked to the Pl/protein kinase C messenger system as well as 
cardiac muscle DA receptors linked to the cAMP/protein kinase A 
messenger system.
Dopamine has an excitatory inotropic effect which is disproportionate 
with its capacity to elevate cardiac muscle cAMP. Dopamine, at 10‘5 M, 
produced a positive inotropic effect on electrically stimulated cardiac 
muscle comparable to that produced by 10'5 M octopamine (Fig. 2, Chapter 
Two). However, DA produced significantly lesser increases in cardiac 
muscle cAMP than did OCT (Figs. 3-5, Chapter Two). This difference does 
not appear to be simply a consequence of excess cAMP, and thus an 
oversaturation of protein kinase A, produced by OCT. This hypothesis is 
supported by the observation that there was no significant difference in 
elevation of cardiac muscle cAMP by DA, NE or EPI, while the effect of DA 
on evoked contractions was much greater than that of either NE or EPI. 
Therefore, the overall inotropic effect of DA must involve some other 
mechanism, in addition to activation of protein kinase A, in Limulus cardiac 
muscle.
The similarity of proctolin, phorbol ester and dopamine effects on 
several preparations suggests that DA, like proctolin, activates protein 
kinase C in Limulus cardiac muscle. All of these agents elicited 
contracture and rhythmic contractions of deganglionated cardiac muscle. 
Additionally, the action of dopamine to induce the deganglionated 
myocardium to beat rhythmically is consistent with earlier findings in 
which dopamine produced myogenic activity during glutamate-induced 
contractures of deganglionated cardiac muscle (Watson et al., 1985).
Dopamine may exert its proctolin-like actions independent of its
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effect on cardiac muscle cAMP. However, the observation that OCT or 
forskolin produce slight proctolin-like or DA-like effects in some 
preparations raises the possibility that direct second messenger 
interaction may occur between the protein kinase A and protein kinase C 
systems in Limulus cardiac muscle. In other systems, protein kinase C 
activation directly influences adenylate cyclase activity through guanine 
nucleotide-binding proteins (Proll et al., 1985; Aiyar et al., 1986).
Several facts suggest, however, that DA-induced cAMP synthesis in 
Limulus cardiac muscle is independent of its actions on protein kinase C. 
First, proctolin, which activates C-kinase, had no effect on levels of 
cardiac muscle cAMP. Second, removal of external calcium (which blocks 
the effects of DA, proctolin or phorbol ester on deganglionated 
preparations) does not influence increases in cardiac muscle cAMP 
produced by DA (unpublished results). Finally, OCT and forskolin, agents 
which increase cardiac muscle cAMP, rarely produced contracture of 
Limulus cardiac muscle or the appearance of rhythmic contractions, while 
DA consistently elicited these effects. These findings suggest that the 
similarity of inotropic actions of amines and peptides on the Limulus heart 
is a consequence of a common substrate for protein kinases A and C (e. g. 
the sarcoplasmic reticulum), rather than a result of direct second 
messenger interaction.
The inotropic actions of octopamine, dopamine and proctolin on the 
Limulus heart are overtly similar, yet appear to occur via several 
independent mechanisms. Synergy of cAMP and PI action has been 
demonstrated in the vertebrate heart (Suzuki and Wang, 1987). The calcium 
pump protein phospholamban of the sarcoplasmic reticulum is 
phosphorylated by cAMP-dependent protein kinase, but this phosphorylation
177
is also stimulated by activation of the PI system. Additional studies may 
reveal that multiple kinase activation is a common regulatory scheme in 
the control of heart contraction strength.
Cyclic nucleotides and limadrin actions on the Limulus heart
Cyclic AMP may underly the excitatory chronotropic actions of 
limadrin on the Limulus heart, as suggested by the physiological and 
biochemical data presented. The actions of limadrin and the 
phosphodiesterase inhibitor IBMX were alike in several respects. First, 
both agents produced a long-lasting increase in heart rate. Second, the 
positive chronotropic effect of either limadrin (White and Watson, 1984) or 
IBMX (Table 1, Fig. 7, Chapter One) is the result of the action of these 
agents to increase burst frequency in the cardiac ganglion. Third, both IBMX 
and limadrin elevate cardiac ganglion cAMP within 3-10 min of application 
to the isolated cardiac ganglion, a finding consistent with the time course 
of their effects on heart rate. Therefore, limadrin-induced increases of 
cAMP in the cardiac ganglion are probably responsible for its positive 
effect on heart rate, while the significance of limadrin- and IBMX- induced 
increases in cardiac ganglion cGMP remains uncertain.
The biphasic inotropic actions of limadrin and IBMX may be a 
consequence of activation of both cAMP- and cGMP- dependent protein 
kinases in Limulus cardiac muscle. Both limadrin and IBMX increase cardiac 
muscle cAMP and have short-term positive inotropic effects. The 
subsequent decrease in heart contraction amplitude in preparations exposed 
to these agents may be a consequence of elevated heart rate, increased 
cardiac muscle cGMP, or both.
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The similar inotropic actions of limadrin and IBMX provide further 
evidence that cAMP, and perhaps cGMP, are important in the overall control 
of heart contraction strength. These findings also suggest that an 
endogenous cardioactive agent may utilize both of these second messengers 
to produce its overall effect on the cardiac rhythm. Limadrin, like IBMX, 
may produce its characteristic actions on the Limulus heart as a 
consequence of its effects on cyclic nucleotide metabolism at several loci 
within this system (cardiac muscle, cardiac ganglion and neuromuscular 
junction) which contribute to the strength of heart contractions. However, 
in comparison to IBMX, little has been done to characterize the site of 
inotropic actions of limadrin.
Limadrin as a FMRFamide-like oeptide in Limulus
FMRFamide is a cardioactive peptide in many species of molluscs 
(reviewed by Greenberg and Price, 1980; Price et al, 1987). Additionally, 
cAMP mediates the effects of FMRFamide, as well as serotonin, on a number 
of moliuscan hearts (Higgins et al., 1978; Painter, 1982a; Greenberg et al.,
1983).
In Limulus. partially purified limadrin increased levels of cyclic 
nucleotides in Limulus cardiac ganglia and cardiac muscle. Earlier work 
(White and Watson, 1984) indicated that this cardioactive FMRFamide-like 
factor (MW 4400 daltons) in the Limulus brain is subject to enzymatic 
degradation by pronase and trypsin, and that it elevates heart rate by 
increasing the burst rate of the cardiac ganglion. Therefore, FMRFamide or 
FMRFamide-like peptides, as well as several amines, may act on the 
neurogenic (Limulusl and myogenic (moliuscan) heart via the second
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messenger cAMP.
The FMRFamide-like peptides isolated from the Limulus brain, cardiac 
ganglion and ventral nerve cord were similar in hydophobicity to either 
FMRFamide or pQDPFLRFamide, as evidenced by their retention time on HPLC 
(Fig. 12, Chapter Three). However, the synthetic peptides act on the 
Limulus heart only at very high concentrations (10*5 M peptide produced 
increases in heart rate of only 10 to 25%), while greater effects (50 to 70% 
increases in heart rate) were observed after application of brain extracts 
which contained only 10'8 M iR-FMRFamide in one ml (experiment three).
Several possibilities exist to explain this discrepancy. First, the 
FMRFamide-like peptides in Limulus may not be identical to FMRFamide or 
pQDPFLRFamide. For example, numerous FMRFamide-like peptides are 
present in molluscs which differ from the Helix peptide by a single amino 
acid substitution (reviewed by Price et al, 1987). Second, the peptides 
isolated by HPLC may exist in Limulus as part of a larger molecule. This 
hypothesis is suggested by the fact that these peptides co-elute on gel 
filtration columns very soon after the void volume, and that an approximate 
MW of 4400 daltons has been reported for limadrin (White and Watson,
1984). The endogenous limadrin peptide may contain the amino acid 
sequences of both of these peptides. During extraction and purification 
procedures this polypeptide could be fragmented, producing smaller 
peptides which have litle or no effect on the Limulus heart. Finally, 
extracts of limadrin after gel filtration might also contain other 
cardioexcitatory molecules, such as acetylcholine. Therefore, purification 
and sequencing of limadrin are neccessary to fully characterize the 
physiological and biochemical actions of this cardioexcitatory 
FMRFamide-like peptide in Limulus.
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In summary, proctolin and the Limulus FMRFamide-like peptide 
limadrin appear to utilize discrete second messenger systems to produce 
amine-like excitation of heart contraction strength (proctolin, which 
activates protein kinase C) or rate (limadrin, which activates protein 
kinase A). Dopamine appears to activate both C- and A-kinases in Limulus 
cardiac muscle. These findings indicate that peptides and amines activate 
a number of second messenger systems to produce characteristic 
alterations in the Limulus heartbeat.
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CHAPTER FIVE 
CONCLUSIONS AND FUTURE DIRECTIONS
The present study demonstrates the importance of cyclic nucleotide 
and phosphatidylinositol (PI) metabolism in multiple actions of amines and 
peptides on the neurogenic Limulus heart. Amines and the Limulus 
FMRFamide-like peptide limadrin increase heart contraction rate by 
increasing cAMP in the cardiac ganglion. Amines also utilize cAMP to 
enhance cardiac muscle contractility and neuromuscular transmission. 
Proctolin, and apparently dopamine as well, activate the PI second 
messenger system to produce several characteristic effects on Limulus 
cardiac muscle. Apparently, amines and peptides exert similar excitatory 
chrontropic and inotropic effects on the neurogenic Limulus heart by 
co-utilizing several second messenger systems in the cardiac ganglion and 
in cardiac muscle.
Future experiments on amines, peptides and second messengers
1. Determination of the role of cAMP in amine actions on pacemaker 
neuron?.
As discussed in Chapter One, amine excitation of burst rate in the 
Limulus cardiac ganglion involves a cAMP-dependent mechanism. Since 
amines excite pacemaker neurons to produce their positive chronotropic 
actions (Augustine and Fetterer, 1985), it seems more than likely that
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amines increase cAMP within these pacemaker neurons to increase their 
frequency of firing. It is not possible, at present, to assay individual 
pacemaker neurons for cAMP content. Additionally, attempts to record from 
pacemaker neurons have been unsuccessful up to this point. The 
demonstration that forskolin and IBMX produce amine-like increases in the 
activity of these neurons, as is true of their actions on heart contraction 
rate and on cardiac ganglion burst rate, is necessary to confirm that cAMP 
elevation in these neurons is indeed responsible for the chronotropic action 
of amines on the Limulus heart.
Another cAMP-dependent action of amines in the Limulus cardiac 
ganglion was suggested by experiments in this study in which manganese 
was applied to the cardiac ganglion to block pacemaker input onto follower 
neurons. Apparently, manganese does not completely block transmitter 
released by pacemaker neurons onto follower cells. Application of amines, 
forskolin or IBMX elicited burst-like potentials in follower neurons, 
suggesting that amines may utilize cAMP to enhance synaptic efficacy 
between pacemaker and follower neurons. Increased cAMP in pacemaker 
terminals may result in increased transmitter release. A rigorous 
electrophysiological analysis of pacemaker neurons and of the pacemaker/ 
follower synapse is necessary to characterize cAMP-dependent actions of 
amines on the Limulus cardiac ganglion. These studies are clearly needed 
before an investigation of the substrate-level effects of amines on cardiac 
ganglion neurons is warranted (see number 4 below).
2. Further characterization of neuropeptides in Limulus
In Chapter Three, several proctolin-like and FMRFamide-like peptides
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in various Limulus tissues were purified by high pressure liquid 
chromatography (HPLC). The determination of amino acid sequences of these 
neuropeptides will indicate whether they are structurally identical to 
known peptides, or exist as novel peptides in Limulus. an essential piece of 
information.
The actions of proctolin on the Limulus heart have been described in 
detail only for the synthetic peptide (H-Arg-Tyr-Leu-Pro-Thr-OH), which 
was originally purified from the cockroach Periplaneta (Brown and Starrat,
1975). If a Limulus proctolin-like peptide (e. g. PP1) has the same amino 
acid sequence as cockroach proctolin, then the physiological and 
biochemical experiments using synthetic proctolin in Limulus can be 
considered physiologically relevant. Additionally, proctolin-like peptides of 
a different structure (e. g. PP2, and possibly PP1) may be synthesized in 
order to characterize their actions in Limulus.
Sequence analysis is of critical importance in the determination of 
the relationship between Limulus iR-FMRFamide and limadrin. Specifically, 
are either of the two FMRFamide-like peptides purified by HPLC responsible 
for the cardioexcitatory actions of the FMRFamide-like limadrin molecule?
If these two peptides are identical to clam FMRFamide and Helix 
pQDPFLRFamide, then they probably are not, since these synthetic peptides 
have little effect on the Limulus heart (Table 6, Chapter Four).
Alternatively, the Limulus FMRFamide-like peptides may be more active 
analogs of the synthetic peptides, or limadrin may be active only as a high 
molecular weight polypeptide. All of these possibilities underline the 
necessity to sequence the Limulus FMRFamide-like peptides purified by 
HPLC and characterize the structure and action of limadrin.
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3. Determination of particular second messengers involved in specific
actions of proctolin and dopamine on Limulus cardiac muscle
Activation of either protein kinase A (by amines, Chapter Two) or 
protein kinase C (by proctolin and dopamine, Chapter Four) is important in 
the enhancement of cardiac muscle contractility. The myogenic actions of 
proctolin and dopamine appear to be a result of activation of protein kinase 
C and not of protein kinase A (Chapter Four). Cyclic AMP is involved in the 
inotropic actions of dopamine, but other second messengers of the PI 
signalling system appear to be important in the effects of dopamine, as well 
as proctolin, on Limulus cardiac muscle.
Proctolin and dopamine may interact with cardiac muscle receptors 
coupled with phospholipase C to produce phosphoinositides, such as IP3, IP4
and diacylglycerol. It remains to be seen which of these metabolites is 
increased in Limulus cardiac muscle by either proctolin or dopamine. 
Biochemical studies focusing on the effects of peptides and amines on 
inositol lipids in Limulus cardiac muscle should be complemented with an 
investigation of the respective roles played by particular second 
messengers in specific inotropic and myogenic actions. For example, it may 
be that increased muscle contractility produced by proctolin is a 
consequence of any or all of the following events: internal calcium release 
promoted by IPg , calcium flux across the sarcolemma induced by IP4, or 
activation of a voltage-sensitive Ca++ channel by DAG / C-kinase.
4. Determination of the subcellular substrates for activation of protein 
kinase A and protein C in Limulus cardiac muscle.
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As mentioned above, dopamine shares the cAMP system with other 
amines in actions on cardiac muscle contractility, but shares the PI system 
with proctolin in actions on contractility as well as on myogenicity. The 
biochemical basis for the overtly sim ilar responses of proctolin and DA on 
cardiac muscle may be a convergence of these second messenger systems on 
particular cellular substrates. A first step in the analysis of the 
subcellular sites of inotropic action of amines and peptides might be the 
determination of the effects of the amines and proctolin on protein 
phosphorylation in cardiac muscle. Extracts of 32P-treated cardiac muscle 
exposed to amines, peptides or specific pharmacological agents may be 
subjected to gel electrophoresis in order to elucidate the effect of these 
agents on particular protein bands. For example, forskolin may 
phosphorylate the same cardiac muscle proteins as octopamine, suggesting 
that these proteins are normally regulated by the activity of protein kinase 
A. The comparison of proctolin-, OCT- and DA-induced protein 
phosphorylation may give some insight into the subcellular basis for 
similarities and differences in the action of amines and peptides on Limulus 
cardiac muscle.
5. Investigation of the physiological significance of cGMP in Limulus 
cardiac muscle
Cyclic GMP is not involved in excitatory amine actions in the Limulus 
heart (Chapters One and Two). Amines and forskolin had no effect on cGMP 
metabolism in the Limulus cardiac ganglion. The phosphodiesterase 
inhibitor IBMX significantly increased cardiac ganglion cGMP, but its effect
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on burst activity appears to be limited to its capacity to increase cAMP.
In cardiac muscle, on the other hand, IBMX and the FMRFamide-like 
peptide limadrin may exert a cGMP-dependent effect to decrease muscle 
contractility (Chapter Four). This peptide, like IBMX, increased cardiac 
muscle cGMP. However, while IBMX clearly inhibits electrically evoked 
contractions, the direct action of limadrin on cardiac muscle contractility 
has not been determined. In addition, the physiological significance of 
decreased cardiac muscle contractility, especially in response to an agent 
which increases heart contraction rate, is not obvious. Purification of 
limadrin is necessary in order to characterize the physiological and 
biochemical actions of limadrin in Limulus cardiac muscle.
The neurogenic Limulus heart is a useful model system in which to 
study the mechanisms underlying coordinated and multiple actions of 
endogenous amines and peptides on particular cellular targets. Amines and 
peptides produce their characteristic effects on the Limulus heartbeat by 
activation of particular intracellular signalling systems. The variety of 
second messenger systems which may be involved in neuromodulation of the 
Limulus heart presents an interesting opportunity to study second 
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Horseshoe crabs (Limulus oolvphemus  ^were obtained from three 
sources: they were purchased from the supply department of the Marine 
Biological Laboratories at Woods Hole, Massachussetts, or collected from 
either Great Bay, New Hampshire or from Raritan Bay, New Jersey. 
Horseshoe crabs were maintained on a diet of mussels in flow-through sea 
tables (ambient temperature) located at the Jackson Estuarine 
Laboratories, UNH. Several weeks prior to use, crabs were transferred to 
recirculating sea tables (10-15 °C) located at the Zoology Department, UNH. 
Adult horseshoe crabs of either sex (carapace width 15-25 cm) were used 
in this study.
Whelks (Busycon contrarium. 6-10 cm length) were purchased from 
Gulf Marine Specimens Co. (Panacea, Florida) and kept in recirculating sea 
tables (10-15 °C) at UNH. Whelks remained healthy for several months in 
this system. Cockroaches fPeriplaneta americana^ were purchased from 
Carolina Biological Supply Co. (Burlington, North Carolina) and maintained 
on a diet of cereal at room temperature (20-23 °C).
Dissections (Limulust
Limulus hearts were removed according to the method of Pax and
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Sanborn (1967). For each preparation, a section of the dorsal carapace was 
removed, and the heart with associated cardiac ganglion was excised from 
underlying tissues. The heart was placed in natural sea water (obtained 
from Portsmouth Harbor, New Hampshire) at room temperature and cleaned 
of adhering tissues.
Hearts were then either placed in perfusion chambers for 
pharmacological experiments or dissected further to yield the isolated 
cardiac ganglion and the deganglionated myocardium. The cardiac ganglion 
was removed by grasping its anterior end, severing the motor roots and 
teasing the ganglion away from the underlying muscle fibers. Cardiac 
ganglia were then placed in perfusion chambers for extracellular or 
intracellular recording, or used for biochemical experiments (see tissue 
incubation and extraction protpcol below).
The deganglionated myocardium was stripped of residual motor 
nerves and cut into 1-2 cm cardiac muscle rings, which were used either in 
pharmacological experiments examining muscle contractility or for 
biochemistry. The residual motor nerves were left attached to the 
myocardium in those experiments involving recordings from the 
neuromuscular junct;on.
Sources of Drugs
Pharmacolocical agents utilized in this study were obtained from the 
following sources:
1. Amines: dopamine, epinephrine, norepinephrine, octopamine (Sigma 
Chemical Co., St. Louis, Missouri).
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2. Peptides: proctolin, FMRFamide (Peninsula Laboratories, Belmont, 
California), Helix FMRFamide-like peptide pQDPFLRFamide (Bachem 
Laboratories, Torrence, California).
3. Cyclic nucleotide analogues: dibutyryl cAMP, dibutyryl cGMP, 8-bromo 
cAMP, 8-bromo cGMP (Sigma); 8-benzylthio cAMP, 8-parachloro phenylthio 
cAMP (ICN Pharmaceuticals, Irvine, California).
4. Phosphodiesterase inhibitors: 3-isobutyl 1-methyl xanthine, 
papaverine, theophylline (Sigma); RO-20-1724 (a gift from Hoffman 
LaRoche, Nutiey, New Jersey); SQ 20,009 (Squibb, Princeton, New Jersey).
5. Phorbol esters: phorbol 12,13 dibutyrate, phorbol 12-myristate 
13-acetate, 1-oleyl 2-acetyl sn-glycerol (Sigma).
6. Others: forskolin (Calbiochem, San Diego, California); phentolamine 
(CIBA-GEIGY, Summit, New Jersey).
Preparation and Storage of Drugs
Drug solutions were either made by mixing powder in seawater or by 
adding an aliquot of a stock drug solution to seawater and mixing. Carriers 
for stock solutions were: dH20  for peptides, 0.1 N acetic acid for amines,
95% alcohol for forskolin and dimethyl sulfoxide for RO-20-1724. All 
stocks were diluted £ 1000 times. Control experiments indicated that the
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equivalent carrier concentration did not affect the cardiac ganglion or 
cardiac muscle by itself.
Tissue incubation and extraction - cyclic nucleotides
Isolated cardiac ganglia or pieces of heart muscle (1 cm rings 
excised from the region between the 2 ^ 1 0  61*1 ostia) were placed in vials 
containing 5 ml (cardiac ganglia) or 10 ml (cardiac muscle) of seawater at 
room temperature. The vials were continuously shaken for 1 hour, at which 
time tests were initiated by the addition of drug solutions. The tissues 
were removed after incubation and homogenized in ice-cold 6% 
trichloroacetic acid (TCA). The homogenates were centrifuged (cardiac 
ganglia at 10,000 x g; cardiac muscle at 5,000 x g) for 30 min at 4 °C. The 
supernatants were extracted with four, 5 ml washes of diethyl ether, and 
the aqueous phases dried on a vacuum centrifuge (Savant Instr., Hicksville, 
New York) and stored at -20 °C until assay. The tissue pellet from each 
homogenate was boiled in 1N NaOH for determination of protein content 
(Lowry et al., 1951).
Radioimmunoassay for cyclic nucleotides
Levels of cAMP and cGMP in Limulus cardiac ganglia or cardiac 
muscle were determined by radioimmunoassay (RIA). Duplicate cAMP or 
cGMP standards (Sigma) and samples were diluted in 50 pL RIA buffer B 
(.05 M sodium acetate at pH 6.0, containing 0.1% gelatin and 0.1% sodium 
azide) and added to 10 x 75 mm incubation tubes. Tracer (10,000 cpm, 
125l-labeled cAMP or cGMP, Chemicon Inc., La Jolla, Cal.) in 100 pL buffer B
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containing 1% normal rabbit serum (NRS) was added, and the volume brought 
to 600 pL with buffer B. Cyclic AMP or cyclic GMP antibodies (Chemicon) 
were diluted (cAMP,1/400; cGMP, 1/200) in 100 pL buffer A (.02 M sodium 
phosphate at pH 7.4, containing 0.1% gelatin and 0.1% sodium azide) with 1% 
NRS and added to each tube, except blanks. All tubes were then vortexed 
and incubated for 1 hour at room temperature.
Separation of bound and free 125l was accomplished by adding 100 pL 
secondary anbtibody (25% goat anti-rabbit gamma globulin in buffer A with 
1 % NRS) to each tube. After 30 min, the tubes were centrifuged (1800 x g 
for 30 min at 4 °C) and the supernatants were decanted. The pellets were 
solubolized (100 pi Protosol and 30 pL glacial acetic acid), mixed with 1 
ml scintillation fluor, and counted (Beckman LS 7000).
Counts were converted to pmol cAMP or cGMP by linear regression of 
the working portion of the standard RIA curve. The zero standard cpm 
(35-50% of total cpm added) was used as the reference, or 100% bound. A 
series of dilutions from extracts of Limulus cardiac ganglia and cardiac 
muscle tissue displayed parallel inhibition of tracer binding as compared to 
standards, for either the cAMP or the cGMP RIA (Fig. 1). Both assays were 
sensitive to 0.1 pmol cyclic nucleotide. Neither cAMP or cGMP antibodies 
react with other cyclic nucleotides or cyclic nucleotide metabolic products 
(Chemicon).
Tissue extraction - peptides
Limulus tissues were excised, weighed and boiled for 10 min in 0.1 N 
acetic acid containing .01% thiodiglycol. Tissues were stored at -20 °C 
until they were homogenized. The supernatants were centrifuged at 12,000
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Fig. 1. Radioimmunoassay (RIA) for cyclic nucleotides in Limulus cardiac tissues. A. Cardiac 
ganglion and cardiac muscle TCA extracts displayed parallel binding affinity towards the cAMP 
antibody (1/400 dilution) in comparison to cAMP standards. B. Parallel inhibiton was also 
observed for these extracts in the RIA for cGMP (1/200 dilution).
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x g for 30 min at 0 °C. Peptide distribution measurements were performed 
on these supernatants. Further purification of selected tissues was 
initiated by re-extracting the dried supernatants with ice-cold TCA 
followed by centrifugation (12,000 x g for 30 min at 0 °C). The 
supernatants were further extracted with diethyl ether, and the aqueous 
phases were dried and stored at -20 °C until chromatographic purification 
techniques were applied.
Peptide assays
FMRFamide-like and procto I in-like activities in extracts of Limulus 
nervous tissue were determined by both RIA and bioassay. Assays were 
performed at each stage of the purification sequence to quantify the level 
of immunoreactive (iR-) and bioactive FMRFamide-like or proctolin-like 
material in each fraction and to concentrate active fractions.
FMRFamide RIA
All RIA constituents were made up in RIA buffer of the following 
composition: .05 M sodium phosphate containing 0.1% bovine serum albumin 
and .02% sodium azide, at pH 7.4. Samples or standards were added to glass 
10 x 75 mm incubatiuon tubes in 50 pL aliquots. Tracer consisted of 
125I-TMRF (iodinations performed by Hazelton and Meloy Laboratories, 
Springfield, Virginia): approximately 20,000 cpm in 100 pL buffer were 
added to each tube. Assay buffer was added to each tube to bring the 
volume to 1 ml and all tubes were vortexed. FMRFamide antibody was added 
to all tubes except blanks and totals (Ab 231 at 1/10,00 in RIA buffer). The
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FMRFamide antibody was kindly provided by Tom O'Donohue (NIH, Bethesda, 
Maryland). Details of its characterization can be found in O'Donohue et al. 
(1984 ). All tubes were vortexed and incubated at 4 °C for 24 to 36 hr. The 
separation protocol and calculation tecnique employed were identical to 
those utilized for the RIA of cyclic nucleotides, except for the buffer used.
This assay was sensitive to 5 to 10 pg of synthetic FMRFamide, and 
extracts o f Limulus brains or abdominal ganglia displayed parallel binding 
characteristics with FMRFamide (Fig. 2b).
Proctoiin RIA
The protocol for detection of proctolin in Limulus by RIA was similar 
to that fo r FMRFamide, utilizing proctolin antibody "E" (generously provided 
by Barbara Beltz, Harvard Medical School, Cambridge, Massachusetts). This 
antibody has been characterized previously (Schwarz, 1983). In this study, 
antibody "E" was prepared from frozen stock at a dilution of 1/5000 in RIA 
buffer, lodinated proctolin was obtained from Hazelton and diluted to yield 
20,000 cpm  in 100 p.L buffer. The proctolin RIA was sensitive to 10 pg of 
synthetic proctolin, and extracts of Limulus nervous tissue exhibited 
parallel inhibition of antibody / tracer binding in comparison to standard 
proctolin (Fig. 2a).
FMRFamide Bioassay
The radula protractor muscle (RPM) of the left-handed whelk 
(Busvcon contrariuml was used to determine FMRFamide-like bioactivity in 
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Fig. 2 . Radio im m unoassay (RIA) for peptides in extracts of L iO lu Ius tissues. A. Acetic ac id  
extracts  o f L im ulus brain and  ventral nerve cord inhibited b inding of 125l - proctolin to 
an tibody "E " (diluted 1/5000). Serial d ilu tions of tissue extracts d isp layed  parallel 
inh ib ition  w ith  proctolin  standards. B. In a sim ilar fashion, these extracts displaced 125l - 
TM R F am ide  from  antibody 231 (diluted 1/10,000).
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be found in Watson et al., 1984. The RPM was placed in a vertical 1 ml 
seawater perfusion chamber and the radula tied to a Grass Ft. 03 force 
transducer. Sustained contractures of this muscle could be elicited by 
addition of synthetic FMRFamide to the chamber by syringe. Samples were 
adjusted to pH 7.6 and added in the same fashion as standards. The assay 
was viable for many hours. Sensitivity of this preparation was 
approximately 1 ng/ml. The quantity of FMRFamide-like activity in 
extracts was calculated by linear regression. Comparison of the tension 
produced by the sample, to a standard curve of contracture tension elicited 
by doses of synthetic FMRFamide, allowed expression of sample activity in 
terms of pg FMRFamide equivalents (Fig 3).
Proctolin Bioassav
The cockroach (Periplaneta americana't hindgut preparation was used 
to screen Limulus extracts for proctolin-like bioactivity. The proctodeum 
and rectum of the cockroach were isolated and tied off at either end. The 
preparation was placed in the same type of recording chamber used for the 
Busycon RPM and perfused with aerated cockroach saline of the following 
composition: 140 mM NaCI, 5 mM KCI, 1 mM MgCI2, 5 mM CaCI2, 4 mM
NaHCOg, 5 mM Hepes buffer at pH 7.4 and containing 20 mM glucose and 2
mM trehalose sugars. Samples were adjusted to pH 7.4 and added in 1 ml 
aliquots by syringe in the same manner as for the RPM bioassay. Synthetic 
proctolin elicited both a sustained contracture and individual contractions 
of the hindgut at a threshold dose of approximately 3 ng/ml. Reproducible 
























Fig. 3. Busvcon radula protractor muscle bioassav. A. Standard and extract dilution curves 
for FMRFamide assay. FMRFamide-like activity in extracts was quantified by comparing the 
contracture tension produced by a given sample to the linear regression of the standard curve. 
B. Synthetic FMRFamide (5 ng) and an extract of Umulus brain (0.1 brain equiv. in 1 ml) 
elicited contracture of the Busycon RPM. Samples were added at the arrow and washed off 
after peak contracture was reached. Calibration: vertical. 150 mg: horizontal 2  min.
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Proctolin-like activity was measured by the degree of contracture produced 



























Fig. 4. Periplaneta hindgut bioassay for pfoctolin. A. Standard and extract dilution curves. 
The degree of hindgut contracture was used to quantify the amount of proctolin-like activity 
present in extracts. B. Application of either synthetic proctolin (10 ng in 1 ml) or an 
extract of Ltmulus brain (0.1 brain equiv. in 1 ml) caused a similar response in this 
preparation. Samples were added at the arrow and washed off after peak contracture was 
established. Calibration: vertical 250 mg; horizontal 2  min.
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